id	sid	tid	token	lemma	pos
ajrhss-1713	1	1	american	american	PROPN
ajrhss-1713	1	2	journal	journal	PROPN
ajrhss-1713	1	3	of	of	ADP
ajrhss-1713	1	4	research	research	NOUN
ajrhss-1713	1	5	in	in	ADP
ajrhss-1713	1	6	humanities	humanity	NOUN
ajrhss-1713	1	7	and	and	CCONJ
ajrhss-1713	1	8	social	social	ADJ
ajrhss-1713	1	9	sciences	science	NOUN
ajrhss-1713	1	10	issn	issn	PROPN
ajrhss-1713	1	11	(	(	PUNCT
ajrhss-1713	1	12	e	e	NOUN
ajrhss-1713	1	13	):	):	PUNCT
ajrhss-1713	1	14	2832	2832	NUM
ajrhss-1713	1	15	-	-	SYM
ajrhss-1713	1	16	8019	8019	NUM
ajrhss-1713	1	17	volume	volume	NOUN
ajrhss-1713	1	18	20	20	NUM
ajrhss-1713	1	19	,	,	PUNCT
ajrhss-1713	1	20	|	|	ADV
ajrhss-1713	1	21	january	january	PROPN
ajrhss-1713	1	22	,	,	PUNCT
ajrhss-1713	1	23	2024	2024	NUM
ajrhss-1713	1	24	p	p	NOUN
ajrhss-1713	1	25	a	a	DET
ajrhss-1713	1	26	g	g	NOUN
ajrhss-1713	1	27	e	e	NOUN
ajrhss-1713	1	28	|	|	ADV
ajrhss-1713	1	29	1	1	NUM
ajrhss-1713	1	30	www.americanjournal.org	www.americanjournal.org	NOUN
ajrhss-1713	1	31	features	feature	NOUN
ajrhss-1713	1	32	of	of	ADP
ajrhss-1713	1	33	the	the	DET
ajrhss-1713	1	34	blood	blood	NOUN
ajrhss-1713	1	35	hemostasis	hemostasis	NOUN
ajrhss-1713	1	36	system	system	NOUN
ajrhss-1713	1	37	in	in	ADP
ajrhss-1713	1	38	children	child	NOUN
ajrhss-1713	1	39	with	with	ADP
ajrhss-1713	1	40	chronic	chronic	ADJ
ajrhss-1713	1	41	pneumonia	pneumonia	NOUN
ajrhss-1713	1	42	sh	sh	PROPN
ajrhss-1713	1	43	.	.	PROPN
ajrhss-1713	1	44	m.	m.	PROPN
ajrhss-1713	1	45	ibatova	ibatova	PROPN
ajrhss-1713	1	46	,	,	PUNCT
ajrhss-1713	1	47	o.x	o.x	PROPN
ajrhss-1713	1	48	.	.	PROPN
ajrhss-1713	1	49	shakarboyeva	shakarboyeva	PROPN
ajrhss-1713	1	50	samarkand	samarkand	PROPN
ajrhss-1713	1	51	state	state	PROPN
ajrhss-1713	1	52	medical	medical	PROPN
ajrhss-1713	1	53	university	university	PROPN
ajrhss-1713	1	54	,	,	PUNCT
ajrhss-1713	1	55	republic	republic	NOUN
ajrhss-1713	1	56	of	of	ADP
ajrhss-1713	1	57	uzbekistan	uzbekistan	PROPN
ajrhss-1713	1	58	a	a	DET
ajrhss-1713	1	59	b	b	PROPN
ajrhss-1713	1	60	s	s	ADP
ajrhss-1713	1	61	t	t	PROPN
ajrhss-1713	1	62	r	r	NOUN
ajrhss-1713	1	63	a	a	DET
ajrhss-1713	1	64	c	c	NOUN
ajrhss-1713	1	65	t	t	NOUN
ajrhss-1713	1	66	k	k	X
ajrhss-1713	1	67	e	e	PROPN
ajrhss-1713	1	68	y	y	PROPN
ajrhss-1713	1	69	w	w	NOUN
ajrhss-1713	2	1	o	o	NOUN
ajrhss-1713	2	2	r	r	NOUN
ajrhss-1713	2	3	d	d	X
ajrhss-1713	2	4	s	s	VERB
ajrhss-1713	2	5	we	we	PRON
ajrhss-1713	2	6	examined	examine	VERB
ajrhss-1713	2	7	100	100	NUM
ajrhss-1713	2	8	children	child	NOUN
ajrhss-1713	2	9	with	with	ADP
ajrhss-1713	2	10	chronic	chronic	ADJ
ajrhss-1713	2	11	pneumonia	pneumonia	NOUN
ajrhss-1713	2	12	,	,	PUNCT
ajrhss-1713	2	13	who	who	PRON
ajrhss-1713	2	14	were	be	AUX
ajrhss-1713	2	15	divided	divide	VERB
ajrhss-1713	2	16	into	into	ADP
ajrhss-1713	2	17	two	two	NUM
ajrhss-1713	2	18	groups	group	NOUN
ajrhss-1713	2	19	:	:	PUNCT
ajrhss-1713	2	20	group	group	NOUN
ajrhss-1713	2	21	i	i	PRON
ajrhss-1713	2	22	consisted	consist	VERB
ajrhss-1713	2	23	of	of	ADP
ajrhss-1713	2	24	30	30	NUM
ajrhss-1713	2	25	patients	patient	NOUN
ajrhss-1713	2	26	aged	age	VERB
ajrhss-1713	2	27	12	12	NUM
ajrhss-1713	2	28	-	-	SYM
ajrhss-1713	2	29	14	14	NUM
ajrhss-1713	2	30	years	year	NOUN
ajrhss-1713	2	31	(	(	PUNCT
ajrhss-1713	2	32	with	with	ADP
ajrhss-1713	2	33	bronchial	bronchial	ADJ
ajrhss-1713	2	34	deformation	deformation	NOUN
ajrhss-1713	2	35	24	24	NUM
ajrhss-1713	2	36	patients	patient	NOUN
ajrhss-1713	2	37	;	;	PUNCT
ajrhss-1713	2	38	with	with	ADP
ajrhss-1713	2	39	bronchiectasis	bronchiectasis	NOUN
ajrhss-1713	2	40	6	6	NUM
ajrhss-1713	2	41	)	)	PUNCT
ajrhss-1713	2	42	,	,	PUNCT
ajrhss-1713	2	43	group	group	NOUN
ajrhss-1713	2	44	ii	ii	PROPN
ajrhss-1713	2	45	70	70	NUM
ajrhss-1713	2	46	patients	patient	NOUN
ajrhss-1713	2	47	aged	age	VERB
ajrhss-1713	2	48	15	15	NUM
ajrhss-1713	2	49	15	15	NUM
ajrhss-1713	2	50	years	year	NOUN
ajrhss-1713	2	51	.	.	PUNCT
ajrhss-1713	3	1	16	16	NUM
ajrhss-1713	3	2	years	year	NOUN
ajrhss-1713	3	3	(	(	PUNCT
ajrhss-1713	3	4	with	with	ADP
ajrhss-1713	3	5	bronchial	bronchial	ADJ
ajrhss-1713	3	6	deformation	deformation	NOUN
ajrhss-1713	3	7	46	46	NUM
ajrhss-1713	3	8	patients	patient	NOUN
ajrhss-1713	3	9	;	;	PUNCT
ajrhss-1713	3	10	with	with	ADP
ajrhss-1713	3	11	bronchiectasis	bronchiectasis	NOUN
ajrhss-1713	3	12	24	24	NUM
ajrhss-1713	3	13	)	)	PUNCT
ajrhss-1713	3	14	.	.	PUNCT
ajrhss-1713	4	1	an	an	DET
ajrhss-1713	4	2	analysis	analysis	NOUN
ajrhss-1713	4	3	of	of	ADP
ajrhss-1713	4	4	the	the	DET
ajrhss-1713	4	5	indicators	indicator	NOUN
ajrhss-1713	4	6	of	of	ADP
ajrhss-1713	4	7	the	the	DET
ajrhss-1713	4	8	blood	blood	NOUN
ajrhss-1713	4	9	hemostasis	hemostasis	NOUN
ajrhss-1713	4	10	system	system	NOUN
ajrhss-1713	4	11	in	in	ADP
ajrhss-1713	4	12	patients	patient	NOUN
ajrhss-1713	4	13	with	with	ADP
ajrhss-1713	4	14	chronic	chronic	ADJ
ajrhss-1713	4	15	pneumonia	pneumonia	NOUN
ajrhss-1713	4	16	was	be	AUX
ajrhss-1713	4	17	carried	carry	VERB
ajrhss-1713	4	18	out	out	ADP
ajrhss-1713	4	19	.	.	PUNCT
ajrhss-1713	5	1	the	the	DET
ajrhss-1713	5	2	presented	present	VERB
ajrhss-1713	5	3	data	datum	NOUN
ajrhss-1713	5	4	emphasize	emphasize	VERB
ajrhss-1713	5	5	the	the	DET
ajrhss-1713	5	6	significant	significant	ADJ
ajrhss-1713	5	7	pathogenetic	pathogenetic	ADJ
ajrhss-1713	5	8	significance	significance	NOUN
ajrhss-1713	5	9	of	of	ADP
ajrhss-1713	5	10	changes	change	NOUN
ajrhss-1713	5	11	in	in	ADP
ajrhss-1713	5	12	hemostasis	hemostasis	NOUN
ajrhss-1713	5	13	in	in	ADP
ajrhss-1713	5	14	patients	patient	NOUN
ajrhss-1713	5	15	with	with	ADP
ajrhss-1713	5	16	chronic	chronic	ADJ
ajrhss-1713	5	17	pneumonia	pneumonia	NOUN
ajrhss-1713	5	18	,	,	PUNCT
ajrhss-1713	5	19	which	which	PRON
ajrhss-1713	5	20	requires	require	VERB
ajrhss-1713	5	21	the	the	DET
ajrhss-1713	5	22	search	search	NOUN
ajrhss-1713	5	23	for	for	ADP
ajrhss-1713	5	24	new	new	ADJ
ajrhss-1713	5	25	methods	method	NOUN
ajrhss-1713	5	26	of	of	ADP
ajrhss-1713	5	27	pathogenetic	pathogenetic	ADJ
ajrhss-1713	5	28	therapy	therapy	NOUN
ajrhss-1713	5	29	based	base	VERB
ajrhss-1713	5	30	on	on	ADP
ajrhss-1713	5	31	anticoagulant	anticoagulant	ADJ
ajrhss-1713	5	32	effects	effect	NOUN
ajrhss-1713	5	33	.	.	PUNCT
ajrhss-1713	6	1	chronic	chronic	ADJ
ajrhss-1713	6	2	pneumonia	pneumonia	NOUN
ajrhss-1713	6	3	,	,	PUNCT
ajrhss-1713	6	4	patients	patient	NOUN
ajrhss-1713	6	5	,	,	PUNCT
ajrhss-1713	6	6	blood	blood	NOUN
ajrhss-1713	6	7	,	,	PUNCT
ajrhss-1713	6	8	hemostasis	hemostasis	NOUN
ajrhss-1713	6	9	,	,	PUNCT
ajrhss-1713	6	10	indicators	indicator	NOUN
ajrhss-1713	6	11	,	,	PUNCT
ajrhss-1713	6	12	shifts	shift	NOUN
ajrhss-1713	6	13	.	.	PUNCT
ajrhss-1713	7	1	introduction	introduction	NOUN
ajrhss-1713	7	2	the	the	DET
ajrhss-1713	7	3	lungs	lung	NOUN
ajrhss-1713	7	4	play	play	VERB
ajrhss-1713	7	5	a	a	DET
ajrhss-1713	7	6	significant	significant	ADJ
ajrhss-1713	7	7	role	role	NOUN
ajrhss-1713	7	8	in	in	ADP
ajrhss-1713	7	9	maintaining	maintain	VERB
ajrhss-1713	7	10	the	the	DET
ajrhss-1713	7	11	physiological	physiological	ADJ
ajrhss-1713	7	12	balance	balance	NOUN
ajrhss-1713	7	13	of	of	ADP
ajrhss-1713	7	14	the	the	DET
ajrhss-1713	7	15	coagulation	coagulation	NOUN
ajrhss-1713	7	16	,	,	PUNCT
ajrhss-1713	7	17	fibrinolytic	fibrinolytic	ADJ
ajrhss-1713	7	18	system	system	NOUN
ajrhss-1713	7	19	and	and	CCONJ
ajrhss-1713	7	20	in	in	ADP
ajrhss-1713	7	21	the	the	DET
ajrhss-1713	7	22	regulation	regulation	NOUN
ajrhss-1713	7	23	of	of	ADP
ajrhss-1713	7	24	hemostasis	hemostasis	NOUN
ajrhss-1713	8	1	[	[	X
ajrhss-1713	8	2	3,4,6,11	3,4,6,11	NOUN
ajrhss-1713	8	3	]	]	PUNCT
ajrhss-1713	8	4	.	.	PUNCT
ajrhss-1713	9	1	thus	thus	ADV
ajrhss-1713	9	2	,	,	PUNCT
ajrhss-1713	9	3	the	the	DET
ajrhss-1713	9	4	lungs	lung	NOUN
ajrhss-1713	9	5	are	be	AUX
ajrhss-1713	9	6	the	the	DET
ajrhss-1713	9	7	site	site	NOUN
ajrhss-1713	9	8	of	of	ADP
ajrhss-1713	9	9	fibrinolysis	fibrinolysis	NOUN
ajrhss-1713	9	10	,	,	PUNCT
ajrhss-1713	9	11	the	the	DET
ajrhss-1713	9	12	richest	rich	ADJ
ajrhss-1713	9	13	source	source	NOUN
ajrhss-1713	9	14	of	of	ADP
ajrhss-1713	9	15	heparin	heparin	NOUN
ajrhss-1713	9	16	.	.	PUNCT
ajrhss-1713	10	1	in	in	ADP
ajrhss-1713	10	2	addition	addition	NOUN
ajrhss-1713	10	3	,	,	PUNCT
ajrhss-1713	10	4	in	in	ADP
ajrhss-1713	10	5	the	the	DET
ajrhss-1713	10	6	reticuloendothelial	reticuloendothelial	ADJ
ajrhss-1713	10	7	cells	cell	NOUN
ajrhss-1713	10	8	of	of	ADP
ajrhss-1713	10	9	the	the	DET
ajrhss-1713	10	10	connective	connective	ADJ
ajrhss-1713	10	11	tissue	tissue	NOUN
ajrhss-1713	10	12	of	of	ADP
ajrhss-1713	10	13	the	the	DET
ajrhss-1713	10	14	lungs	lung	NOUN
ajrhss-1713	10	15	,	,	PUNCT
ajrhss-1713	10	16	the	the	DET
ajrhss-1713	10	17	possibility	possibility	NOUN
ajrhss-1713	10	18	of	of	ADP
ajrhss-1713	10	19	synthesizing	synthesize	VERB
ajrhss-1713	10	20	fibrinogen	fibrinogen	NOUN
ajrhss-1713	10	21	,	,	PUNCT
ajrhss-1713	10	22	prothrombin	prothrombin	NOUN
ajrhss-1713	10	23	,	,	PUNCT
ajrhss-1713	10	24	tissue	tissue	NOUN
ajrhss-1713	10	25	thromboplastin	thromboplastin	NOUN
ajrhss-1713	10	26	and	and	CCONJ
ajrhss-1713	10	27	ac	ac	PROPN
ajrhss-1713	10	28	globulin	globulin	NOUN
ajrhss-1713	10	29	is	be	AUX
ajrhss-1713	10	30	allowed	allow	VERB
ajrhss-1713	10	31	[	[	PUNCT
ajrhss-1713	10	32	8,10	8,10	NUM
ajrhss-1713	10	33	]	]	PUNCT
ajrhss-1713	10	34	.	.	PUNCT
ajrhss-1713	11	1	naturally	naturally	ADV
ajrhss-1713	11	2	,	,	PUNCT
ajrhss-1713	11	3	the	the	DET
ajrhss-1713	11	4	inflammatory	inflammatory	ADJ
ajrhss-1713	11	5	process	process	NOUN
ajrhss-1713	11	6	in	in	ADP
ajrhss-1713	11	7	the	the	DET
ajrhss-1713	11	8	lungs	lung	NOUN
ajrhss-1713	11	9	can	can	AUX
ajrhss-1713	11	10	be	be	AUX
ajrhss-1713	11	11	accompanied	accompany	VERB
ajrhss-1713	11	12	by	by	ADP
ajrhss-1713	11	13	changes	change	NOUN
ajrhss-1713	11	14	in	in	ADP
ajrhss-1713	11	15	the	the	DET
ajrhss-1713	11	16	blood	blood	NOUN
ajrhss-1713	11	17	coagulation	coagulation	NOUN
ajrhss-1713	11	18	system	system	NOUN
ajrhss-1713	11	19	.	.	PUNCT
ajrhss-1713	12	1	of	of	ADP
ajrhss-1713	12	2	particular	particular	ADJ
ajrhss-1713	12	3	interest	interest	NOUN
ajrhss-1713	12	4	are	be	AUX
ajrhss-1713	12	5	these	these	DET
ajrhss-1713	12	6	changes	change	NOUN
ajrhss-1713	12	7	in	in	ADP
ajrhss-1713	12	8	chronic	chronic	ADJ
ajrhss-1713	12	9	lung	lung	NOUN
ajrhss-1713	12	10	pathology	pathology	NOUN
ajrhss-1713	12	11	in	in	ADP
ajrhss-1713	12	12	children	child	NOUN
ajrhss-1713	12	13	,	,	PUNCT
ajrhss-1713	12	14	when	when	SCONJ
ajrhss-1713	12	15	emerging	emerge	VERB
ajrhss-1713	12	16	hemocoagulation	hemocoagulation	NOUN
ajrhss-1713	12	17	disorders	disorder	NOUN
ajrhss-1713	12	18	can	can	AUX
ajrhss-1713	12	19	aggravate	aggravate	VERB
ajrhss-1713	12	20	hypoxia	hypoxia	NOUN
ajrhss-1713	12	21	and	and	CCONJ
ajrhss-1713	12	22	determine	determine	VERB
ajrhss-1713	12	23	the	the	DET
ajrhss-1713	12	24	course	course	NOUN
ajrhss-1713	12	25	and	and	CCONJ
ajrhss-1713	12	26	prognosis	prognosis	NOUN
ajrhss-1713	12	27	of	of	ADP
ajrhss-1713	12	28	the	the	DET
ajrhss-1713	12	29	disease	disease	NOUN
ajrhss-1713	12	30	[	[	X
ajrhss-1713	12	31	1,2,5,7,9	1,2,5,7,9	X
ajrhss-1713	12	32	]	]	PUNCT
ajrhss-1713	12	33	.	.	PUNCT
ajrhss-1713	13	1	violation	violation	NOUN
ajrhss-1713	13	2	in	in	ADP
ajrhss-1713	13	3	the	the	DET
ajrhss-1713	13	4	hemostasis	hemostasis	NOUN
ajrhss-1713	13	5	system	system	NOUN
ajrhss-1713	13	6	in	in	ADP
ajrhss-1713	13	7	chronic	chronic	ADJ
ajrhss-1713	13	8	lung	lung	NOUN
ajrhss-1713	13	9	pathology	pathology	NOUN
ajrhss-1713	13	10	determines	determine	VERB
ajrhss-1713	13	11	the	the	DET
ajrhss-1713	13	12	severity	severity	NOUN
ajrhss-1713	13	13	of	of	ADP
ajrhss-1713	13	14	the	the	DET
ajrhss-1713	13	15	disease	disease	NOUN
ajrhss-1713	13	16	,	,	PUNCT
ajrhss-1713	13	17	the	the	DET
ajrhss-1713	13	18	presence	presence	NOUN
ajrhss-1713	13	19	of	of	ADP
ajrhss-1713	13	20	an	an	DET
ajrhss-1713	13	21	exacerbation	exacerbation	NOUN
ajrhss-1713	13	22	,	,	PUNCT
ajrhss-1713	13	23	the	the	DET
ajrhss-1713	13	24	degree	degree	NOUN
ajrhss-1713	13	25	of	of	ADP
ajrhss-1713	13	26	pulmonary	pulmonary	ADJ
ajrhss-1713	13	27	heart	heart	NOUN
ajrhss-1713	13	28	failure	failure	NOUN
ajrhss-1713	13	29	,	,	PUNCT
ajrhss-1713	13	30	so	so	ADV
ajrhss-1713	13	31	monitoring	monitor	VERB
ajrhss-1713	13	32	this	this	DET
ajrhss-1713	13	33	system	system	NOUN
ajrhss-1713	13	34	is	be	AUX
ajrhss-1713	13	35	important	important	ADJ
ajrhss-1713	13	36	.	.	PUNCT
ajrhss-1713	14	1	purpose	purpose	NOUN
ajrhss-1713	14	2	of	of	ADP
ajrhss-1713	14	3	the	the	DET
ajrhss-1713	14	4	study	study	NOUN
ajrhss-1713	14	5	to	to	PART
ajrhss-1713	14	6	analyze	analyze	VERB
ajrhss-1713	14	7	the	the	DET
ajrhss-1713	14	8	parameters	parameter	NOUN
ajrhss-1713	14	9	of	of	ADP
ajrhss-1713	14	10	the	the	DET
ajrhss-1713	14	11	blood	blood	NOUN
ajrhss-1713	14	12	hemostasis	hemostasis	NOUN
ajrhss-1713	14	13	system	system	NOUN
ajrhss-1713	14	14	in	in	ADP
ajrhss-1713	14	15	children	child	NOUN
ajrhss-1713	14	16	with	with	ADP
ajrhss-1713	14	17	chronic	chronic	ADJ
ajrhss-1713	14	18	pneumonia	pneumonia	NOUN
ajrhss-1713	14	19	.	.	PUNCT
ajrhss-1713	15	1	materials	material	NOUN
ajrhss-1713	15	2	and	and	CCONJ
ajrhss-1713	15	3	methods	method	NOUN
ajrhss-1713	15	4	of	of	ADP
ajrhss-1713	15	5	research	research	NOUN
ajrhss-1713	15	6	100	100	NUM
ajrhss-1713	15	7	patients	patient	NOUN
ajrhss-1713	15	8	with	with	ADP
ajrhss-1713	15	9	chronic	chronic	ADJ
ajrhss-1713	15	10	pneumonia	pneumonia	NOUN
ajrhss-1713	15	11	were	be	AUX
ajrhss-1713	15	12	examined	examine	VERB
ajrhss-1713	15	13	,	,	PUNCT
ajrhss-1713	15	14	who	who	PRON
ajrhss-1713	15	15	were	be	AUX
ajrhss-1713	15	16	divided	divide	VERB
ajrhss-1713	15	17	into	into	ADP
ajrhss-1713	15	18	two	two	NUM
ajrhss-1713	15	19	groups	group	NOUN
ajrhss-1713	15	20	:	:	PUNCT
ajrhss-1713	15	21	group	group	NOUN
ajrhss-1713	15	22	i	i	PRON
ajrhss-1713	15	23	consisted	consist	VERB
ajrhss-1713	15	24	of	of	ADP
ajrhss-1713	15	25	30	30	NUM
ajrhss-1713	15	26	patients	patient	NOUN
ajrhss-1713	15	27	aged	age	VERB
ajrhss-1713	15	28	12	12	NUM
ajrhss-1713	15	29	-	-	SYM
ajrhss-1713	15	30	14	14	NUM
ajrhss-1713	15	31	years	year	NOUN
ajrhss-1713	15	32	(	(	PUNCT
ajrhss-1713	15	33	with	with	ADP
ajrhss-1713	15	34	bronchial	bronchial	ADJ
ajrhss-1713	15	35	deformation	deformation	NOUN
ajrhss-1713	15	36	24	24	NUM
ajrhss-1713	15	37	patients	patient	NOUN
ajrhss-1713	15	38	;	;	PUNCT
ajrhss-1713	15	39	with	with	ADP
ajrhss-1713	15	40	bronchiectasis	bronchiectasis	NOUN
ajrhss-1713	15	41	american	american	PROPN
ajrhss-1713	15	42	journal	journal	PROPN
ajrhss-1713	15	43	of	of	ADP
ajrhss-1713	15	44	research	research	NOUN
ajrhss-1713	15	45	in	in	ADP
ajrhss-1713	15	46	humanities	humanity	NOUN
ajrhss-1713	15	47	and	and	CCONJ
ajrhss-1713	15	48	social	social	ADJ
ajrhss-1713	15	49	sciences	science	NOUN
ajrhss-1713	15	50	volume	volume	NOUN
ajrhss-1713	15	51	20	20	NUM
ajrhss-1713	15	52	january	january	PROPN
ajrhss-1713	15	53	,	,	PUNCT
ajrhss-1713	15	54	2024	2024	NUM
ajrhss-1713	15	55	p	p	NOUN
ajrhss-1713	15	56	a	a	DET
ajrhss-1713	15	57	g	g	NOUN
ajrhss-1713	15	58	e	e	NOUN
ajrhss-1713	15	59	|	|	ADV
ajrhss-1713	15	60	2	2	NUM
ajrhss-1713	15	61	www.americanjournal.org	www.americanjournal.org	NOUN
ajrhss-1713	15	62	6	6	NUM
ajrhss-1713	15	63	)	)	PUNCT
ajrhss-1713	15	64	,	,	PUNCT
ajrhss-1713	15	65	group	group	NOUN
ajrhss-1713	15	66	ii	ii	PROPN
ajrhss-1713	15	67	70	70	NUM
ajrhss-1713	15	68	patients	patient	NOUN
ajrhss-1713	15	69	aged	age	VERB
ajrhss-1713	15	70	15	15	NUM
ajrhss-1713	15	71	years	year	NOUN
ajrhss-1713	15	72	.	.	PUNCT
ajrhss-1713	16	1	and	and	CCONJ
ajrhss-1713	16	2	older	old	ADJ
ajrhss-1713	16	3	-16	-16	ADJ
ajrhss-1713	16	4	years	year	NOUN
ajrhss-1713	16	5	(	(	PUNCT
ajrhss-1713	16	6	with	with	ADP
ajrhss-1713	16	7	bronchial	bronchial	ADJ
ajrhss-1713	16	8	deformation	deformation	NOUN
ajrhss-1713	16	9	46	46	NUM
ajrhss-1713	16	10	patients	patient	NOUN
ajrhss-1713	16	11	;	;	PUNCT
ajrhss-1713	16	12	with	with	ADP
ajrhss-1713	16	13	bronchiectasis	bronchiectasis	NOUN
ajrhss-1713	16	14	24	24	NUM
ajrhss-1713	16	15	)	)	PUNCT
ajrhss-1713	16	16	.	.	PUNCT
ajrhss-1713	17	1	recalcification	recalcification	NOUN
ajrhss-1713	17	2	time	time	NOUN
ajrhss-1713	17	3	according	accord	VERB
ajrhss-1713	17	4	to	to	ADP
ajrhss-1713	17	5	the	the	DET
ajrhss-1713	17	6	method	method	NOUN
ajrhss-1713	17	7	of	of	ADP
ajrhss-1713	17	8	k.	k.	PROPN
ajrhss-1713	17	9	bergerhoff	bergerhoff	PROPN
ajrhss-1713	17	10	and	and	CCONJ
ajrhss-1713	17	11	rock	rock	NOUN
ajrhss-1713	17	12	.	.	PUNCT
ajrhss-1713	18	1	determination	determination	NOUN
ajrhss-1713	18	2	of	of	ADP
ajrhss-1713	18	3	prothrombin	prothrombin	ADJ
ajrhss-1713	18	4	time	time	NOUN
ajrhss-1713	18	5	using	use	VERB
ajrhss-1713	18	6	the	the	DET
ajrhss-1713	18	7	method	method	NOUN
ajrhss-1713	18	8	of	of	ADP
ajrhss-1713	18	9	a.l	a.l	PROPN
ajrhss-1713	18	10	.	.	PROPN
ajrhss-1713	18	11	quick	quick	ADJ
ajrhss-1713	18	12	;	;	PUNCT
ajrhss-1713	18	13	plasma	plasma	NOUN
ajrhss-1713	18	14	fibrinogen	fibrinogen	NOUN
ajrhss-1713	18	15	concentration	concentration	NOUN
ajrhss-1713	18	16	was	be	AUX
ajrhss-1713	18	17	determined	determine	VERB
ajrhss-1713	18	18	by	by	ADP
ajrhss-1713	18	19	the	the	DET
ajrhss-1713	18	20	gravimetric	gravimetric	ADJ
ajrhss-1713	18	21	method	method	NOUN
ajrhss-1713	18	22	of	of	ADP
ajrhss-1713	18	23	r.a	r.a	PROPN
ajrhss-1713	18	24	.	.	PROPN
ajrhss-1713	18	25	rutberg	rutberg	PROPN
ajrhss-1713	18	26	;	;	PUNCT
ajrhss-1713	18	27	free	free	ADJ
ajrhss-1713	18	28	heparin	heparin	ADJ
ajrhss-1713	18	29	level	level	NOUN
ajrhss-1713	18	30	according	accord	VERB
ajrhss-1713	18	31	to	to	ADP
ajrhss-1713	18	32	e.	e.	PROPN
ajrhss-1713	18	33	simrey	simrey	PROPN
ajrhss-1713	18	34	's	's	PART
ajrhss-1713	18	35	method	method	NOUN
ajrhss-1713	18	36	.	.	PUNCT
ajrhss-1713	19	1	ethanol	ethanol	NOUN
ajrhss-1713	19	2	test	test	NOUN
ajrhss-1713	19	3	according	accord	VERB
ajrhss-1713	19	4	to	to	ADP
ajrhss-1713	19	5	v.g	v.g	PROPN
ajrhss-1713	19	6	.	.	PROPN
ajrhss-1713	19	7	lychev	lychev	PROPN
ajrhss-1713	19	8	;	;	PUNCT
ajrhss-1713	19	9	lipinski	lipinski	PROPN
ajrhss-1713	19	10	protamine	protamine	PROPN
ajrhss-1713	19	11	sulfate	sulfate	PROPN
ajrhss-1713	19	12	test	test	NOUN
ajrhss-1713	19	13	;	;	PUNCT
ajrhss-1713	19	14	fibrinolytic	fibrinolytic	ADJ
ajrhss-1713	19	15	activity	activity	NOUN
ajrhss-1713	19	16	according	accord	VERB
ajrhss-1713	19	17	to	to	ADP
ajrhss-1713	19	18	the	the	DET
ajrhss-1713	19	19	method	method	NOUN
ajrhss-1713	19	20	of	of	ADP
ajrhss-1713	19	21	m.a	m.a	PROPN
ajrhss-1713	19	22	.	.	PROPN
ajrhss-1713	19	23	kotovshchikova	kotovshchikova	PROPN
ajrhss-1713	19	24	and	and	CCONJ
ajrhss-1713	19	25	b.i	b.i	PROPN
ajrhss-1713	19	26	.	.	PROPN
ajrhss-1713	19	27	kuznik	kuznik	PROPN
ajrhss-1713	19	28	.	.	PUNCT
ajrhss-1713	20	1	plasma	plasma	NOUN
ajrhss-1713	20	2	tolerance	tolerance	NOUN
ajrhss-1713	20	3	to	to	ADP
ajrhss-1713	20	4	heparin	heparin	NOUN
ajrhss-1713	20	5	according	accord	VERB
ajrhss-1713	20	6	to	to	ADP
ajrhss-1713	20	7	l.	l.	PROPN
ajrhss-1713	20	8	poller	poller	PROPN
ajrhss-1713	20	9	’s	’s	PART
ajrhss-1713	20	10	method	method	NOUN
ajrhss-1713	20	11	.	.	PUNCT
ajrhss-1713	21	1	results	result	NOUN
ajrhss-1713	21	2	of	of	ADP
ajrhss-1713	21	3	the	the	DET
ajrhss-1713	21	4	study	study	NOUN
ajrhss-1713	21	5	and	and	CCONJ
ajrhss-1713	21	6	their	their	PRON
ajrhss-1713	21	7	discussion	discussion	NOUN
ajrhss-1713	21	8	studies	study	NOUN
ajrhss-1713	21	9	of	of	ADP
ajrhss-1713	21	10	the	the	DET
ajrhss-1713	21	11	indicators	indicator	NOUN
ajrhss-1713	21	12	of	of	ADP
ajrhss-1713	21	13	the	the	DET
ajrhss-1713	21	14	hemostasis	hemostasis	NOUN
ajrhss-1713	21	15	system	system	NOUN
ajrhss-1713	21	16	were	be	AUX
ajrhss-1713	21	17	carried	carry	VERB
ajrhss-1713	21	18	out	out	ADP
ajrhss-1713	21	19	for	for	ADP
ajrhss-1713	21	20	the	the	DET
ajrhss-1713	21	21	first	first	ADJ
ajrhss-1713	21	22	time	time	NOUN
ajrhss-1713	21	23	on	on	ADP
ajrhss-1713	21	24	the	the	DET
ajrhss-1713	21	25	days	day	NOUN
ajrhss-1713	21	26	of	of	ADP
ajrhss-1713	21	27	admission	admission	NOUN
ajrhss-1713	21	28	to	to	ADP
ajrhss-1713	21	29	the	the	DET
ajrhss-1713	21	30	clinic	clinic	NOUN
ajrhss-1713	21	31	in	in	ADP
ajrhss-1713	21	32	the	the	DET
ajrhss-1713	21	33	acute	acute	ADJ
ajrhss-1713	21	34	phase	phase	NOUN
ajrhss-1713	21	35	,	,	PUNCT
ajrhss-1713	21	36	against	against	ADP
ajrhss-1713	21	37	the	the	DET
ajrhss-1713	21	38	background	background	NOUN
ajrhss-1713	21	39	of	of	ADP
ajrhss-1713	21	40	heparin	heparin	ADJ
ajrhss-1713	21	41	therapy	therapy	NOUN
ajrhss-1713	21	42	(	(	PUNCT
ajrhss-1713	21	43	7	7	NUM
ajrhss-1713	21	44	-	-	SYM
ajrhss-1713	21	45	8	8	NUM
ajrhss-1713	21	46	days	day	NOUN
ajrhss-1713	21	47	of	of	ADP
ajrhss-1713	21	48	treatment	treatment	NOUN
ajrhss-1713	21	49	)	)	PUNCT
ajrhss-1713	21	50	,	,	PUNCT
ajrhss-1713	21	51	and	and	CCONJ
ajrhss-1713	21	52	after	after	ADP
ajrhss-1713	21	53	the	the	DET
ajrhss-1713	21	54	treatment	treatment	NOUN
ajrhss-1713	21	55	before	before	ADP
ajrhss-1713	21	56	discharge	discharge	NOUN
ajrhss-1713	21	57	.	.	PUNCT
ajrhss-1713	22	1	the	the	DET
ajrhss-1713	22	2	results	result	NOUN
ajrhss-1713	22	3	of	of	ADP
ajrhss-1713	22	4	the	the	DET
ajrhss-1713	22	5	study	study	NOUN
ajrhss-1713	22	6	of	of	ADP
ajrhss-1713	22	7	the	the	DET
ajrhss-1713	22	8	coagulation	coagulation	NOUN
ajrhss-1713	22	9	system	system	NOUN
ajrhss-1713	22	10	are	be	AUX
ajrhss-1713	22	11	presented	present	VERB
ajrhss-1713	22	12	in	in	ADP
ajrhss-1713	22	13	table	table	NOUN
ajrhss-1713	22	14	1	1	NUM
ajrhss-1713	22	15	.	.	PUNCT
ajrhss-1713	22	16	table	table	NOUN
ajrhss-1713	22	17	1	1	NUM
ajrhss-1713	22	18	.	.	PUNCT
ajrhss-1713	23	1	changes	change	NOUN
ajrhss-1713	23	2	in	in	ADP
ajrhss-1713	23	3	hemostasis	hemostasis	NOUN
ajrhss-1713	23	4	parameters	parameter	NOUN
ajrhss-1713	23	5	in	in	ADP
ajrhss-1713	23	6	chronic	chronic	ADJ
ajrhss-1713	23	7	pneumonia	pneumonia	NOUN
ajrhss-1713	23	8	in	in	ADP
ajrhss-1713	23	9	children	child	NOUN
ajrhss-1713	23	10	upon	upon	SCONJ
ajrhss-1713	23	11	admission	admission	NOUN
ajrhss-1713	23	12	in	in	ADP
ajrhss-1713	23	13	the	the	DET
ajrhss-1713	23	14	acute	acute	ADJ
ajrhss-1713	23	15	phase	phase	NOUN
ajrhss-1713	23	16	(	(	PUNCT
ajrhss-1713	23	17	m±m	m±m	NOUN
ajrhss-1713	23	18	)	)	PUNCT
ajrhss-1713	23	19	№	№	NOUN
ajrhss-1713	23	20	indicators	indicator	NOUN
ajrhss-1713	23	21	healthy	healthy	ADJ
ajrhss-1713	23	22	children	child	NOUN
ajrhss-1713	23	23	children	child	NOUN
ajrhss-1713	23	24	with	with	ADP
ajrhss-1713	23	25	chronic	chronic	ADJ
ajrhss-1713	23	26	obstructive	obstructive	ADJ
ajrhss-1713	23	27	pulmonary	pulmonary	ADJ
ajrhss-1713	23	28	disease	disease	NOUN
ajrhss-1713	23	29	3	3	NUM
ajrhss-1713	23	30	-	-	SYM
ajrhss-1713	23	31	7	7	NUM
ajrhss-1713	23	32	years	year	NOUN
ajrhss-1713	23	33	8	8	NUM
ajrhss-1713	23	34	-	-	SYM
ajrhss-1713	23	35	15	15	NUM
ajrhss-1713	23	36	years	year	NOUN
ajrhss-1713	23	37	3	3	NUM
ajrhss-1713	23	38	-	-	SYM
ajrhss-1713	23	39	7	7	NUM
ajrhss-1713	23	40	years	year	NOUN
ajrhss-1713	23	41	n=30	n=30	ADP
ajrhss-1713	23	42	8	8	NUM
ajrhss-1713	23	43	-	-	SYM
ajrhss-1713	23	44	15	15	NUM
ajrhss-1713	23	45	years	year	NOUN
ajrhss-1713	23	46	n=70	n=70	ADJ
ajrhss-1713	23	47	1	1	NUM
ajrhss-1713	23	48	.	.	PUNCT
ajrhss-1713	23	49	plasma	plasma	NOUN
ajrhss-1713	23	50	recalcification	recalcification	NOUN
ajrhss-1713	23	51	time	time	NOUN
ajrhss-1713	23	52	(	(	PUNCT
ajrhss-1713	23	53	sec	sec	PROPN
ajrhss-1713	23	54	)	)	PUNCT
ajrhss-1713	23	55	90,1±6,8	90,1±6,8	NUM
ajrhss-1713	23	56	90,6±7,8	90,6±7,8	NUM
ajrhss-1713	23	57	78,2±5,4	78,2±5,4	NUM
ajrhss-1713	23	58	р<0,05	р<0,05	ADV
ajrhss-1713	23	59	74,6±4,7	74,6±4,7	NUM
ajrhss-1713	23	60	р<0,05	р<0,05	ADV
ajrhss-1713	23	61	2	2	NUM
ajrhss-1713	23	62	.	.	PUNCT
ajrhss-1713	23	63	plasma	plasma	NOUN
ajrhss-1713	23	64	tolerance	tolerance	NOUN
ajrhss-1713	23	65	to	to	ADP
ajrhss-1713	23	66	heparin	heparin	ADJ
ajrhss-1713	23	67	(	(	PUNCT
ajrhss-1713	23	68	min	min	NOUN
ajrhss-1713	23	69	)	)	PUNCT
ajrhss-1713	23	70	8,74±0,69	8,74±0,69	NOUN
ajrhss-1713	23	71	9,38±0,79	9,38±0,79	NOUN
ajrhss-1713	24	1	6,94±0,44	6,94±0,44	NUM
ajrhss-1713	24	2	р<0,05	р<0,05	ADV
ajrhss-1713	24	3	6,45±0,76	6,45±0,76	NUM
ajrhss-1713	24	4	р<0,001	р<0,001	PROPN
ajrhss-1713	25	1	3	3	X
ajrhss-1713	25	2	.	.	PUNCT
ajrhss-1713	25	3	free	free	ADJ
ajrhss-1713	25	4	heparin	heparin	NOUN
ajrhss-1713	25	5	in	in	ADP
ajrhss-1713	25	6	blood	blood	NOUN
ajrhss-1713	25	7	plasma	plasma	NOUN
ajrhss-1713	25	8	(	(	PUNCT
ajrhss-1713	25	9	sec	sec	PROPN
ajrhss-1713	25	10	)	)	PUNCT
ajrhss-1713	25	11	6,4±0,54	6,4±0,54	NUM
ajrhss-1713	25	12	7,1±1,12	7,1±1,12	NUM
ajrhss-1713	25	13	4,2±0,5	4,2±0,5	NUM
ajrhss-1713	25	14	р<0,02	р<0,02	ADP
ajrhss-1713	25	15	3,8±0,52	3,8±0,52	NUM
ajrhss-1713	25	16	р<0,001	р<0,001	PROPN
ajrhss-1713	25	17	4	4	X
ajrhss-1713	25	18	.	.	PUNCT
ajrhss-1713	25	19	plasma	plasma	NOUN
ajrhss-1713	25	20	fibrinogen	fibrinogen	NOUN
ajrhss-1713	25	21	(	(	PUNCT
ajrhss-1713	25	22	g	g	NOUN
ajrhss-1713	25	23	/	/	SYM
ajrhss-1713	25	24	l	l	NOUN
ajrhss-1713	25	25	)	)	PUNCT
ajrhss-1713	25	26	2,94±0,12	2,94±0,12	PROPN
ajrhss-1713	25	27	2,69±0,2	2,69±0,2	NUM
ajrhss-1713	25	28	4,81±0,6	4,81±0,6	NUM
ajrhss-1713	25	29	р<0,001	р<0,001	X
ajrhss-1713	26	1	5,1±0,47	5,1±0,47	NUM
ajrhss-1713	26	2	р<0,001	р<0,001	NOUN
ajrhss-1713	26	3	5	5	X
ajrhss-1713	26	4	.	.	X
ajrhss-1713	26	5	pdf	pdf	NOUN
ajrhss-1713	26	6	(	(	PUNCT
ajrhss-1713	26	7	g	g	NOUN
ajrhss-1713	26	8	/	/	SYM
ajrhss-1713	26	9	l	l	NOUN
ajrhss-1713	26	10	)	)	PUNCT
ajrhss-1713	26	11	2,8±0,9	2,8±0,9	NUM
ajrhss-1713	26	12	2,91±0,92	2,91±0,92	NUM
ajrhss-1713	26	13	3,4±0,76	3,4±0,76	NUM
ajrhss-1713	27	1	р>0,05	р>0,05	NUM
ajrhss-1713	27	2	6,7±0,96	6,7±0,96	NUM
ajrhss-1713	27	3	р<0,05	р<0,05	ADV
ajrhss-1713	27	4	6	6	NUM
ajrhss-1713	27	5	.	.	PUNCT
ajrhss-1713	27	6	ethanol	ethanol	NOUN
ajrhss-1713	27	7	sample	sample	NOUN
ajrhss-1713	27	8	negative	negative	ADJ
ajrhss-1713	27	9	negative	negative	ADJ
ajrhss-1713	27	10	13,3	13,3	NUM
ajrhss-1713	27	11	%	%	NOUN
ajrhss-1713	27	12	positive	positive	ADJ
ajrhss-1713	27	13	20	20	NUM
ajrhss-1713	27	14	%	%	NOUN
ajrhss-1713	27	15	positive	positive	ADJ
ajrhss-1713	27	16	7	7	NUM
ajrhss-1713	27	17	.	.	PUNCT
ajrhss-1713	27	18	protamine	protamine	PROPN
ajrhss-1713	27	19	sulfate	sulfate	PROPN
ajrhss-1713	27	20	test	test	NOUN
ajrhss-1713	27	21	negative	negative	ADJ
ajrhss-1713	27	22	negative	negative	ADJ
ajrhss-1713	27	23	10	10	NUM
ajrhss-1713	27	24	%	%	NOUN
ajrhss-1713	27	25	positive	positive	ADJ
ajrhss-1713	27	26	25,7	25,7	NOUN
ajrhss-1713	27	27	%	%	NOUN
ajrhss-1713	27	28	positive	positive	ADJ
ajrhss-1713	27	29	8	8	NUM
ajrhss-1713	27	30	.	.	PUNCT
ajrhss-1713	27	31	prothrombin	prothrombin	PROPN
ajrhss-1713	27	32	index	index	NOUN
ajrhss-1713	27	33	(	(	PUNCT
ajrhss-1713	27	34	%	%	INTJ
ajrhss-1713	27	35	)	)	PUNCT
ajrhss-1713	27	36	94,5±0,44	94,5±0,44	NUM
ajrhss-1713	28	1	96,0±0,76	96,0±0,76	NUM
ajrhss-1713	29	1	94,8±1,2	94,8±1,2	NUM
ajrhss-1713	29	2	р>0,1	р>0,1	ADV
ajrhss-1713	29	3	99,88±1,02	99,88±1,02	NUM
ajrhss-1713	29	4	р<0,05	р<0,05	ADV
ajrhss-1713	29	5	9	9	NUM
ajrhss-1713	29	6	.	.	PUNCT
ajrhss-1713	30	1	platelets	platelet	NOUN
ajrhss-1713	30	2	(	(	PUNCT
ajrhss-1713	30	3	1	1	NUM
ajrhss-1713	30	4	µl)109	µl)109	VERB
ajrhss-1713	30	5	/l	/l	PUNCT
ajrhss-1713	30	6	239.0	239.0	NUM
ajrhss-1713	30	7	±13,6	±13,6	PROPN
ajrhss-1713	30	8	268±9,76	268±9,76	NUM
ajrhss-1713	30	9	288,2±17,5	288,2±17,5	NUM
ajrhss-1713	30	10	р<0,05	р<0,05	ADV
ajrhss-1713	30	11	300±22,0	300±22,0	NUM
ajrhss-1713	30	12	р<0,05	р<0,05	ADV
ajrhss-1713	30	13	10	10	NUM
ajrhss-1713	30	14	fibrinolytic	fibrinolytic	ADJ
ajrhss-1713	30	15	activity	activity	NOUN
ajrhss-1713	30	16	(	(	PUNCT
ajrhss-1713	30	17	%	%	NOUN
ajrhss-1713	30	18	)	)	PUNCT
ajrhss-1713	30	19	10,2±0,91	10,2±0,91	NUM
ajrhss-1713	30	20	10,7±0,94	10,7±0,94	NUM
ajrhss-1713	30	21	7,71±0,92	7,71±0,92	NOUN
ajrhss-1713	30	22	р<0,05	р<0,05	NOUN
ajrhss-1713	30	23	6,23±0,74	6,23±0,74	NUM
ajrhss-1713	30	24	р<0,001	р<0,001	PROPN
ajrhss-1713	30	25	note	note	NOUN
ajrhss-1713	30	26	:	:	PUNCT
ajrhss-1713	30	27	preliability	preliability	NOUN
ajrhss-1713	30	28	of	of	ADP
ajrhss-1713	30	29	the	the	DET
ajrhss-1713	30	30	difference	difference	NOUN
ajrhss-1713	30	31	between	between	ADP
ajrhss-1713	30	32	the	the	DET
ajrhss-1713	30	33	indicators	indicator	NOUN
ajrhss-1713	30	34	of	of	ADP
ajrhss-1713	30	35	healthy	healthy	ADJ
ajrhss-1713	30	36	and	and	CCONJ
ajrhss-1713	30	37	sick	sick	ADJ
ajrhss-1713	30	38	children	child	NOUN
ajrhss-1713	30	39	as	as	SCONJ
ajrhss-1713	30	40	can	can	AUX
ajrhss-1713	30	41	be	be	AUX
ajrhss-1713	30	42	seen	see	VERB
ajrhss-1713	30	43	from	from	ADP
ajrhss-1713	30	44	table	table	NOUN
ajrhss-1713	30	45	1	1	NUM
ajrhss-1713	30	46	,	,	PUNCT
ajrhss-1713	30	47	during	during	ADP
ajrhss-1713	30	48	the	the	DET
ajrhss-1713	30	49	period	period	NOUN
ajrhss-1713	30	50	of	of	ADP
ajrhss-1713	30	51	exacerbation	exacerbation	NOUN
ajrhss-1713	30	52	of	of	ADP
ajrhss-1713	30	53	chronic	chronic	ADJ
ajrhss-1713	30	54	pneumonia	pneumonia	NOUN
ajrhss-1713	30	55	in	in	ADP
ajrhss-1713	30	56	the	the	DET
ajrhss-1713	30	57	examined	examine	VERB
ajrhss-1713	30	58	children	child	NOUN
ajrhss-1713	30	59	of	of	ADP
ajrhss-1713	30	60	all	all	DET
ajrhss-1713	30	61	age	age	NOUN
ajrhss-1713	30	62	groups	group	NOUN
ajrhss-1713	30	63	,	,	PUNCT
ajrhss-1713	30	64	the	the	DET
ajrhss-1713	30	65	average	average	ADJ
ajrhss-1713	30	66	value	value	NOUN
ajrhss-1713	30	67	of	of	ADP
ajrhss-1713	30	68	recalcification	recalcification	NOUN
ajrhss-1713	30	69	time	time	NOUN
ajrhss-1713	30	70	compared	compare	VERB
ajrhss-1713	30	71	with	with	ADP
ajrhss-1713	30	72	similar	similar	ADJ
ajrhss-1713	30	73	indicators	indicator	NOUN
ajrhss-1713	30	74	in	in	ADP
ajrhss-1713	30	75	healthy	healthy	ADJ
ajrhss-1713	30	76	children	child	NOUN
ajrhss-1713	30	77	was	be	AUX
ajrhss-1713	30	78	accelerated	accelerate	VERB
ajrhss-1713	30	79	78.2±5.4	78.2±5.4	NUM
ajrhss-1713	30	80	74.6±4.7	74.6±4.7	NUM
ajrhss-1713	30	81	(	(	PUNCT
ajrhss-1713	30	82	p	p	X
ajrhss-1713	30	83	<	<	X
ajrhss-1713	30	84	0.05	0.05	NUM
ajrhss-1713	30	85	)	)	PUNCT
ajrhss-1713	30	86	,	,	PUNCT
ajrhss-1713	30	87	which	which	PRON
ajrhss-1713	30	88	indicates	indicate	VERB
ajrhss-1713	30	89	an	an	DET
ajrhss-1713	30	90	increase	increase	NOUN
ajrhss-1713	30	91	in	in	ADP
ajrhss-1713	30	92	overall	overall	ADJ
ajrhss-1713	30	93	blood	blood	NOUN
ajrhss-1713	30	94	clotting	clotting	NOUN
ajrhss-1713	30	95	.	.	PUNCT
ajrhss-1713	31	1	american	american	ADJ
ajrhss-1713	31	2	journal	journal	PROPN
ajrhss-1713	31	3	of	of	ADP
ajrhss-1713	31	4	research	research	NOUN
ajrhss-1713	31	5	in	in	ADP
ajrhss-1713	31	6	humanities	humanity	NOUN
ajrhss-1713	31	7	and	and	CCONJ
ajrhss-1713	31	8	social	social	ADJ
ajrhss-1713	31	9	sciences	science	NOUN
ajrhss-1713	31	10	volume	volume	NOUN
ajrhss-1713	31	11	20	20	NUM
ajrhss-1713	31	12	january	january	PROPN
ajrhss-1713	31	13	,	,	PUNCT
ajrhss-1713	31	14	2024	2024	NUM
ajrhss-1713	31	15	p	p	NOUN
ajrhss-1713	31	16	a	a	PRON
ajrhss-1713	31	17	g	g	NOUN
ajrhss-1713	31	18	e	e	NOUN
ajrhss-1713	32	1	|	|	ADV
ajrhss-1713	32	2	3	3	NUM
ajrhss-1713	32	3	www.americanjournal.org	www.americanjournal.org	NOUN
ajrhss-1713	32	4	it	it	PRON
ajrhss-1713	32	5	was	be	AUX
ajrhss-1713	32	6	found	find	VERB
ajrhss-1713	32	7	that	that	SCONJ
ajrhss-1713	32	8	in	in	ADP
ajrhss-1713	32	9	children	child	NOUN
ajrhss-1713	32	10	with	with	ADP
ajrhss-1713	32	11	bronchiectasis	bronchiectasis	NOUN
ajrhss-1713	32	12	there	there	PRON
ajrhss-1713	32	13	was	be	VERB
ajrhss-1713	32	14	an	an	DET
ajrhss-1713	32	15	even	even	ADV
ajrhss-1713	32	16	greater	great	ADJ
ajrhss-1713	32	17	reduction	reduction	NOUN
ajrhss-1713	32	18	in	in	ADP
ajrhss-1713	32	19	the	the	DET
ajrhss-1713	32	20	time	time	NOUN
ajrhss-1713	32	21	of	of	ADP
ajrhss-1713	32	22	recalcification	recalcification	NOUN
ajrhss-1713	32	23	of	of	ADP
ajrhss-1713	32	24	blood	blood	NOUN
ajrhss-1713	32	25	plasma	plasma	NOUN
ajrhss-1713	32	26	compared	compare	VERB
ajrhss-1713	32	27	to	to	ADP
ajrhss-1713	32	28	the	the	DET
ajrhss-1713	32	29	group	group	NOUN
ajrhss-1713	32	30	of	of	ADP
ajrhss-1713	32	31	healthy	healthy	ADJ
ajrhss-1713	32	32	children	child	NOUN
ajrhss-1713	32	33	and	and	CCONJ
ajrhss-1713	32	34	averaged	average	VERB
ajrhss-1713	32	35	76.04±4.68	76.04±4.68	NUM
ajrhss-1713	32	36	seconds	second	NOUN
ajrhss-1713	32	37	.	.	PUNCT
ajrhss-1713	33	1	(	(	PUNCT
ajrhss-1713	33	2	p<0.001	p<0.001	PROPN
ajrhss-1713	33	3	)	)	PUNCT
ajrhss-1713	33	4	,	,	PUNCT
ajrhss-1713	33	5	and	and	CCONJ
ajrhss-1713	33	6	in	in	ADP
ajrhss-1713	33	7	children	child	NOUN
ajrhss-1713	33	8	with	with	ADP
ajrhss-1713	33	9	bronchial	bronchial	ADJ
ajrhss-1713	33	10	deformation	deformation	NOUN
ajrhss-1713	33	11	without	without	ADP
ajrhss-1713	33	12	their	their	PRON
ajrhss-1713	33	13	expansion	expansion	NOUN
ajrhss-1713	33	14	79.14±3.46	79.14±3.46	DET
ajrhss-1713	33	15	sec	sec	PROPN
ajrhss-1713	33	16	.	.	PUNCT
ajrhss-1713	34	1	(	(	PUNCT
ajrhss-1713	34	2	p>0.1	p>0.1	NOUN
ajrhss-1713	34	3	)	)	PUNCT
ajrhss-1713	34	4	.	.	PUNCT
ajrhss-1713	35	1	the	the	DET
ajrhss-1713	35	2	most	most	ADV
ajrhss-1713	35	3	significant	significant	ADJ
ajrhss-1713	35	4	acceleration	acceleration	NOUN
ajrhss-1713	35	5	in	in	ADP
ajrhss-1713	35	6	the	the	DET
ajrhss-1713	35	7	time	time	NOUN
ajrhss-1713	35	8	of	of	ADP
ajrhss-1713	35	9	recalcification	recalcification	NOUN
ajrhss-1713	35	10	was	be	AUX
ajrhss-1713	35	11	observed	observe	VERB
ajrhss-1713	35	12	in	in	ADP
ajrhss-1713	35	13	children	child	NOUN
ajrhss-1713	35	14	with	with	ADP
ajrhss-1713	35	15	a	a	DET
ajrhss-1713	35	16	serious	serious	ADJ
ajrhss-1713	35	17	condition	condition	NOUN
ajrhss-1713	35	18	during	during	ADP
ajrhss-1713	35	19	complications	complication	NOUN
ajrhss-1713	35	20	.	.	PUNCT
ajrhss-1713	36	1	as	as	SCONJ
ajrhss-1713	36	2	can	can	AUX
ajrhss-1713	36	3	be	be	AUX
ajrhss-1713	36	4	seen	see	VERB
ajrhss-1713	36	5	from	from	ADP
ajrhss-1713	36	6	table	table	NOUN
ajrhss-1713	36	7	1	1	NUM
ajrhss-1713	36	8	,	,	PUNCT
ajrhss-1713	36	9	during	during	ADP
ajrhss-1713	36	10	the	the	DET
ajrhss-1713	36	11	period	period	NOUN
ajrhss-1713	36	12	of	of	ADP
ajrhss-1713	36	13	exacerbation	exacerbation	NOUN
ajrhss-1713	36	14	of	of	ADP
ajrhss-1713	36	15	chronic	chronic	ADJ
ajrhss-1713	36	16	pneumonia	pneumonia	NOUN
ajrhss-1713	36	17	in	in	ADP
ajrhss-1713	36	18	the	the	DET
ajrhss-1713	36	19	examined	examine	VERB
ajrhss-1713	36	20	children	child	NOUN
ajrhss-1713	36	21	in	in	ADP
ajrhss-1713	36	22	all	all	DET
ajrhss-1713	36	23	age	age	NOUN
ajrhss-1713	36	24	groups	group	NOUN
ajrhss-1713	36	25	,	,	PUNCT
ajrhss-1713	36	26	the	the	DET
ajrhss-1713	36	27	average	average	ADJ
ajrhss-1713	36	28	value	value	NOUN
ajrhss-1713	36	29	of	of	ADP
ajrhss-1713	36	30	the	the	DET
ajrhss-1713	36	31	time	time	NOUN
ajrhss-1713	36	32	of	of	ADP
ajrhss-1713	36	33	recalcification	recalcification	NOUN
ajrhss-1713	36	34	in	in	ADP
ajrhss-1713	36	35	comparison	comparison	NOUN
ajrhss-1713	36	36	with	with	ADP
ajrhss-1713	36	37	similar	similar	ADJ
ajrhss-1713	36	38	indicators	indicator	NOUN
ajrhss-1713	36	39	in	in	ADP
ajrhss-1713	36	40	healthy	healthy	ADJ
ajrhss-1713	36	41	children	child	NOUN
ajrhss-1713	36	42	was	be	AUX
ajrhss-1713	36	43	accelerated	accelerate	VERB
ajrhss-1713	36	44	78.2	78.2	NUM
ajrhss-1713	36	45	±	±	NUM
ajrhss-1713	36	46	5	5	NUM
ajrhss-1713	36	47	.	.	NOUN
ajrhss-1713	36	48	4	4	NUM
ajrhss-1713	36	49	74.6±4.7	74.6±4.7	NUM
ajrhss-1713	36	50	(	(	PUNCT
ajrhss-1713	36	51	p<0.05	p<0.05	NOUN
ajrhss-1713	36	52	)	)	PUNCT
ajrhss-1713	36	53	,	,	PUNCT
ajrhss-1713	36	54	which	which	PRON
ajrhss-1713	36	55	indicates	indicate	VERB
ajrhss-1713	36	56	an	an	DET
ajrhss-1713	36	57	increase	increase	NOUN
ajrhss-1713	36	58	in	in	ADP
ajrhss-1713	36	59	the	the	DET
ajrhss-1713	36	60	overall	overall	ADJ
ajrhss-1713	36	61	blood	blood	NOUN
ajrhss-1713	36	62	clotting	clotting	NOUN
ajrhss-1713	36	63	ability	ability	NOUN
ajrhss-1713	36	64	.	.	PUNCT
ajrhss-1713	37	1	when	when	SCONJ
ajrhss-1713	37	2	studying	study	VERB
ajrhss-1713	37	3	the	the	DET
ajrhss-1713	37	4	timing	timing	NOUN
ajrhss-1713	37	5	of	of	ADP
ajrhss-1713	37	6	recalcification	recalcification	NOUN
ajrhss-1713	37	7	of	of	ADP
ajrhss-1713	37	8	blood	blood	NOUN
ajrhss-1713	37	9	plasma	plasma	NOUN
ajrhss-1713	37	10	depending	depend	VERB
ajrhss-1713	37	11	on	on	ADP
ajrhss-1713	37	12	the	the	DET
ajrhss-1713	37	13	form	form	NOUN
ajrhss-1713	37	14	of	of	ADP
ajrhss-1713	37	15	chronic	chronic	ADJ
ajrhss-1713	37	16	pneumonia	pneumonia	NOUN
ajrhss-1713	37	17	,	,	PUNCT
ajrhss-1713	37	18	fig	fig	NOUN
ajrhss-1713	37	19	.	.	PUNCT
ajrhss-1713	38	1	1	1	X
ajrhss-1713	38	2	.	.	X
ajrhss-1713	39	1	it	it	PRON
ajrhss-1713	39	2	was	be	AUX
ajrhss-1713	39	3	found	find	VERB
ajrhss-1713	39	4	that	that	SCONJ
ajrhss-1713	39	5	in	in	ADP
ajrhss-1713	39	6	children	child	NOUN
ajrhss-1713	39	7	with	with	ADP
ajrhss-1713	39	8	bronchiectasis	bronchiectasis	NOUN
ajrhss-1713	39	9	there	there	PRON
ajrhss-1713	39	10	was	be	VERB
ajrhss-1713	39	11	an	an	DET
ajrhss-1713	39	12	even	even	ADV
ajrhss-1713	39	13	greater	great	ADJ
ajrhss-1713	39	14	reduction	reduction	NOUN
ajrhss-1713	39	15	in	in	ADP
ajrhss-1713	39	16	the	the	DET
ajrhss-1713	39	17	time	time	NOUN
ajrhss-1713	39	18	of	of	ADP
ajrhss-1713	39	19	recalcification	recalcification	NOUN
ajrhss-1713	39	20	of	of	ADP
ajrhss-1713	39	21	blood	blood	NOUN
ajrhss-1713	39	22	plasma	plasma	NOUN
ajrhss-1713	39	23	compared	compare	VERB
ajrhss-1713	39	24	to	to	ADP
ajrhss-1713	39	25	the	the	DET
ajrhss-1713	39	26	group	group	NOUN
ajrhss-1713	39	27	of	of	ADP
ajrhss-1713	39	28	healthy	healthy	ADJ
ajrhss-1713	39	29	children	child	NOUN
ajrhss-1713	39	30	and	and	CCONJ
ajrhss-1713	39	31	averaged	average	VERB
ajrhss-1713	39	32	76.04±4.68	76.04±4.68	NUM
ajrhss-1713	39	33	seconds	second	NOUN
ajrhss-1713	39	34	.	.	PUNCT
ajrhss-1713	40	1	(	(	PUNCT
ajrhss-1713	40	2	p<0.001	p<0.001	PROPN
ajrhss-1713	40	3	)	)	PUNCT
ajrhss-1713	40	4	,	,	PUNCT
ajrhss-1713	40	5	and	and	CCONJ
ajrhss-1713	40	6	in	in	ADP
ajrhss-1713	40	7	children	child	NOUN
ajrhss-1713	40	8	with	with	ADP
ajrhss-1713	40	9	bronchial	bronchial	ADJ
ajrhss-1713	40	10	deformation	deformation	NOUN
ajrhss-1713	40	11	without	without	ADP
ajrhss-1713	40	12	their	their	PRON
ajrhss-1713	40	13	expansion	expansion	NOUN
ajrhss-1713	40	14	79.14±3.46	79.14±3.46	DET
ajrhss-1713	40	15	sec	sec	PROPN
ajrhss-1713	40	16	.	.	PUNCT
ajrhss-1713	41	1	(	(	PUNCT
ajrhss-1713	41	2	p>0.1	p>0.1	NOUN
ajrhss-1713	41	3	)	)	PUNCT
ajrhss-1713	41	4	.	.	PUNCT
ajrhss-1713	42	1	the	the	DET
ajrhss-1713	42	2	most	most	ADV
ajrhss-1713	42	3	significant	significant	ADJ
ajrhss-1713	42	4	acceleration	acceleration	NOUN
ajrhss-1713	42	5	in	in	ADP
ajrhss-1713	42	6	the	the	DET
ajrhss-1713	42	7	timing	timing	NOUN
ajrhss-1713	42	8	of	of	ADP
ajrhss-1713	42	9	recalcification	recalcification	NOUN
ajrhss-1713	42	10	was	be	AUX
ajrhss-1713	42	11	observed	observe	VERB
ajrhss-1713	42	12	in	in	ADP
ajrhss-1713	42	13	children	child	NOUN
ajrhss-1713	42	14	with	with	ADP
ajrhss-1713	42	15	a	a	DET
ajrhss-1713	42	16	serious	serious	ADJ
ajrhss-1713	42	17	condition	condition	NOUN
ajrhss-1713	42	18	when	when	SCONJ
ajrhss-1713	42	19	chronic	chronic	ADJ
ajrhss-1713	42	20	pneumonia	pneumonia	NOUN
ajrhss-1713	42	21	was	be	AUX
ajrhss-1713	42	22	complicated	complicate	VERB
ajrhss-1713	42	23	by	by	ADP
ajrhss-1713	42	24	pulmonary	pulmonary	ADJ
ajrhss-1713	42	25	heart	heart	NOUN
ajrhss-1713	42	26	failure	failure	NOUN
ajrhss-1713	42	27	or	or	CCONJ
ajrhss-1713	42	28	the	the	DET
ajrhss-1713	42	29	addition	addition	NOUN
ajrhss-1713	42	30	of	of	ADP
ajrhss-1713	42	31	circulatory	circulatory	ADJ
ajrhss-1713	42	32	failure	failure	NOUN
ajrhss-1713	42	33	.	.	PUNCT
ajrhss-1713	43	1	on	on	ADP
ajrhss-1713	43	2	average	average	ADJ
ajrhss-1713	43	3	,	,	PUNCT
ajrhss-1713	43	4	it	it	PRON
ajrhss-1713	43	5	was	be	AUX
ajrhss-1713	43	6	70.4±3.4	70.4±3.4	NUM
ajrhss-1713	43	7	seconds	second	NOUN
ajrhss-1713	43	8	,	,	PUNCT
ajrhss-1713	43	9	which	which	PRON
ajrhss-1713	43	10	was	be	AUX
ajrhss-1713	43	11	significantly	significantly	ADV
ajrhss-1713	43	12	(	(	PUNCT
ajrhss-1713	43	13	p<0.05	p<0.05	NOUN
ajrhss-1713	43	14	)	)	PUNCT
ajrhss-1713	43	15	higher	high	ADJ
ajrhss-1713	43	16	than	than	ADP
ajrhss-1713	43	17	in	in	ADP
ajrhss-1713	43	18	patients	patient	NOUN
ajrhss-1713	43	19	with	with	ADP
ajrhss-1713	43	20	an	an	DET
ajrhss-1713	43	21	average	average	ADJ
ajrhss-1713	43	22	severity	severity	NOUN
ajrhss-1713	43	23	of	of	ADP
ajrhss-1713	43	24	the	the	DET
ajrhss-1713	43	25	disease	disease	NOUN
ajrhss-1713	43	26	of	of	ADP
ajrhss-1713	43	27	82.68±5.4	82.68±5.4	NUM
ajrhss-1713	43	28	.	.	PUNCT
ajrhss-1713	44	1	according	accord	VERB
ajrhss-1713	44	2	to	to	ADP
ajrhss-1713	44	3	the	the	DET
ajrhss-1713	44	4	bergerhoff	bergerhoff	NOUN
ajrhss-1713	44	5	-	-	PUNCT
ajrhss-1713	44	6	rock	rock	NOUN
ajrhss-1713	44	7	test	test	NOUN
ajrhss-1713	44	8	,	,	PUNCT
ajrhss-1713	44	9	it	it	PRON
ajrhss-1713	44	10	can	can	AUX
ajrhss-1713	44	11	be	be	AUX
ajrhss-1713	44	12	noted	note	VERB
ajrhss-1713	44	13	that	that	SCONJ
ajrhss-1713	44	14	in	in	ADP
ajrhss-1713	44	15	patients	patient	NOUN
ajrhss-1713	44	16	with	with	ADP
ajrhss-1713	44	17	chronic	chronic	ADJ
ajrhss-1713	44	18	obstructive	obstructive	ADJ
ajrhss-1713	44	19	pulmonary	pulmonary	ADJ
ajrhss-1713	44	20	disease	disease	NOUN
ajrhss-1713	44	21	,	,	PUNCT
ajrhss-1713	44	22	shifts	shift	NOUN
ajrhss-1713	44	23	towards	towards	ADP
ajrhss-1713	44	24	hypercoagulation	hypercoagulation	NOUN
ajrhss-1713	44	25	are	be	AUX
ajrhss-1713	44	26	observed	observe	VERB
ajrhss-1713	44	27	,	,	PUNCT
ajrhss-1713	44	28	and	and	CCONJ
ajrhss-1713	44	29	the	the	DET
ajrhss-1713	44	30	severity	severity	NOUN
ajrhss-1713	44	31	of	of	ADP
ajrhss-1713	44	32	these	these	DET
ajrhss-1713	44	33	shifts	shift	NOUN
ajrhss-1713	44	34	depends	depend	VERB
ajrhss-1713	44	35	both	both	PRON
ajrhss-1713	44	36	on	on	ADP
ajrhss-1713	44	37	the	the	DET
ajrhss-1713	44	38	activity	activity	NOUN
ajrhss-1713	44	39	of	of	ADP
ajrhss-1713	44	40	the	the	DET
ajrhss-1713	44	41	inflammatory	inflammatory	ADJ
ajrhss-1713	44	42	process	process	NOUN
ajrhss-1713	44	43	in	in	ADP
ajrhss-1713	44	44	the	the	DET
ajrhss-1713	44	45	bronchopulmonary	bronchopulmonary	ADJ
ajrhss-1713	44	46	system	system	NOUN
ajrhss-1713	44	47	and	and	CCONJ
ajrhss-1713	44	48	on	on	ADP
ajrhss-1713	44	49	the	the	DET
ajrhss-1713	44	50	severity	severity	NOUN
ajrhss-1713	44	51	and	and	CCONJ
ajrhss-1713	44	52	duration	duration	NOUN
ajrhss-1713	44	53	of	of	ADP
ajrhss-1713	44	54	the	the	DET
ajrhss-1713	44	55	disease	disease	NOUN
ajrhss-1713	44	56	.	.	PUNCT
ajrhss-1713	45	1	data	datum	NOUN
ajrhss-1713	45	2	on	on	ADP
ajrhss-1713	45	3	the	the	DET
ajrhss-1713	45	4	content	content	NOUN
ajrhss-1713	45	5	of	of	ADP
ajrhss-1713	45	6	free	free	ADJ
ajrhss-1713	45	7	heparin	heparin	NOUN
ajrhss-1713	45	8	in	in	ADP
ajrhss-1713	45	9	blood	blood	NOUN
ajrhss-1713	45	10	plasma	plasma	NOUN
ajrhss-1713	45	11	in	in	ADP
ajrhss-1713	45	12	patients	patient	NOUN
ajrhss-1713	45	13	with	with	ADP
ajrhss-1713	45	14	chronic	chronic	ADJ
ajrhss-1713	45	15	pneumonia	pneumonia	NOUN
ajrhss-1713	45	16	showed	show	VERB
ajrhss-1713	45	17	significant	significant	ADJ
ajrhss-1713	45	18	changes	change	NOUN
ajrhss-1713	45	19	.	.	PUNCT
ajrhss-1713	46	1	thus	thus	ADV
ajrhss-1713	46	2	,	,	PUNCT
ajrhss-1713	46	3	in	in	ADP
ajrhss-1713	46	4	the	the	DET
ajrhss-1713	46	5	phase	phase	NOUN
ajrhss-1713	46	6	of	of	ADP
ajrhss-1713	46	7	exacerbation	exacerbation	NOUN
ajrhss-1713	46	8	of	of	ADP
ajrhss-1713	46	9	the	the	DET
ajrhss-1713	46	10	disease	disease	NOUN
ajrhss-1713	46	11	,	,	PUNCT
ajrhss-1713	46	12	a	a	DET
ajrhss-1713	46	13	sharp	sharp	ADJ
ajrhss-1713	46	14	(	(	PUNCT
ajrhss-1713	46	15	p<0.001	p<0.001	NOUN
ajrhss-1713	46	16	)	)	PUNCT
ajrhss-1713	46	17	decrease	decrease	NOUN
ajrhss-1713	46	18	in	in	ADP
ajrhss-1713	46	19	the	the	DET
ajrhss-1713	46	20	level	level	NOUN
ajrhss-1713	46	21	of	of	ADP
ajrhss-1713	46	22	free	free	ADJ
ajrhss-1713	46	23	heparin	heparin	NOUN
ajrhss-1713	46	24	was	be	AUX
ajrhss-1713	46	25	observed	observe	VERB
ajrhss-1713	46	26	in	in	ADP
ajrhss-1713	46	27	all	all	DET
ajrhss-1713	46	28	age	age	NOUN
ajrhss-1713	46	29	groups	group	NOUN
ajrhss-1713	46	30	to	to	ADP
ajrhss-1713	46	31	an	an	DET
ajrhss-1713	46	32	average	average	NOUN
ajrhss-1713	46	33	of	of	ADP
ajrhss-1713	46	34	4.2±0.5	4.2±0.5	NUM
ajrhss-1713	46	35	seconds	second	NOUN
ajrhss-1713	46	36	;	;	PUNCT
ajrhss-1713	46	37	3.8±0.52	3.8±0.52	NUM
ajrhss-1713	46	38	,	,	PUNCT
ajrhss-1713	46	39	normal	normal	ADJ
ajrhss-1713	46	40	,	,	PUNCT
ajrhss-1713	46	41	respectively	respectively	ADV
ajrhss-1713	46	42	6.4±0.54	6.4±0.54	NUM
ajrhss-1713	46	43	;	;	PUNCT
ajrhss-1713	46	44	7.1±1.12	7.1±1.12	NUM
ajrhss-1713	46	45	seconds	second	NOUN
ajrhss-1713	46	46	.	.	PUNCT
ajrhss-1713	47	1	taking	take	VERB
ajrhss-1713	47	2	into	into	ADP
ajrhss-1713	47	3	account	account	NOUN
ajrhss-1713	47	4	individual	individual	ADJ
ajrhss-1713	47	5	fluctuations	fluctuation	NOUN
ajrhss-1713	47	6	,	,	PUNCT
ajrhss-1713	47	7	in	in	ADP
ajrhss-1713	47	8	18	18	NUM
ajrhss-1713	47	9	patients	patient	NOUN
ajrhss-1713	47	10	with	with	ADP
ajrhss-1713	47	11	a	a	DET
ajrhss-1713	47	12	recent	recent	ADJ
ajrhss-1713	47	13	(	(	PUNCT
ajrhss-1713	47	14	2	2	NUM
ajrhss-1713	47	15	-	-	PUNCT
ajrhss-1713	47	16	year	year	NOUN
ajrhss-1713	47	17	)	)	PUNCT
ajrhss-1713	47	18	duration	duration	NOUN
ajrhss-1713	47	19	of	of	ADP
ajrhss-1713	47	20	the	the	DET
ajrhss-1713	47	21	disease	disease	NOUN
ajrhss-1713	47	22	,	,	PUNCT
ajrhss-1713	47	23	the	the	DET
ajrhss-1713	47	24	level	level	NOUN
ajrhss-1713	47	25	of	of	ADP
ajrhss-1713	47	26	free	free	ADJ
ajrhss-1713	47	27	heparin	heparin	NOUN
ajrhss-1713	47	28	was	be	AUX
ajrhss-1713	47	29	within	within	ADP
ajrhss-1713	47	30	the	the	DET
ajrhss-1713	47	31	normal	normal	ADJ
ajrhss-1713	47	32	range	range	NOUN
ajrhss-1713	47	33	,	,	PUNCT
ajrhss-1713	47	34	in	in	ADP
ajrhss-1713	47	35	6	6	NUM
ajrhss-1713	47	36	patients	patient	NOUN
ajrhss-1713	47	37	it	it	PRON
ajrhss-1713	47	38	was	be	AUX
ajrhss-1713	47	39	higher	high	ADJ
ajrhss-1713	47	40	than	than	ADP
ajrhss-1713	47	41	the	the	DET
ajrhss-1713	47	42	control	control	NOUN
ajrhss-1713	47	43	values	value	NOUN
ajrhss-1713	47	44	.	.	PUNCT
ajrhss-1713	48	1	with	with	ADP
ajrhss-1713	48	2	pulmonary	pulmonary	ADJ
ajrhss-1713	48	3	heart	heart	NOUN
ajrhss-1713	48	4	failure	failure	NOUN
ajrhss-1713	48	5	,	,	PUNCT
ajrhss-1713	48	6	the	the	DET
ajrhss-1713	48	7	addition	addition	NOUN
ajrhss-1713	48	8	of	of	ADP
ajrhss-1713	48	9	circulatory	circulatory	ADJ
ajrhss-1713	48	10	failure	failure	NOUN
ajrhss-1713	48	11	.	.	PUNCT
ajrhss-1713	49	1	on	on	ADP
ajrhss-1713	49	2	average	average	ADJ
ajrhss-1713	49	3	,	,	PUNCT
ajrhss-1713	49	4	it	it	PRON
ajrhss-1713	49	5	was	be	AUX
ajrhss-1713	49	6	70.4±3.4	70.4±3.4	NUM
ajrhss-1713	49	7	seconds	second	NOUN
ajrhss-1713	49	8	,	,	PUNCT
ajrhss-1713	49	9	which	which	PRON
ajrhss-1713	49	10	was	be	AUX
ajrhss-1713	49	11	significantly	significantly	ADV
ajrhss-1713	49	12	(	(	PUNCT
ajrhss-1713	49	13	p<0.05	p<0.05	NOUN
ajrhss-1713	49	14	)	)	PUNCT
ajrhss-1713	49	15	higher	high	ADJ
ajrhss-1713	49	16	than	than	ADP
ajrhss-1713	49	17	in	in	ADP
ajrhss-1713	49	18	patients	patient	NOUN
ajrhss-1713	49	19	with	with	ADP
ajrhss-1713	49	20	an	an	DET
ajrhss-1713	49	21	average	average	ADJ
ajrhss-1713	49	22	severity	severity	NOUN
ajrhss-1713	49	23	of	of	ADP
ajrhss-1713	49	24	the	the	DET
ajrhss-1713	49	25	disease	disease	NOUN
ajrhss-1713	49	26	of	of	ADP
ajrhss-1713	49	27	82.68±5.4	82.68±5.4	NUM
ajrhss-1713	49	28	.	.	PUNCT
ajrhss-1713	50	1	according	accord	VERB
ajrhss-1713	50	2	to	to	ADP
ajrhss-1713	50	3	the	the	DET
ajrhss-1713	50	4	bergerhof	bergerhof	NOUN
ajrhss-1713	50	5	-	-	PUNCT
ajrhss-1713	50	6	rock	rock	NOUN
ajrhss-1713	50	7	test	test	NOUN
ajrhss-1713	50	8	,	,	PUNCT
ajrhss-1713	50	9	it	it	PRON
ajrhss-1713	50	10	can	can	AUX
ajrhss-1713	50	11	be	be	AUX
ajrhss-1713	50	12	noted	note	VERB
ajrhss-1713	50	13	that	that	SCONJ
ajrhss-1713	50	14	in	in	ADP
ajrhss-1713	50	15	patients	patient	NOUN
ajrhss-1713	50	16	with	with	ADP
ajrhss-1713	50	17	chronic	chronic	ADJ
ajrhss-1713	50	18	pneumonia	pneumonia	NOUN
ajrhss-1713	50	19	there	there	PRON
ajrhss-1713	50	20	are	be	VERB
ajrhss-1713	50	21	shifts	shift	NOUN
ajrhss-1713	50	22	towards	towards	ADP
ajrhss-1713	50	23	hypercoagulation	hypercoagulation	NOUN
ajrhss-1713	50	24	,	,	PUNCT
ajrhss-1713	50	25	and	and	CCONJ
ajrhss-1713	50	26	the	the	DET
ajrhss-1713	50	27	severity	severity	NOUN
ajrhss-1713	50	28	of	of	ADP
ajrhss-1713	50	29	these	these	DET
ajrhss-1713	50	30	shifts	shift	NOUN
ajrhss-1713	50	31	depends	depend	VERB
ajrhss-1713	50	32	both	both	PRON
ajrhss-1713	50	33	on	on	ADP
ajrhss-1713	50	34	the	the	DET
ajrhss-1713	50	35	activity	activity	NOUN
ajrhss-1713	50	36	of	of	ADP
ajrhss-1713	50	37	the	the	DET
ajrhss-1713	50	38	inflammatory	inflammatory	ADJ
ajrhss-1713	50	39	process	process	NOUN
ajrhss-1713	50	40	in	in	ADP
ajrhss-1713	50	41	the	the	DET
ajrhss-1713	50	42	bronchopulmonary	bronchopulmonary	ADJ
ajrhss-1713	50	43	system	system	NOUN
ajrhss-1713	50	44	and	and	CCONJ
ajrhss-1713	50	45	on	on	ADP
ajrhss-1713	50	46	the	the	DET
ajrhss-1713	50	47	severity	severity	NOUN
ajrhss-1713	50	48	and	and	CCONJ
ajrhss-1713	50	49	data	datum	NOUN
ajrhss-1713	50	50	on	on	ADP
ajrhss-1713	50	51	the	the	DET
ajrhss-1713	50	52	content	content	NOUN
ajrhss-1713	50	53	of	of	ADP
ajrhss-1713	50	54	free	free	ADJ
ajrhss-1713	50	55	heparin	heparin	NOUN
ajrhss-1713	50	56	in	in	ADP
ajrhss-1713	50	57	blood	blood	NOUN
ajrhss-1713	50	58	plasma	plasma	NOUN
ajrhss-1713	50	59	in	in	ADP
ajrhss-1713	50	60	patients	patient	NOUN
ajrhss-1713	50	61	with	with	ADP
ajrhss-1713	50	62	chronic	chronic	ADJ
ajrhss-1713	50	63	pneumonia	pneumonia	NOUN
ajrhss-1713	50	64	showed	show	VERB
ajrhss-1713	50	65	significant	significant	ADJ
ajrhss-1713	50	66	changes	change	NOUN
ajrhss-1713	50	67	.	.	PUNCT
ajrhss-1713	51	1	thus	thus	ADV
ajrhss-1713	51	2	,	,	PUNCT
ajrhss-1713	51	3	in	in	ADP
ajrhss-1713	51	4	the	the	DET
ajrhss-1713	51	5	phase	phase	NOUN
ajrhss-1713	51	6	of	of	ADP
ajrhss-1713	51	7	exacerbation	exacerbation	NOUN
ajrhss-1713	51	8	of	of	ADP
ajrhss-1713	51	9	the	the	DET
ajrhss-1713	51	10	disease	disease	NOUN
ajrhss-1713	51	11	,	,	PUNCT
ajrhss-1713	51	12	a	a	DET
ajrhss-1713	51	13	sharp	sharp	ADJ
ajrhss-1713	51	14	(	(	PUNCT
ajrhss-1713	51	15	p<0.001	p<0.001	NOUN
ajrhss-1713	51	16	)	)	PUNCT
ajrhss-1713	51	17	decrease	decrease	NOUN
ajrhss-1713	51	18	in	in	ADP
ajrhss-1713	51	19	the	the	DET
ajrhss-1713	51	20	level	level	NOUN
ajrhss-1713	51	21	of	of	ADP
ajrhss-1713	51	22	free	free	ADJ
ajrhss-1713	51	23	heparin	heparin	NOUN
ajrhss-1713	51	24	was	be	AUX
ajrhss-1713	51	25	observed	observe	VERB
ajrhss-1713	51	26	in	in	ADP
ajrhss-1713	51	27	all	all	DET
ajrhss-1713	51	28	age	age	NOUN
ajrhss-1713	51	29	groups	group	NOUN
ajrhss-1713	51	30	to	to	ADP
ajrhss-1713	51	31	an	an	DET
ajrhss-1713	51	32	average	average	NOUN
ajrhss-1713	51	33	of	of	ADP
ajrhss-1713	51	34	4.2±0.5	4.2±0.5	NUM
ajrhss-1713	51	35	seconds	second	NOUN
ajrhss-1713	51	36	;	;	PUNCT
ajrhss-1713	51	37	3.8±0.52	3.8±0.52	NUM
ajrhss-1713	51	38	,	,	PUNCT
ajrhss-1713	51	39	normal	normal	ADJ
ajrhss-1713	51	40	,	,	PUNCT
ajrhss-1713	51	41	respectively	respectively	ADV
ajrhss-1713	51	42	6.4±0.54	6.4±0.54	NUM
ajrhss-1713	51	43	;	;	PUNCT
ajrhss-1713	51	44	7.1±1.12	7.1±1.12	NUM
ajrhss-1713	51	45	seconds	second	NOUN
ajrhss-1713	51	46	.	.	PUNCT
ajrhss-1713	52	1	taking	take	VERB
ajrhss-1713	52	2	into	into	ADP
ajrhss-1713	52	3	account	account	NOUN
ajrhss-1713	52	4	individual	individual	ADJ
ajrhss-1713	52	5	fluctuations	fluctuation	NOUN
ajrhss-1713	52	6	,	,	PUNCT
ajrhss-1713	52	7	in	in	ADP
ajrhss-1713	52	8	18	18	NUM
ajrhss-1713	52	9	patients	patient	NOUN
ajrhss-1713	52	10	with	with	ADP
ajrhss-1713	52	11	a	a	DET
ajrhss-1713	52	12	recent	recent	ADJ
ajrhss-1713	52	13	(	(	PUNCT
ajrhss-1713	52	14	2	2	NUM
ajrhss-1713	52	15	-	-	PUNCT
ajrhss-1713	52	16	year	year	NOUN
ajrhss-1713	52	17	)	)	PUNCT
ajrhss-1713	52	18	duration	duration	NOUN
ajrhss-1713	52	19	of	of	ADP
ajrhss-1713	52	20	the	the	DET
ajrhss-1713	52	21	disease	disease	NOUN
ajrhss-1713	52	22	,	,	PUNCT
ajrhss-1713	52	23	the	the	DET
ajrhss-1713	52	24	level	level	NOUN
ajrhss-1713	52	25	of	of	ADP
ajrhss-1713	52	26	free	free	ADJ
ajrhss-1713	52	27	heparin	heparin	NOUN
ajrhss-1713	52	28	was	be	AUX
ajrhss-1713	52	29	within	within	ADP
ajrhss-1713	52	30	the	the	DET
ajrhss-1713	52	31	normal	normal	ADJ
ajrhss-1713	52	32	range	range	NOUN
ajrhss-1713	52	33	,	,	PUNCT
ajrhss-1713	52	34	in	in	ADP
ajrhss-1713	52	35	6	6	NUM
ajrhss-1713	52	36	patients	patient	NOUN
ajrhss-1713	52	37	it	it	PRON
ajrhss-1713	52	38	was	be	AUX
ajrhss-1713	52	39	higher	high	ADJ
ajrhss-1713	52	40	than	than	ADP
ajrhss-1713	52	41	the	the	DET
ajrhss-1713	52	42	control	control	NOUN
ajrhss-1713	52	43	values	value	NOUN
ajrhss-1713	52	44	.	.	PUNCT
ajrhss-1713	53	1	so	so	ADV
ajrhss-1713	53	2	,	,	PUNCT
ajrhss-1713	53	3	in	in	ADP
ajrhss-1713	53	4	the	the	DET
ajrhss-1713	53	5	first	first	ADJ
ajrhss-1713	53	6	days	day	NOUN
ajrhss-1713	53	7	of	of	ADP
ajrhss-1713	53	8	admission	admission	NOUN
ajrhss-1713	53	9	to	to	ADP
ajrhss-1713	53	10	the	the	DET
ajrhss-1713	53	11	clinic	clinic	NOUN
ajrhss-1713	53	12	,	,	PUNCT
ajrhss-1713	53	13	the	the	DET
ajrhss-1713	53	14	level	level	NOUN
ajrhss-1713	53	15	of	of	ADP
ajrhss-1713	53	16	free	free	ADJ
ajrhss-1713	53	17	heparin	heparin	NOUN
ajrhss-1713	53	18	in	in	ADP
ajrhss-1713	53	19	these	these	DET
ajrhss-1713	53	20	patients	patient	NOUN
ajrhss-1713	53	21	slightly	slightly	ADV
ajrhss-1713	53	22	exceeds	exceed	VERB
ajrhss-1713	53	23	the	the	DET
ajrhss-1713	53	24	general	general	ADJ
ajrhss-1713	53	25	indicators	indicator	NOUN
ajrhss-1713	53	26	and	and	CCONJ
ajrhss-1713	53	27	averages	average	NOUN
ajrhss-1713	53	28	5.75±0.95	5.75±0.95	NUM
ajrhss-1713	53	29	;	;	PUNCT
ajrhss-1713	53	30	4.84±0.64	4.84±0.64	PROPN
ajrhss-1713	53	31	sec	sec	PROPN
ajrhss-1713	53	32	.	.	PUNCT
ajrhss-1713	54	1	(	(	PUNCT
ajrhss-1713	54	2	p>0.05	p>0.05	PROPN
ajrhss-1713	54	3	)	)	PUNCT
ajrhss-1713	54	4	.	.	PUNCT
ajrhss-1713	55	1	based	base	VERB
ajrhss-1713	55	2	on	on	ADP
ajrhss-1713	55	3	the	the	DET
ajrhss-1713	55	4	data	datum	NOUN
ajrhss-1713	55	5	obtained	obtain	VERB
ajrhss-1713	55	6	,	,	PUNCT
ajrhss-1713	55	7	it	it	PRON
ajrhss-1713	55	8	can	can	AUX
ajrhss-1713	55	9	be	be	AUX
ajrhss-1713	55	10	noted	note	VERB
ajrhss-1713	55	11	that	that	SCONJ
ajrhss-1713	55	12	the	the	DET
ajrhss-1713	55	13	level	level	NOUN
ajrhss-1713	55	14	of	of	ADP
ajrhss-1713	55	15	free	free	ADJ
ajrhss-1713	55	16	heparin	heparin	NOUN
ajrhss-1713	55	17	in	in	ADP
ajrhss-1713	55	18	the	the	DET
ajrhss-1713	55	19	blood	blood	NOUN
ajrhss-1713	55	20	of	of	ADP
ajrhss-1713	55	21	children	child	NOUN
ajrhss-1713	55	22	with	with	ADP
ajrhss-1713	55	23	chronic	chronic	ADJ
ajrhss-1713	55	24	pneumonia	pneumonia	NOUN
ajrhss-1713	55	25	in	in	ADP
ajrhss-1713	55	26	the	the	DET
ajrhss-1713	55	27	acute	acute	ADJ
ajrhss-1713	55	28	phase	phase	NOUN
ajrhss-1713	55	29	of	of	ADP
ajrhss-1713	55	30	the	the	DET
ajrhss-1713	55	31	disease	disease	NOUN
ajrhss-1713	55	32	tends	tend	VERB
ajrhss-1713	55	33	to	to	PART
ajrhss-1713	55	34	decrease	decrease	VERB
ajrhss-1713	55	35	.	.	PUNCT
ajrhss-1713	56	1	a	a	DET
ajrhss-1713	56	2	decrease	decrease	NOUN
ajrhss-1713	56	3	in	in	ADP
ajrhss-1713	56	4	the	the	DET
ajrhss-1713	56	5	content	content	NOUN
ajrhss-1713	56	6	of	of	ADP
ajrhss-1713	56	7	free	free	ADJ
ajrhss-1713	56	8	heparin	heparin	NOUN
ajrhss-1713	56	9	indicates	indicate	VERB
ajrhss-1713	56	10	an	an	DET
ajrhss-1713	56	11	increased	increase	VERB
ajrhss-1713	56	12	readiness	readiness	NOUN
ajrhss-1713	56	13	of	of	ADP
ajrhss-1713	56	14	the	the	DET
ajrhss-1713	56	15	blood	blood	NOUN
ajrhss-1713	56	16	to	to	PART
ajrhss-1713	56	17	clot	clot	VERB
ajrhss-1713	56	18	due	due	ADJ
ajrhss-1713	56	19	to	to	ADP
ajrhss-1713	56	20	an	an	DET
ajrhss-1713	56	21	exacerbation	exacerbation	NOUN
ajrhss-1713	56	22	of	of	ADP
ajrhss-1713	56	23	the	the	DET
ajrhss-1713	56	24	inflammatory	inflammatory	ADJ
ajrhss-1713	56	25	process	process	NOUN
ajrhss-1713	56	26	in	in	ADP
ajrhss-1713	56	27	the	the	DET
ajrhss-1713	56	28	lungs	lung	NOUN
ajrhss-1713	56	29	.	.	PUNCT
ajrhss-1713	57	1	the	the	DET
ajrhss-1713	57	2	american	american	PROPN
ajrhss-1713	57	3	journal	journal	PROPN
ajrhss-1713	57	4	of	of	ADP
ajrhss-1713	57	5	research	research	NOUN
ajrhss-1713	57	6	in	in	ADP
ajrhss-1713	57	7	humanities	humanity	NOUN
ajrhss-1713	57	8	and	and	CCONJ
ajrhss-1713	57	9	social	social	ADJ
ajrhss-1713	57	10	sciences	science	NOUN
ajrhss-1713	57	11	volume	volume	NOUN
ajrhss-1713	57	12	20	20	NUM
ajrhss-1713	57	13	january	january	PROPN
ajrhss-1713	57	14	,	,	PUNCT
ajrhss-1713	57	15	2024	2024	NUM
ajrhss-1713	57	16	p	p	NOUN
ajrhss-1713	57	17	a	a	DET
ajrhss-1713	57	18	g	g	NOUN
ajrhss-1713	57	19	e	e	NOUN
ajrhss-1713	57	20	|	|	ADV
ajrhss-1713	57	21	4	4	NUM
ajrhss-1713	57	22	www.americanjournal.org	www.americanjournal.org	NOUN
ajrhss-1713	57	23	higher	high	ADJ
ajrhss-1713	57	24	content	content	NOUN
ajrhss-1713	57	25	of	of	ADP
ajrhss-1713	57	26	free	free	ADJ
ajrhss-1713	57	27	heparin	heparin	NOUN
ajrhss-1713	57	28	in	in	ADP
ajrhss-1713	57	29	the	the	DET
ajrhss-1713	57	30	blood	blood	NOUN
ajrhss-1713	57	31	that	that	PRON
ajrhss-1713	57	32	we	we	PRON
ajrhss-1713	57	33	have	have	AUX
ajrhss-1713	57	34	established	establish	VERB
ajrhss-1713	57	35	in	in	ADP
ajrhss-1713	57	36	the	the	DET
ajrhss-1713	57	37	bronchiectasis	bronchiectasis	NOUN
ajrhss-1713	57	38	variant	variant	NOUN
ajrhss-1713	57	39	and	and	CCONJ
ajrhss-1713	57	40	in	in	ADP
ajrhss-1713	57	41	severe	severe	ADJ
ajrhss-1713	57	42	cases	case	NOUN
ajrhss-1713	57	43	of	of	ADP
ajrhss-1713	57	44	the	the	DET
ajrhss-1713	57	45	disease	disease	NOUN
ajrhss-1713	57	46	is	be	AUX
ajrhss-1713	57	47	apparently	apparently	ADV
ajrhss-1713	57	48	a	a	DET
ajrhss-1713	57	49	consequence	consequence	NOUN
ajrhss-1713	57	50	of	of	ADP
ajrhss-1713	57	51	an	an	DET
ajrhss-1713	57	52	increase	increase	NOUN
ajrhss-1713	57	53	in	in	ADP
ajrhss-1713	57	54	the	the	DET
ajrhss-1713	57	55	number	number	NOUN
ajrhss-1713	57	56	of	of	ADP
ajrhss-1713	57	57	mast	mast	NOUN
ajrhss-1713	57	58	cells	cell	NOUN
ajrhss-1713	57	59	in	in	ADP
ajrhss-1713	57	60	the	the	DET
ajrhss-1713	57	61	focus	focus	NOUN
ajrhss-1713	57	62	of	of	ADP
ajrhss-1713	57	63	inflammation	inflammation	NOUN
ajrhss-1713	57	64	and	and	CCONJ
ajrhss-1713	57	65	the	the	DET
ajrhss-1713	57	66	manifestation	manifestation	NOUN
ajrhss-1713	57	67	of	of	ADP
ajrhss-1713	57	68	one	one	NUM
ajrhss-1713	57	69	of	of	ADP
ajrhss-1713	57	70	the	the	DET
ajrhss-1713	57	71	mechanisms	mechanism	NOUN
ajrhss-1713	57	72	of	of	ADP
ajrhss-1713	57	73	compensatory	compensatory	ADJ
ajrhss-1713	57	74	and	and	CCONJ
ajrhss-1713	57	75	adaptive	adaptive	ADJ
ajrhss-1713	57	76	reactions	reaction	NOUN
ajrhss-1713	57	77	of	of	ADP
ajrhss-1713	57	78	the	the	DET
ajrhss-1713	57	79	body	body	NOUN
ajrhss-1713	57	80	to	to	ADP
ajrhss-1713	57	81	the	the	DET
ajrhss-1713	57	82	constant	constant	ADJ
ajrhss-1713	57	83	hypoxic	hypoxic	ADJ
ajrhss-1713	57	84	state	state	NOUN
ajrhss-1713	57	85	of	of	ADP
ajrhss-1713	57	86	patients	patient	NOUN
ajrhss-1713	57	87	in	in	ADP
ajrhss-1713	57	88	this	this	DET
ajrhss-1713	57	89	group	group	NOUN
ajrhss-1713	57	90	,	,	PUNCT
ajrhss-1713	57	91	since	since	SCONJ
ajrhss-1713	57	92	heparin	heparin	ADJ
ajrhss-1713	57	93	increases	increase	VERB
ajrhss-1713	57	94	tissue	tissue	NOUN
ajrhss-1713	57	95	tolerance	tolerance	NOUN
ajrhss-1713	57	96	to	to	PART
ajrhss-1713	57	97	oxygen	oxygen	VERB
ajrhss-1713	57	98	and	and	CCONJ
ajrhss-1713	57	99	adapts	adapt	VERB
ajrhss-1713	57	100	them	they	PRON
ajrhss-1713	57	101	to	to	ADP
ajrhss-1713	57	102	oxygen	oxygen	NOUN
ajrhss-1713	57	103	deficiency	deficiency	NOUN
ajrhss-1713	57	104	.	.	PUNCT
ajrhss-1713	58	1	analysis	analysis	NOUN
ajrhss-1713	58	2	of	of	ADP
ajrhss-1713	58	3	our	our	PRON
ajrhss-1713	58	4	results	result	NOUN
ajrhss-1713	58	5	revealed	reveal	VERB
ajrhss-1713	58	6	an	an	DET
ajrhss-1713	58	7	increase	increase	NOUN
ajrhss-1713	58	8	in	in	ADP
ajrhss-1713	58	9	fibrinogen	fibrinogen	NOUN
ajrhss-1713	58	10	content	content	NOUN
ajrhss-1713	58	11	in	in	ADP
ajrhss-1713	58	12	the	the	DET
ajrhss-1713	58	13	blood	blood	NOUN
ajrhss-1713	58	14	plasma	plasma	NOUN
ajrhss-1713	58	15	in	in	ADP
ajrhss-1713	58	16	children	child	NOUN
ajrhss-1713	58	17	with	with	ADP
ajrhss-1713	58	18	this	this	DET
ajrhss-1713	58	19	pathology	pathology	NOUN
ajrhss-1713	58	20	aged	age	VERB
ajrhss-1713	58	21	13	13	NUM
ajrhss-1713	58	22	to	to	PART
ajrhss-1713	58	23	16	16	NUM
ajrhss-1713	58	24	years	year	NOUN
ajrhss-1713	58	25	,	,	PUNCT
ajrhss-1713	58	26	4.81±0.6	4.81±0.6	NOUN
ajrhss-1713	58	27	,	,	PUNCT
ajrhss-1713	58	28	while	while	SCONJ
ajrhss-1713	58	29	in	in	ADP
ajrhss-1713	58	30	the	the	DET
ajrhss-1713	58	31	control	control	NOUN
ajrhss-1713	58	32	group	group	NOUN
ajrhss-1713	58	33	it	it	PRON
ajrhss-1713	58	34	was	be	AUX
ajrhss-1713	58	35	2.94±0.12	2.94±0.12	NUM
ajrhss-1713	58	36	;	;	PUNCT
ajrhss-1713	58	37	2.69±0.2	2.69±0.2	NUM
ajrhss-1713	58	38	(	(	PUNCT
ajrhss-1713	58	39	p<0.001	p<0.001	PROPN
ajrhss-1713	58	40	)	)	PUNCT
ajrhss-1713	58	41	.	.	PUNCT
ajrhss-1713	59	1	severe	severe	ADJ
ajrhss-1713	59	2	hyperfibrinogenemia	hyperfibrinogenemia	NOUN
ajrhss-1713	59	3	in	in	ADP
ajrhss-1713	59	4	our	our	PRON
ajrhss-1713	59	5	studies	study	NOUN
ajrhss-1713	59	6	occurs	occur	VERB
ajrhss-1713	59	7	due	due	ADJ
ajrhss-1713	59	8	to	to	ADP
ajrhss-1713	59	9	an	an	DET
ajrhss-1713	59	10	increase	increase	NOUN
ajrhss-1713	59	11	in	in	ADP
ajrhss-1713	59	12	inflammatory	inflammatory	ADJ
ajrhss-1713	59	13	fibrinogen	fibrinogen	NOUN
ajrhss-1713	59	14	a	a	NOUN
ajrhss-1713	59	15	,	,	PUNCT
ajrhss-1713	59	16	which	which	PRON
ajrhss-1713	59	17	is	be	AUX
ajrhss-1713	59	18	an	an	DET
ajrhss-1713	59	19	indicator	indicator	NOUN
ajrhss-1713	59	20	of	of	ADP
ajrhss-1713	59	21	inflammation	inflammation	NOUN
ajrhss-1713	59	22	(	(	PUNCT
ajrhss-1713	59	23	caused	cause	VERB
ajrhss-1713	59	24	by	by	ADP
ajrhss-1713	59	25	the	the	DET
ajrhss-1713	59	26	inflammatory	inflammatory	ADJ
ajrhss-1713	59	27	process	process	NOUN
ajrhss-1713	59	28	)	)	PUNCT
ajrhss-1713	59	29	and	and	CCONJ
ajrhss-1713	59	30	is	be	AUX
ajrhss-1713	59	31	aimed	aim	VERB
ajrhss-1713	59	32	at	at	ADP
ajrhss-1713	59	33	limiting	limit	VERB
ajrhss-1713	59	34	the	the	DET
ajrhss-1713	59	35	focus	focus	NOUN
ajrhss-1713	59	36	of	of	ADP
ajrhss-1713	59	37	inflammation	inflammation	NOUN
ajrhss-1713	59	38	.	.	PUNCT
ajrhss-1713	60	1	somewhat	somewhat	ADV
ajrhss-1713	60	2	different	different	ADJ
ajrhss-1713	60	3	results	result	NOUN
ajrhss-1713	60	4	were	be	AUX
ajrhss-1713	60	5	obtained	obtain	VERB
ajrhss-1713	60	6	in	in	ADP
ajrhss-1713	60	7	the	the	DET
ajrhss-1713	60	8	study	study	NOUN
ajrhss-1713	60	9	of	of	ADP
ajrhss-1713	60	10	the	the	DET
ajrhss-1713	60	11	content	content	NOUN
ajrhss-1713	60	12	of	of	ADP
ajrhss-1713	60	13	fibrinogen	fibrinogen	NOUN
ajrhss-1713	60	14	in	in	ADP
ajrhss-1713	60	15	patients	patient	NOUN
ajrhss-1713	60	16	with	with	ADP
ajrhss-1713	60	17	bronchiectasis	bronchiectasis	NOUN
ajrhss-1713	60	18	and	and	CCONJ
ajrhss-1713	60	19	with	with	ADP
ajrhss-1713	60	20	a	a	DET
ajrhss-1713	60	21	severe	severe	ADJ
ajrhss-1713	60	22	course	course	NOUN
ajrhss-1713	60	23	of	of	ADP
ajrhss-1713	60	24	the	the	DET
ajrhss-1713	60	25	disease	disease	NOUN
ajrhss-1713	60	26	,	,	PUNCT
ajrhss-1713	60	27	so	so	SCONJ
ajrhss-1713	60	28	these	these	DET
ajrhss-1713	60	29	patients	patient	NOUN
ajrhss-1713	60	30	showed	show	VERB
ajrhss-1713	60	31	the	the	DET
ajrhss-1713	60	32	greatest	great	ADJ
ajrhss-1713	60	33	increase	increase	NOUN
ajrhss-1713	60	34	in	in	ADP
ajrhss-1713	60	35	the	the	DET
ajrhss-1713	60	36	content	content	NOUN
ajrhss-1713	60	37	of	of	ADP
ajrhss-1713	60	38	fibrinogen	fibrinogen	NOUN
ajrhss-1713	60	39	in	in	ADP
ajrhss-1713	60	40	the	the	DET
ajrhss-1713	60	41	blood	blood	NOUN
ajrhss-1713	60	42	plasma	plasma	NOUN
ajrhss-1713	60	43	compared	compare	VERB
ajrhss-1713	60	44	with	with	ADP
ajrhss-1713	60	45	patients	patient	NOUN
ajrhss-1713	60	46	with	with	ADP
ajrhss-1713	60	47	bronchial	bronchial	ADJ
ajrhss-1713	60	48	deformity	deformity	NOUN
ajrhss-1713	60	49	,	,	PUNCT
ajrhss-1713	60	50	with	with	ADP
ajrhss-1713	60	51	moderate	moderate	ADJ
ajrhss-1713	60	52	severity	severity	NOUN
ajrhss-1713	60	53	of	of	ADP
ajrhss-1713	60	54	the	the	DET
ajrhss-1713	60	55	disease	disease	NOUN
ajrhss-1713	60	56	(	(	PUNCT
ajrhss-1713	60	57	p<0.05	p<0.05	NOUN
ajrhss-1713	60	58	)	)	PUNCT
ajrhss-1713	60	59	and	and	CCONJ
ajrhss-1713	60	60	was	be	AUX
ajrhss-1713	60	61	5.8±0.35	5.8±0.35	NUM
ajrhss-1713	60	62	;	;	PUNCT
ajrhss-1713	60	63	6.8±0.52	6.8±0.52	NUM
ajrhss-1713	60	64	,	,	PUNCT
ajrhss-1713	60	65	which	which	PRON
ajrhss-1713	60	66	indicates	indicate	VERB
ajrhss-1713	60	67	the	the	DET
ajrhss-1713	60	68	highest	high	ADJ
ajrhss-1713	60	69	activity	activity	NOUN
ajrhss-1713	60	70	of	of	ADP
ajrhss-1713	60	71	the	the	DET
ajrhss-1713	60	72	inflammatory	inflammatory	ADJ
ajrhss-1713	60	73	process	process	NOUN
ajrhss-1713	60	74	in	in	ADP
ajrhss-1713	60	75	these	these	DET
ajrhss-1713	60	76	patients	patient	NOUN
ajrhss-1713	60	77	.	.	PUNCT
ajrhss-1713	61	1	data	datum	NOUN
ajrhss-1713	61	2	on	on	ADP
ajrhss-1713	61	3	the	the	DET
ajrhss-1713	61	4	prothrombin	prothrombin	ADJ
ajrhss-1713	61	5	index	index	NOUN
ajrhss-1713	61	6	in	in	ADP
ajrhss-1713	61	7	patients	patient	NOUN
ajrhss-1713	61	8	with	with	ADP
ajrhss-1713	61	9	chronic	chronic	ADJ
ajrhss-1713	61	10	pneumonia	pneumonia	NOUN
ajrhss-1713	61	11	are	be	AUX
ajrhss-1713	61	12	subject	subject	ADJ
ajrhss-1713	61	13	to	to	ADP
ajrhss-1713	61	14	fairly	fairly	ADV
ajrhss-1713	61	15	minor	minor	ADJ
ajrhss-1713	61	16	fluctuations	fluctuation	NOUN
ajrhss-1713	61	17	(	(	PUNCT
ajrhss-1713	61	18	table	table	NOUN
ajrhss-1713	61	19	1	1	NUM
ajrhss-1713	61	20	)	)	PUNCT
ajrhss-1713	61	21	.	.	PUNCT
ajrhss-1713	62	1	in	in	ADP
ajrhss-1713	62	2	the	the	DET
ajrhss-1713	62	3	phase	phase	NOUN
ajrhss-1713	62	4	of	of	ADP
ajrhss-1713	62	5	exacerbation	exacerbation	NOUN
ajrhss-1713	62	6	of	of	ADP
ajrhss-1713	62	7	chronic	chronic	ADJ
ajrhss-1713	62	8	pneumonia	pneumonia	NOUN
ajrhss-1713	62	9	,	,	PUNCT
ajrhss-1713	62	10	a	a	DET
ajrhss-1713	62	11	significant	significant	ADJ
ajrhss-1713	62	12	increase	increase	NOUN
ajrhss-1713	62	13	in	in	ADP
ajrhss-1713	62	14	the	the	DET
ajrhss-1713	62	15	average	average	ADJ
ajrhss-1713	62	16	indicator	indicator	NOUN
ajrhss-1713	62	17	was	be	AUX
ajrhss-1713	62	18	observed	observe	VERB
ajrhss-1713	62	19	in	in	ADP
ajrhss-1713	62	20	patients	patient	NOUN
ajrhss-1713	62	21	from	from	ADP
ajrhss-1713	62	22	8	8	NUM
ajrhss-1713	62	23	to	to	PART
ajrhss-1713	62	24	15	15	NUM
ajrhss-1713	62	25	years	year	NOUN
ajrhss-1713	62	26	old	old	ADJ
ajrhss-1713	62	27	and	and	CCONJ
ajrhss-1713	62	28	amounted	amount	VERB
ajrhss-1713	62	29	to	to	ADP
ajrhss-1713	62	30	99.88±1.02	99.88±1.02	NUM
ajrhss-1713	62	31	(	(	PUNCT
ajrhss-1713	62	32	p<0.05	p<0.05	NOUN
ajrhss-1713	62	33	)	)	PUNCT
ajrhss-1713	62	34	.	.	PUNCT
ajrhss-1713	63	1	in	in	ADP
ajrhss-1713	63	2	sick	sick	ADJ
ajrhss-1713	63	3	children	child	NOUN
ajrhss-1713	63	4	aged	age	VERB
ajrhss-1713	63	5	3	3	NUM
ajrhss-1713	63	6	to	to	PART
ajrhss-1713	63	7	7	7	NUM
ajrhss-1713	63	8	years	year	NOUN
ajrhss-1713	63	9	,	,	PUNCT
ajrhss-1713	63	10	there	there	PRON
ajrhss-1713	63	11	was	be	VERB
ajrhss-1713	63	12	a	a	DET
ajrhss-1713	63	13	slight	slight	ADJ
ajrhss-1713	63	14	increase	increase	NOUN
ajrhss-1713	63	15	in	in	ADP
ajrhss-1713	63	16	prothrombin	prothrombin	ADJ
ajrhss-1713	63	17	activity	activity	NOUN
ajrhss-1713	63	18	94.8±1.2	94.8±1.2	NUM
ajrhss-1713	63	19	(	(	PUNCT
ajrhss-1713	63	20	p>0.1	p>0.1	NOUN
ajrhss-1713	63	21	)	)	PUNCT
ajrhss-1713	63	22	,	,	PUNCT
ajrhss-1713	63	23	while	while	SCONJ
ajrhss-1713	63	24	in	in	ADP
ajrhss-1713	63	25	the	the	DET
ajrhss-1713	63	26	group	group	NOUN
ajrhss-1713	63	27	of	of	ADP
ajrhss-1713	63	28	healthy	healthy	ADJ
ajrhss-1713	63	29	children	child	NOUN
ajrhss-1713	63	30	this	this	DET
ajrhss-1713	63	31	figure	figure	NOUN
ajrhss-1713	63	32	averaged	average	VERB
ajrhss-1713	63	33	94.5±0.44	94.5±0.44	NUM
ajrhss-1713	63	34	;	;	PUNCT
ajrhss-1713	63	35	96.0±0.76	96.0±0.76	NUM
ajrhss-1713	63	36	%	%	NOUN
ajrhss-1713	63	37	.	.	PUNCT
ajrhss-1713	64	1	as	as	SCONJ
ajrhss-1713	64	2	can	can	AUX
ajrhss-1713	64	3	be	be	AUX
ajrhss-1713	64	4	seen	see	VERB
ajrhss-1713	64	5	from	from	ADP
ajrhss-1713	64	6	the	the	DET
ajrhss-1713	64	7	above	above	ADJ
ajrhss-1713	64	8	data	datum	NOUN
ajrhss-1713	64	9	,	,	PUNCT
ajrhss-1713	64	10	the	the	DET
ajrhss-1713	64	11	prothrombin	prothrombin	ADJ
ajrhss-1713	64	12	index	index	NOUN
ajrhss-1713	64	13	in	in	ADP
ajrhss-1713	64	14	sick	sick	ADJ
ajrhss-1713	64	15	children	child	NOUN
ajrhss-1713	64	16	with	with	ADP
ajrhss-1713	64	17	chronic	chronic	ADJ
ajrhss-1713	64	18	pneumonia	pneumonia	NOUN
ajrhss-1713	64	19	has	have	VERB
ajrhss-1713	64	20	a	a	DET
ajrhss-1713	64	21	deviation	deviation	NOUN
ajrhss-1713	64	22	from	from	ADP
ajrhss-1713	64	23	the	the	DET
ajrhss-1713	64	24	norm	norm	NOUN
ajrhss-1713	64	25	.	.	PUNCT
ajrhss-1713	65	1	at	at	ADP
ajrhss-1713	65	2	the	the	DET
ajrhss-1713	65	3	same	same	ADJ
ajrhss-1713	65	4	time	time	NOUN
ajrhss-1713	65	5	,	,	PUNCT
ajrhss-1713	65	6	the	the	DET
ajrhss-1713	65	7	most	most	ADV
ajrhss-1713	65	8	significant	significant	ADJ
ajrhss-1713	65	9	deviation	deviation	NOUN
ajrhss-1713	65	10	from	from	ADP
ajrhss-1713	65	11	the	the	DET
ajrhss-1713	65	12	level	level	NOUN
ajrhss-1713	65	13	of	of	ADP
ajrhss-1713	65	14	control	control	NOUN
ajrhss-1713	65	15	figures	figure	NOUN
ajrhss-1713	65	16	was	be	AUX
ajrhss-1713	65	17	observed	observe	VERB
ajrhss-1713	65	18	in	in	ADP
ajrhss-1713	65	19	the	the	DET
ajrhss-1713	65	20	phase	phase	NOUN
ajrhss-1713	65	21	of	of	ADP
ajrhss-1713	65	22	exacerbation	exacerbation	NOUN
ajrhss-1713	65	23	of	of	ADP
ajrhss-1713	65	24	the	the	DET
ajrhss-1713	65	25	disease	disease	NOUN
ajrhss-1713	65	26	.	.	PUNCT
ajrhss-1713	66	1	a	a	DET
ajrhss-1713	66	2	study	study	NOUN
ajrhss-1713	66	3	of	of	ADP
ajrhss-1713	66	4	the	the	DET
ajrhss-1713	66	5	platelet	platelet	NOUN
ajrhss-1713	66	6	link	link	NOUN
ajrhss-1713	66	7	of	of	ADP
ajrhss-1713	66	8	hemostasis	hemostasis	NOUN
ajrhss-1713	66	9	showed	show	VERB
ajrhss-1713	66	10	that	that	SCONJ
ajrhss-1713	66	11	during	during	ADP
ajrhss-1713	66	12	the	the	DET
ajrhss-1713	66	13	period	period	NOUN
ajrhss-1713	66	14	of	of	ADP
ajrhss-1713	66	15	exacerbation	exacerbation	NOUN
ajrhss-1713	66	16	of	of	ADP
ajrhss-1713	66	17	chronic	chronic	ADJ
ajrhss-1713	66	18	pneumonia	pneumonia	NOUN
ajrhss-1713	66	19	,	,	PUNCT
ajrhss-1713	66	20	an	an	DET
ajrhss-1713	66	21	increase	increase	NOUN
ajrhss-1713	66	22	in	in	ADP
ajrhss-1713	66	23	the	the	DET
ajrhss-1713	66	24	number	number	NOUN
ajrhss-1713	66	25	of	of	ADP
ajrhss-1713	66	26	platelets	platelet	NOUN
ajrhss-1713	66	27	was	be	AUX
ajrhss-1713	66	28	observed	observe	VERB
ajrhss-1713	66	29	in	in	ADP
ajrhss-1713	66	30	all	all	DET
ajrhss-1713	66	31	age	age	NOUN
ajrhss-1713	66	32	groups	group	NOUN
ajrhss-1713	66	33	(	(	PUNCT
ajrhss-1713	66	34	288.2±17.5	288.2±17.5	NOUN
ajrhss-1713	66	35	;	;	PUNCT
ajrhss-1713	66	36	300±22.0	300±22.0	NUM
ajrhss-1713	66	37	)	)	PUNCT
ajrhss-1713	66	38	.	.	PUNCT
ajrhss-1713	67	1	of	of	ADP
ajrhss-1713	67	2	these	these	PRON
ajrhss-1713	67	3	,	,	PUNCT
ajrhss-1713	67	4	in	in	ADP
ajrhss-1713	67	5	some	some	DET
ajrhss-1713	67	6	children	child	NOUN
ajrhss-1713	67	7	of	of	ADP
ajrhss-1713	67	8	patients	patient	NOUN
ajrhss-1713	67	9	with	with	ADP
ajrhss-1713	67	10	bronchiectasis	bronchiectasis	NOUN
ajrhss-1713	67	11	and	and	CCONJ
ajrhss-1713	67	12	a	a	DET
ajrhss-1713	67	13	serious	serious	ADJ
ajrhss-1713	67	14	condition	condition	NOUN
ajrhss-1713	67	15	,	,	PUNCT
ajrhss-1713	67	16	hyperthrombocytosis	hyperthrombocytosis	NOUN
ajrhss-1713	67	17	was	be	AUX
ajrhss-1713	67	18	observed	observe	VERB
ajrhss-1713	67	19	(	(	PUNCT
ajrhss-1713	67	20	329.8±13.1	329.8±13.1	ADJ
ajrhss-1713	67	21	;	;	PUNCT
ajrhss-1713	67	22	342.4±18.7	342.4±18.7	NUM
ajrhss-1713	67	23	)	)	PUNCT
ajrhss-1713	67	24	,	,	PUNCT
ajrhss-1713	67	25	which	which	PRON
ajrhss-1713	67	26	we	we	PRON
ajrhss-1713	67	27	assessed	assess	VERB
ajrhss-1713	67	28	as	as	ADP
ajrhss-1713	67	29	a	a	DET
ajrhss-1713	67	30	thrombophilic	thrombophilic	NOUN
ajrhss-1713	67	31	condition	condition	NOUN
ajrhss-1713	67	32	.	.	PUNCT
ajrhss-1713	68	1	an	an	DET
ajrhss-1713	68	2	analysis	analysis	NOUN
ajrhss-1713	68	3	of	of	ADP
ajrhss-1713	68	4	blood	blood	NOUN
ajrhss-1713	68	5	fibrinolytic	fibrinolytic	ADJ
ajrhss-1713	68	6	activity	activity	NOUN
ajrhss-1713	68	7	(	(	PUNCT
ajrhss-1713	68	8	fak	fak	PROPN
ajrhss-1713	68	9	)	)	PUNCT
ajrhss-1713	68	10	showed	show	VERB
ajrhss-1713	68	11	that	that	SCONJ
ajrhss-1713	68	12	in	in	ADP
ajrhss-1713	68	13	children	child	NOUN
ajrhss-1713	68	14	with	with	ADP
ajrhss-1713	68	15	this	this	DET
ajrhss-1713	68	16	disease	disease	NOUN
ajrhss-1713	68	17	at	at	ADP
ajrhss-1713	68	18	the	the	DET
ajrhss-1713	68	19	age	age	NOUN
ajrhss-1713	68	20	of	of	ADP
ajrhss-1713	68	21	13	13	NUM
ajrhss-1713	68	22	-	-	SYM
ajrhss-1713	68	23	16	16	NUM
ajrhss-1713	68	24	years	year	NOUN
ajrhss-1713	68	25	,	,	PUNCT
ajrhss-1713	68	26	an	an	DET
ajrhss-1713	68	27	insignificant	insignificant	ADJ
ajrhss-1713	68	28	decrease	decrease	NOUN
ajrhss-1713	68	29	in	in	ADP
ajrhss-1713	68	30	the	the	DET
ajrhss-1713	68	31	average	average	ADJ
ajrhss-1713	68	32	level	level	NOUN
ajrhss-1713	68	33	of	of	ADP
ajrhss-1713	68	34	7.71	7.71	NUM
ajrhss-1713	68	35	±	±	NOUN
ajrhss-1713	68	36	0.92	0.92	NUM
ajrhss-1713	68	37	%	%	NOUN
ajrhss-1713	68	38	was	be	AUX
ajrhss-1713	68	39	observed	observe	VERB
ajrhss-1713	68	40	at	at	ADP
ajrhss-1713	68	41	admission	admission	NOUN
ajrhss-1713	68	42	,	,	PUNCT
ajrhss-1713	68	43	with	with	ADP
ajrhss-1713	68	44	a	a	DET
ajrhss-1713	68	45	norm	norm	NOUN
ajrhss-1713	68	46	of	of	ADP
ajrhss-1713	68	47	10.2	10.2	NUM
ajrhss-1713	68	48	±	±	NUM
ajrhss-1713	68	49	0.91	0.91	NUM
ajrhss-1713	68	50	%	%	NOUN
ajrhss-1713	68	51	.	.	PUNCT
ajrhss-1713	69	1	the	the	DET
ajrhss-1713	69	2	most	most	ADV
ajrhss-1713	69	3	pronounced	pronounced	ADJ
ajrhss-1713	69	4	decrease	decrease	NOUN
ajrhss-1713	69	5	in	in	ADP
ajrhss-1713	69	6	fibrinolytic	fibrinolytic	ADJ
ajrhss-1713	69	7	activity	activity	NOUN
ajrhss-1713	69	8	was	be	AUX
ajrhss-1713	69	9	observed	observe	VERB
ajrhss-1713	69	10	in	in	ADP
ajrhss-1713	69	11	patients	patient	NOUN
ajrhss-1713	69	12	aged	age	VERB
ajrhss-1713	69	13	8	8	NUM
ajrhss-1713	69	14	-	-	SYM
ajrhss-1713	69	15	15	15	NUM
ajrhss-1713	69	16	years	year	NOUN
ajrhss-1713	69	17	(	(	PUNCT
ajrhss-1713	69	18	6.23±0.74	6.23±0.74	NOUN
ajrhss-1713	69	19	p<0.001	p<0.001	NOUN
ajrhss-1713	69	20	)	)	PUNCT
ajrhss-1713	69	21	.	.	PUNCT
ajrhss-1713	70	1	fak	fak	PROPN
ajrhss-1713	70	2	blood	blood	NOUN
ajrhss-1713	70	3	was	be	AUX
ajrhss-1713	70	4	detected	detect	VERB
ajrhss-1713	70	5	in	in	ADP
ajrhss-1713	70	6	3	3	NUM
ajrhss-1713	70	7	%	%	NOUN
ajrhss-1713	70	8	of	of	ADP
ajrhss-1713	70	9	sick	sick	ADJ
ajrhss-1713	70	10	children	child	NOUN
ajrhss-1713	70	11	with	with	ADP
ajrhss-1713	70	12	a	a	DET
ajrhss-1713	70	13	serious	serious	ADJ
ajrhss-1713	70	14	condition	condition	NOUN
ajrhss-1713	70	15	with	with	ADP
ajrhss-1713	70	16	pulmonary	pulmonary	ADJ
ajrhss-1713	70	17	heart	heart	NOUN
ajrhss-1713	70	18	failure	failure	NOUN
ajrhss-1713	70	19	.	.	PUNCT
ajrhss-1713	71	1	so	so	ADV
ajrhss-1713	71	2	,	,	PUNCT
ajrhss-1713	71	3	in	in	ADP
ajrhss-1713	71	4	the	the	DET
ajrhss-1713	71	5	phase	phase	NOUN
ajrhss-1713	71	6	of	of	ADP
ajrhss-1713	71	7	exacerbation	exacerbation	NOUN
ajrhss-1713	71	8	of	of	ADP
ajrhss-1713	71	9	the	the	DET
ajrhss-1713	71	10	disease	disease	NOUN
ajrhss-1713	71	11	,	,	PUNCT
ajrhss-1713	71	12	fac	fac	PROPN
ajrhss-1713	71	13	in	in	ADP
ajrhss-1713	71	14	these	these	DET
ajrhss-1713	71	15	patients	patient	NOUN
ajrhss-1713	71	16	was	be	AUX
ajrhss-1713	71	17	11.48±0.96	11.48±0.96	NUM
ajrhss-1713	71	18	p<0.05	p<0.05	NOUN
ajrhss-1713	71	19	compared	compare	VERB
ajrhss-1713	71	20	with	with	ADP
ajrhss-1713	71	21	the	the	DET
ajrhss-1713	71	22	control	control	NOUN
ajrhss-1713	71	23	group	group	NOUN
ajrhss-1713	71	24	10.20±0.91	10.20±0.91	PROPN
ajrhss-1713	71	25	.	.	PUNCT
ajrhss-1713	72	1	in	in	ADP
ajrhss-1713	72	2	children	child	NOUN
ajrhss-1713	72	3	with	with	ADP
ajrhss-1713	72	4	a	a	DET
ajrhss-1713	72	5	moderately	moderately	ADV
ajrhss-1713	72	6	severe	severe	ADJ
ajrhss-1713	72	7	condition	condition	NOUN
ajrhss-1713	72	8	,	,	PUNCT
ajrhss-1713	72	9	the	the	DET
ajrhss-1713	72	10	index	index	NOUN
ajrhss-1713	72	11	of	of	ADP
ajrhss-1713	72	12	fibrinolytic	fibrinolytic	ADJ
ajrhss-1713	72	13	activity	activity	NOUN
ajrhss-1713	72	14	of	of	ADP
ajrhss-1713	72	15	the	the	DET
ajrhss-1713	72	16	blood	blood	NOUN
ajrhss-1713	72	17	was	be	AUX
ajrhss-1713	72	18	significantly	significantly	ADV
ajrhss-1713	72	19	reduced	reduce	VERB
ajrhss-1713	72	20	(	(	PUNCT
ajrhss-1713	72	21	p<0.001	p<0.001	PROPN
ajrhss-1713	72	22	)	)	PUNCT
ajrhss-1713	72	23	.	.	PUNCT
ajrhss-1713	73	1	an	an	DET
ajrhss-1713	73	2	increase	increase	NOUN
ajrhss-1713	73	3	in	in	ADP
ajrhss-1713	73	4	fac	fac	PROPN
ajrhss-1713	73	5	is	be	AUX
ajrhss-1713	73	6	explained	explain	VERB
ajrhss-1713	73	7	by	by	ADP
ajrhss-1713	73	8	significant	significant	ADJ
ajrhss-1713	73	9	hypoxia	hypoxia	NOUN
ajrhss-1713	73	10	of	of	ADP
ajrhss-1713	73	11	organs	organ	NOUN
ajrhss-1713	73	12	and	and	CCONJ
ajrhss-1713	73	13	tissues	tissue	NOUN
ajrhss-1713	73	14	,	,	PUNCT
ajrhss-1713	73	15	a	a	DET
ajrhss-1713	73	16	compensatory	compensatory	ADJ
ajrhss-1713	73	17	response	response	NOUN
ajrhss-1713	73	18	of	of	ADP
ajrhss-1713	73	19	the	the	DET
ajrhss-1713	73	20	body	body	NOUN
ajrhss-1713	73	21	to	to	ADP
ajrhss-1713	73	22	increased	increase	VERB
ajrhss-1713	73	23	blood	blood	NOUN
ajrhss-1713	73	24	clotting	clotting	NOUN
ajrhss-1713	73	25	,	,	PUNCT
ajrhss-1713	73	26	and	and	CCONJ
ajrhss-1713	73	27	a	a	DET
ajrhss-1713	73	28	factor	factor	NOUN
ajrhss-1713	73	29	preventing	prevent	VERB
ajrhss-1713	73	30	thrombosis	thrombosis	NOUN
ajrhss-1713	73	31	.	.	PUNCT
ajrhss-1713	74	1	summarizing	summarize	VERB
ajrhss-1713	74	2	the	the	DET
ajrhss-1713	74	3	above	above	ADJ
ajrhss-1713	74	4	data	datum	NOUN
ajrhss-1713	74	5	,	,	PUNCT
ajrhss-1713	74	6	it	it	PRON
ajrhss-1713	74	7	should	should	AUX
ajrhss-1713	74	8	be	be	AUX
ajrhss-1713	74	9	noted	note	VERB
ajrhss-1713	74	10	a	a	DET
ajrhss-1713	74	11	clear	clear	ADJ
ajrhss-1713	74	12	dependence	dependence	NOUN
ajrhss-1713	74	13	of	of	ADP
ajrhss-1713	74	14	the	the	DET
ajrhss-1713	74	15	state	state	NOUN
ajrhss-1713	74	16	of	of	ADP
ajrhss-1713	74	17	the	the	DET
ajrhss-1713	74	18	blood	blood	NOUN
ajrhss-1713	74	19	coagulation	coagulation	NOUN
ajrhss-1713	74	20	system	system	NOUN
ajrhss-1713	74	21	on	on	ADP
ajrhss-1713	74	22	the	the	DET
ajrhss-1713	74	23	phase	phase	NOUN
ajrhss-1713	74	24	of	of	ADP
ajrhss-1713	74	25	the	the	DET
ajrhss-1713	74	26	course	course	NOUN
ajrhss-1713	74	27	,	,	PUNCT
ajrhss-1713	74	28	the	the	DET
ajrhss-1713	74	29	clinical	clinical	ADJ
ajrhss-1713	74	30	form	form	NOUN
ajrhss-1713	74	31	,	,	PUNCT
ajrhss-1713	74	32	the	the	DET
ajrhss-1713	74	33	duration	duration	NOUN
ajrhss-1713	74	34	of	of	ADP
ajrhss-1713	74	35	the	the	DET
ajrhss-1713	74	36	disease	disease	NOUN
ajrhss-1713	74	37	,	,	PUNCT
ajrhss-1713	74	38	and	and	CCONJ
ajrhss-1713	74	39	the	the	DET
ajrhss-1713	74	40	severity	severity	NOUN
ajrhss-1713	74	41	of	of	ADP
ajrhss-1713	74	42	the	the	DET
ajrhss-1713	74	43	patients	patient	NOUN
ajrhss-1713	74	44	'	'	PART
ajrhss-1713	74	45	condition	condition	NOUN
ajrhss-1713	74	46	.	.	PUNCT
ajrhss-1713	75	1	as	as	SCONJ
ajrhss-1713	75	2	can	can	AUX
ajrhss-1713	75	3	be	be	AUX
ajrhss-1713	75	4	seen	see	VERB
ajrhss-1713	75	5	from	from	ADP
ajrhss-1713	75	6	the	the	DET
ajrhss-1713	75	7	above	above	ADJ
ajrhss-1713	75	8	data	datum	NOUN
ajrhss-1713	75	9	,	,	PUNCT
ajrhss-1713	75	10	the	the	DET
ajrhss-1713	75	11	prothrombin	prothrombin	ADJ
ajrhss-1713	75	12	index	index	NOUN
ajrhss-1713	75	13	in	in	ADP
ajrhss-1713	75	14	sick	sick	ADJ
ajrhss-1713	75	15	children	child	NOUN
ajrhss-1713	75	16	with	with	ADP
ajrhss-1713	75	17	chronic	chronic	ADJ
ajrhss-1713	75	18	pneumonia	pneumonia	NOUN
ajrhss-1713	75	19	has	have	VERB
ajrhss-1713	75	20	a	a	DET
ajrhss-1713	75	21	deviation	deviation	NOUN
ajrhss-1713	75	22	from	from	ADP
ajrhss-1713	75	23	the	the	DET
ajrhss-1713	75	24	norm	norm	NOUN
ajrhss-1713	75	25	.	.	PUNCT
ajrhss-1713	76	1	at	at	ADP
ajrhss-1713	76	2	the	the	DET
ajrhss-1713	76	3	same	same	ADJ
ajrhss-1713	76	4	time	time	NOUN
ajrhss-1713	76	5	,	,	PUNCT
ajrhss-1713	76	6	the	the	DET
ajrhss-1713	76	7	most	most	ADV
ajrhss-1713	76	8	significant	significant	ADJ
ajrhss-1713	76	9	deviation	deviation	NOUN
ajrhss-1713	76	10	from	from	ADP
ajrhss-1713	76	11	the	the	DET
ajrhss-1713	76	12	level	level	NOUN
ajrhss-1713	76	13	of	of	ADP
ajrhss-1713	76	14	control	control	NOUN
ajrhss-1713	76	15	figures	figure	NOUN
ajrhss-1713	76	16	was	be	AUX
ajrhss-1713	76	17	observed	observe	VERB
ajrhss-1713	76	18	in	in	ADP
ajrhss-1713	76	19	the	the	DET
ajrhss-1713	76	20	phase	phase	NOUN
ajrhss-1713	76	21	of	of	ADP
ajrhss-1713	76	22	exacerbation	exacerbation	NOUN
ajrhss-1713	76	23	of	of	ADP
ajrhss-1713	76	24	the	the	DET
ajrhss-1713	76	25	disease	disease	NOUN
ajrhss-1713	76	26	.	.	PUNCT
ajrhss-1713	77	1	american	american	PROPN
ajrhss-1713	77	2	journal	journal	PROPN
ajrhss-1713	77	3	of	of	ADP
ajrhss-1713	77	4	research	research	NOUN
ajrhss-1713	77	5	in	in	ADP
ajrhss-1713	77	6	humanities	humanity	NOUN
ajrhss-1713	77	7	and	and	CCONJ
ajrhss-1713	77	8	social	social	ADJ
ajrhss-1713	77	9	sciences	science	NOUN
ajrhss-1713	77	10	volume	volume	NOUN
ajrhss-1713	77	11	20	20	NUM
ajrhss-1713	77	12	january	january	PROPN
ajrhss-1713	77	13	,	,	PUNCT
ajrhss-1713	77	14	2024	2024	NUM
ajrhss-1713	77	15	p	p	NOUN
ajrhss-1713	77	16	a	a	DET
ajrhss-1713	77	17	g	g	NOUN
ajrhss-1713	77	18	e	e	NOUN
ajrhss-1713	77	19	|	|	ADV
ajrhss-1713	77	20	5	5	NUM
ajrhss-1713	77	21	www.americanjournal.org	www.americanjournal.org	NOUN
ajrhss-1713	77	22	a	a	DET
ajrhss-1713	77	23	study	study	NOUN
ajrhss-1713	77	24	of	of	ADP
ajrhss-1713	77	25	the	the	DET
ajrhss-1713	77	26	platelet	platelet	NOUN
ajrhss-1713	77	27	link	link	NOUN
ajrhss-1713	77	28	of	of	ADP
ajrhss-1713	77	29	hemostasis	hemostasis	NOUN
ajrhss-1713	77	30	showed	show	VERB
ajrhss-1713	77	31	that	that	SCONJ
ajrhss-1713	77	32	during	during	ADP
ajrhss-1713	77	33	the	the	DET
ajrhss-1713	77	34	period	period	NOUN
ajrhss-1713	77	35	of	of	ADP
ajrhss-1713	77	36	exacerbation	exacerbation	NOUN
ajrhss-1713	77	37	of	of	ADP
ajrhss-1713	77	38	chronic	chronic	ADJ
ajrhss-1713	77	39	pneumonia	pneumonia	NOUN
ajrhss-1713	77	40	,	,	PUNCT
ajrhss-1713	77	41	an	an	DET
ajrhss-1713	77	42	increase	increase	NOUN
ajrhss-1713	77	43	in	in	ADP
ajrhss-1713	77	44	the	the	DET
ajrhss-1713	77	45	number	number	NOUN
ajrhss-1713	77	46	of	of	ADP
ajrhss-1713	77	47	platelets	platelet	NOUN
ajrhss-1713	77	48	was	be	AUX
ajrhss-1713	77	49	observed	observe	VERB
ajrhss-1713	77	50	in	in	ADP
ajrhss-1713	77	51	all	all	DET
ajrhss-1713	77	52	age	age	NOUN
ajrhss-1713	77	53	groups	group	NOUN
ajrhss-1713	77	54	(	(	PUNCT
ajrhss-1713	77	55	288.2±17.5	288.2±17.5	NOUN
ajrhss-1713	77	56	;	;	PUNCT
ajrhss-1713	77	57	300±22.0	300±22.0	NUM
ajrhss-1713	77	58	)	)	PUNCT
ajrhss-1713	77	59	.	.	PUNCT
ajrhss-1713	78	1	of	of	ADP
ajrhss-1713	78	2	these	these	PRON
ajrhss-1713	78	3	,	,	PUNCT
ajrhss-1713	78	4	in	in	ADP
ajrhss-1713	78	5	some	some	DET
ajrhss-1713	78	6	children	child	NOUN
ajrhss-1713	78	7	of	of	ADP
ajrhss-1713	78	8	patients	patient	NOUN
ajrhss-1713	78	9	with	with	ADP
ajrhss-1713	78	10	bronchiectasis	bronchiectasis	NOUN
ajrhss-1713	78	11	and	and	CCONJ
ajrhss-1713	78	12	a	a	DET
ajrhss-1713	78	13	serious	serious	ADJ
ajrhss-1713	78	14	condition	condition	NOUN
ajrhss-1713	78	15	,	,	PUNCT
ajrhss-1713	78	16	hyperthrombocytosis	hyperthrombocytosis	NOUN
ajrhss-1713	78	17	was	be	AUX
ajrhss-1713	78	18	observed	observe	VERB
ajrhss-1713	78	19	(	(	PUNCT
ajrhss-1713	78	20	329.8±13.1	329.8±13.1	ADJ
ajrhss-1713	78	21	;	;	PUNCT
ajrhss-1713	78	22	342.4±18.7	342.4±18.7	NUM
ajrhss-1713	78	23	)	)	PUNCT
ajrhss-1713	78	24	,	,	PUNCT
ajrhss-1713	78	25	which	which	PRON
ajrhss-1713	78	26	we	we	PRON
ajrhss-1713	78	27	assessed	assess	VERB
ajrhss-1713	78	28	as	as	ADP
ajrhss-1713	78	29	a	a	DET
ajrhss-1713	78	30	thrombophilic	thrombophilic	NOUN
ajrhss-1713	78	31	condition	condition	NOUN
ajrhss-1713	78	32	.	.	PUNCT
ajrhss-1713	79	1	when	when	SCONJ
ajrhss-1713	79	2	studying	study	VERB
ajrhss-1713	79	3	the	the	DET
ajrhss-1713	79	4	hemostasis	hemostasis	NOUN
ajrhss-1713	79	5	system	system	NOUN
ajrhss-1713	79	6	in	in	ADP
ajrhss-1713	79	7	patients	patient	NOUN
ajrhss-1713	79	8	with	with	ADP
ajrhss-1713	79	9	chronic	chronic	ADJ
ajrhss-1713	79	10	pneumonia	pneumonia	NOUN
ajrhss-1713	79	11	depending	depend	VERB
ajrhss-1713	79	12	on	on	ADP
ajrhss-1713	79	13	the	the	DET
ajrhss-1713	79	14	clinical	clinical	ADJ
ajrhss-1713	79	15	form	form	NOUN
ajrhss-1713	79	16	,	,	PUNCT
ajrhss-1713	79	17	age	age	NOUN
ajrhss-1713	79	18	and	and	CCONJ
ajrhss-1713	79	19	severity	severity	NOUN
ajrhss-1713	79	20	of	of	ADP
ajrhss-1713	79	21	the	the	DET
ajrhss-1713	79	22	patients	patient	NOUN
ajrhss-1713	79	23	'	'	PART
ajrhss-1713	79	24	condition	condition	NOUN
ajrhss-1713	79	25	,	,	PUNCT
ajrhss-1713	79	26	we	we	PRON
ajrhss-1713	79	27	encountered	encounter	VERB
ajrhss-1713	79	28	large	large	ADJ
ajrhss-1713	79	29	fluctuations	fluctuation	NOUN
ajrhss-1713	79	30	of	of	ADP
ajrhss-1713	79	31	these	these	DET
ajrhss-1713	79	32	indicators	indicator	NOUN
ajrhss-1713	79	33	.	.	PUNCT
ajrhss-1713	80	1	in	in	ADP
ajrhss-1713	80	2	this	this	DET
ajrhss-1713	80	3	regard	regard	NOUN
ajrhss-1713	80	4	,	,	PUNCT
ajrhss-1713	80	5	we	we	PRON
ajrhss-1713	80	6	identified	identify	VERB
ajrhss-1713	80	7	the	the	DET
ajrhss-1713	80	8	following	follow	VERB
ajrhss-1713	80	9	types	type	NOUN
ajrhss-1713	80	10	of	of	ADP
ajrhss-1713	80	11	changes	change	NOUN
ajrhss-1713	80	12	in	in	ADP
ajrhss-1713	80	13	the	the	DET
ajrhss-1713	80	14	functional	functional	ADJ
ajrhss-1713	80	15	state	state	NOUN
ajrhss-1713	80	16	of	of	ADP
ajrhss-1713	80	17	the	the	DET
ajrhss-1713	80	18	hemostasis	hemostasis	NOUN
ajrhss-1713	80	19	system	system	NOUN
ajrhss-1713	80	20	in	in	ADP
ajrhss-1713	80	21	chronic	chronic	ADJ
ajrhss-1713	80	22	pneumonia	pneumonia	NOUN
ajrhss-1713	80	23	in	in	ADP
ajrhss-1713	80	24	children	child	NOUN
ajrhss-1713	80	25	.	.	PUNCT
ajrhss-1713	81	1	we	we	PRON
ajrhss-1713	81	2	regarded	regard	VERB
ajrhss-1713	81	3	the	the	DET
ajrhss-1713	81	4	increase	increase	NOUN
ajrhss-1713	81	5	or	or	CCONJ
ajrhss-1713	81	6	decrease	decrease	VERB
ajrhss-1713	81	7	in	in	ADP
ajrhss-1713	81	8	hemostasis	hemostasis	NOUN
ajrhss-1713	81	9	indicators	indicator	NOUN
ajrhss-1713	81	10	from	from	ADP
ajrhss-1713	81	11	the	the	DET
ajrhss-1713	81	12	initial	initial	ADJ
ajrhss-1713	81	13	level	level	NOUN
ajrhss-1713	81	14	of	of	ADP
ajrhss-1713	81	15	healthy	healthy	ADJ
ajrhss-1713	81	16	children	child	NOUN
ajrhss-1713	81	17	by	by	ADP
ajrhss-1713	81	18	50	50	NUM
ajrhss-1713	81	19	-	-	SYM
ajrhss-1713	81	20	60	60	NUM
ajrhss-1713	81	21	%	%	NOUN
ajrhss-1713	81	22	as	as	ADP
ajrhss-1713	81	23	a	a	DET
ajrhss-1713	81	24	compensatory	compensatory	ADJ
ajrhss-1713	81	25	type	type	NOUN
ajrhss-1713	81	26	,	,	PUNCT
ajrhss-1713	81	27	60	60	NUM
ajrhss-1713	81	28	-	-	SYM
ajrhss-1713	81	29	90	90	NUM
ajrhss-1713	81	30	%	%	NOUN
ajrhss-1713	81	31	subcompensatory	subcompensatory	ADJ
ajrhss-1713	81	32	type	type	NOUN
ajrhss-1713	81	33	,	,	PUNCT
ajrhss-1713	81	34	100	100	NUM
ajrhss-1713	81	35	%	%	NOUN
ajrhss-1713	81	36	or	or	CCONJ
ajrhss-1713	81	37	more	more	ADJ
ajrhss-1713	81	38	decompensatory	decompensatory	NOUN
ajrhss-1713	81	39	type	type	NOUN
ajrhss-1713	81	40	i	i	PRON
ajrhss-1713	81	41	and	and	CCONJ
ajrhss-1713	81	42	below	below	ADP
ajrhss-1713	81	43	40	40	NUM
ajrhss-1713	81	44	%	%	NOUN
ajrhss-1713	81	45	decompensatory	decompensatory	NOUN
ajrhss-1713	81	46	type	type	NOUN
ajrhss-1713	81	47	ii	ii	NOUN
ajrhss-1713	81	48	hemostasis	hemostasis	NOUN
ajrhss-1713	81	49	disorders	disorder	NOUN
ajrhss-1713	81	50	table	table	NOUN
ajrhss-1713	81	51	2	2	NUM
ajrhss-1713	81	52	.	.	PUNCT
ajrhss-1713	81	53	a	a	DET
ajrhss-1713	81	54	compensatory	compensatory	ADJ
ajrhss-1713	81	55	type	type	NOUN
ajrhss-1713	81	56	of	of	ADP
ajrhss-1713	81	57	disorder	disorder	NOUN
ajrhss-1713	81	58	was	be	AUX
ajrhss-1713	81	59	observed	observe	VERB
ajrhss-1713	81	60	in	in	ADP
ajrhss-1713	81	61	60	60	NUM
ajrhss-1713	81	62	%	%	NOUN
ajrhss-1713	81	63	of	of	ADP
ajrhss-1713	81	64	patients	patient	NOUN
ajrhss-1713	81	65	aged	age	VERB
ajrhss-1713	81	66	3	3	NUM
ajrhss-1713	81	67	-	-	SYM
ajrhss-1713	81	68	7	7	NUM
ajrhss-1713	81	69	years	year	NOUN
ajrhss-1713	81	70	and	and	CCONJ
ajrhss-1713	81	71	44.3	44.3	NUM
ajrhss-1713	81	72	%	%	NOUN
ajrhss-1713	81	73	at	at	ADP
ajrhss-1713	81	74	the	the	DET
ajrhss-1713	81	75	age	age	NOUN
ajrhss-1713	81	76	of	of	ADP
ajrhss-1713	81	77	8	8	NUM
ajrhss-1713	81	78	-	-	SYM
ajrhss-1713	81	79	15	15	NUM
ajrhss-1713	81	80	years	year	NOUN
ajrhss-1713	81	81	.	.	PUNCT
ajrhss-1713	82	1	when	when	SCONJ
ajrhss-1713	82	2	assessed	assess	VERB
ajrhss-1713	82	3	from	from	ADP
ajrhss-1713	82	4	the	the	DET
ajrhss-1713	82	5	clinical	clinical	ADJ
ajrhss-1713	82	6	form	form	NOUN
ajrhss-1713	82	7	,	,	PUNCT
ajrhss-1713	82	8	a	a	DET
ajrhss-1713	82	9	compensatory	compensatory	ADJ
ajrhss-1713	82	10	type	type	NOUN
ajrhss-1713	82	11	of	of	ADP
ajrhss-1713	82	12	disorder	disorder	NOUN
ajrhss-1713	82	13	was	be	AUX
ajrhss-1713	82	14	observed	observe	VERB
ajrhss-1713	82	15	in	in	ADP
ajrhss-1713	82	16	34.3	34.3	NUM
ajrhss-1713	82	17	%	%	NOUN
ajrhss-1713	82	18	of	of	ADP
ajrhss-1713	82	19	patients	patient	NOUN
ajrhss-1713	82	20	with	with	ADP
ajrhss-1713	82	21	bronchial	bronchial	ADJ
ajrhss-1713	82	22	deformity	deformity	NOUN
ajrhss-1713	82	23	without	without	ADP
ajrhss-1713	82	24	their	their	PRON
ajrhss-1713	82	25	expansion	expansion	NOUN
ajrhss-1713	82	26	.	.	PUNCT
ajrhss-1713	83	1	and	and	CCONJ
ajrhss-1713	83	2	in	in	ADP
ajrhss-1713	83	3	patients	patient	NOUN
ajrhss-1713	83	4	with	with	ADP
ajrhss-1713	83	5	moderate	moderate	ADJ
ajrhss-1713	83	6	severity	severity	NOUN
ajrhss-1713	83	7	,	,	PUNCT
ajrhss-1713	83	8	a	a	DET
ajrhss-1713	83	9	compensatory	compensatory	ADJ
ajrhss-1713	83	10	type	type	NOUN
ajrhss-1713	83	11	of	of	ADP
ajrhss-1713	83	12	hemostasis	hemostasis	NOUN
ajrhss-1713	83	13	disorder	disorder	NOUN
ajrhss-1713	83	14	was	be	AUX
ajrhss-1713	83	15	observed	observe	VERB
ajrhss-1713	83	16	in	in	ADP
ajrhss-1713	83	17	28.6	28.6	NUM
ajrhss-1713	83	18	%	%	NOUN
ajrhss-1713	83	19	.	.	PUNCT
ajrhss-1713	84	1	table	table	NOUN
ajrhss-1713	84	2	2	2	NUM
ajrhss-1713	84	3	.	.	PUNCT
ajrhss-1713	84	4	comparative	comparative	ADJ
ajrhss-1713	84	5	assessment	assessment	NOUN
ajrhss-1713	84	6	of	of	ADP
ajrhss-1713	84	7	hemostasis	hemostasis	NOUN
ajrhss-1713	84	8	indicators	indicator	NOUN
ajrhss-1713	84	9	in	in	ADP
ajrhss-1713	84	10	relation	relation	NOUN
ajrhss-1713	84	11	to	to	ADP
ajrhss-1713	84	12	the	the	DET
ajrhss-1713	84	13	number	number	NOUN
ajrhss-1713	84	14	of	of	ADP
ajrhss-1713	84	15	patients	patient	NOUN
ajrhss-1713	84	16	(	(	PUNCT
ajrhss-1713	84	17	%	%	INTJ
ajrhss-1713	84	18	)	)	PUNCT
ajrhss-1713	84	19	in	in	ADP
ajrhss-1713	84	20	d	d	X
ajrhss-1713	84	21	ic	ic	PROPN
ajrhss-1713	84	22	a	a	PRON
ajrhss-1713	84	23	to	to	ADP
ajrhss-1713	84	24	rs	rs	PROPN
ajrhss-1713	85	1	c	c	NOUN
ajrhss-1713	85	2	o	o	NOUN
ajrhss-1713	86	1	m	m	VERB
ajrhss-1713	86	2	p	p	X
ajrhss-1713	86	3	en	en	ADP
ajrhss-1713	86	4	sa	sa	NOUN
ajrhss-1713	86	5	to	to	ADP
ajrhss-1713	86	6	ry	ry	PROPN
ajrhss-1713	86	7	t	t	PROPN
ajrhss-1713	86	8	y	y	PROPN
ajrhss-1713	87	1	p	p	PROPN
ajrhss-1713	87	2	e	e	PROPN
ajrhss-1713	87	3	s	s	PROPN
ajrhss-1713	87	4	u	u	X
ajrhss-1713	87	5	b	b	X
ajrhss-1713	87	6	co	co	NOUN
ajrhss-1713	87	7	m	m	PROPN
ajrhss-1713	87	8	p	p	NOUN
ajrhss-1713	87	9	en	en	ADP
ajrhss-1713	87	10	sa	sa	NOUN
ajrhss-1713	87	11	to	to	PART
ajrhss-1713	87	12	ry	ry	VERB
ajrhss-1713	87	13	ty	ty	INTJ
ajrhss-1713	87	14	p	p	X
ajrhss-1713	87	15	e	e	PROPN
ajrhss-1713	87	16	d	d	X
ajrhss-1713	87	17	ec	ec	PROPN
ajrhss-1713	88	1	o	o	NOUN
ajrhss-1713	88	2	m	m	VERB
ajrhss-1713	88	3	p	p	X
ajrhss-1713	88	4	en	en	ADP
ajrhss-1713	88	5	sa	sa	NOUN
ajrhss-1713	88	6	to	to	PART
ajrhss-1713	88	7	ry	ry	VERB
ajrhss-1713	88	8	ty	ty	INTJ
ajrhss-1713	88	9	p	p	NOUN
ajrhss-1713	89	1	e	e	NOUN
ajrhss-1713	90	1	i	i	NOUN
ajrhss-1713	91	1	d	d	NOUN
ajrhss-1713	91	2	ec	ec	PROPN
ajrhss-1713	92	1	o	o	NOUN
ajrhss-1713	92	2	m	m	VERB
ajrhss-1713	92	3	p	p	X
ajrhss-1713	92	4	en	en	ADP
ajrhss-1713	92	5	sa	sa	NOUN
ajrhss-1713	92	6	to	to	PART
ajrhss-1713	92	7	ry	ry	VERB
ajrhss-1713	92	8	ty	ty	INTJ
ajrhss-1713	92	9	p	p	X
ajrhss-1713	92	10	e	e	PROPN
ajrhss-1713	92	11	ii	ii	NOUN
ajrhss-1713	92	12	in	in	ADP
ajrhss-1713	92	13	children	child	NOUN
ajrhss-1713	92	14	aged	age	VERB
ajrhss-1713	92	15	3	3	NUM
ajrhss-1713	92	16	to	to	PART
ajrhss-1713	92	17	7	7	NUM
ajrhss-1713	92	18	years	year	NOUN
ajrhss-1713	92	19	n=30	n=30	ADV
ajrhss-1713	92	20	60	60	NUM
ajrhss-1713	92	21	26,6	26,6	PROPN
ajrhss-1713	92	22	13,4	13,4	NUM
ajrhss-1713	92	23	for	for	ADP
ajrhss-1713	92	24	children	child	NOUN
ajrhss-1713	92	25	8	8	NUM
ajrhss-1713	92	26	to	to	PART
ajrhss-1713	92	27	15	15	NUM
ajrhss-1713	92	28	years	year	NOUN
ajrhss-1713	92	29	old	old	ADJ
ajrhss-1713	93	1	n=70	n=70	ADJ
ajrhss-1713	93	2	44,3	44,3	NUM
ajrhss-1713	93	3	38,6	38,6	NUM
ajrhss-1713	93	4	12,8	12,8	NUM
ajrhss-1713	93	5	4,3	4,3	NUM
ajrhss-1713	93	6	with	with	ADP
ajrhss-1713	93	7	bronchial	bronchial	ADJ
ajrhss-1713	93	8	deformity	deformity	NOUN
ajrhss-1713	93	9	n=70	n=70	ADJ
ajrhss-1713	93	10	with	with	ADP
ajrhss-1713	93	11	bronchiectasis	bronchiectasis	NOUN
ajrhss-1713	93	12	n=30	n=30	NOUN
ajrhss-1713	93	13	34,3	34,3	PROPN
ajrhss-1713	93	14	65,7	65,7	NOUN
ajrhss-1713	93	15	with	with	ADP
ajrhss-1713	93	16	moderate	moderate	ADJ
ajrhss-1713	93	17	condition	condition	NOUN
ajrhss-1713	93	18	n=84	n=84	NOUN
ajrhss-1713	93	19	with	with	ADP
ajrhss-1713	93	20	serious	serious	ADJ
ajrhss-1713	93	21	condition	condition	NOUN
ajrhss-1713	93	22	n=16	n=16	NOUN
ajrhss-1713	93	23	33,4	33,4	NUM
ajrhss-1713	93	24	56,6	56,6	NUM
ajrhss-1713	93	25	10	10	NUM
ajrhss-1713	93	26	in	in	ADP
ajrhss-1713	93	27	patients	patient	NOUN
ajrhss-1713	93	28	with	with	ADP
ajrhss-1713	93	29	a	a	DET
ajrhss-1713	93	30	compensatory	compensatory	ADJ
ajrhss-1713	93	31	type	type	NOUN
ajrhss-1713	93	32	of	of	ADP
ajrhss-1713	93	33	hemostasis	hemostasis	NOUN
ajrhss-1713	93	34	disorder	disorder	NOUN
ajrhss-1713	93	35	during	during	ADP
ajrhss-1713	93	36	exacerbation	exacerbation	NOUN
ajrhss-1713	93	37	of	of	ADP
ajrhss-1713	93	38	chronic	chronic	ADJ
ajrhss-1713	93	39	pneumonia	pneumonia	NOUN
ajrhss-1713	93	40	,	,	PUNCT
ajrhss-1713	93	41	a	a	DET
ajrhss-1713	93	42	moderate	moderate	ADJ
ajrhss-1713	93	43	activation	activation	NOUN
ajrhss-1713	93	44	of	of	ADP
ajrhss-1713	93	45	the	the	DET
ajrhss-1713	93	46	procoagulant	procoagulant	NOUN
ajrhss-1713	93	47	link	link	NOUN
ajrhss-1713	93	48	of	of	ADP
ajrhss-1713	93	49	the	the	DET
ajrhss-1713	93	50	hemostasis	hemostasis	NOUN
ajrhss-1713	93	51	system	system	NOUN
ajrhss-1713	93	52	occurs	occur	VERB
ajrhss-1713	93	53	.	.	PUNCT
ajrhss-1713	94	1	the	the	DET
ajrhss-1713	94	2	activation	activation	NOUN
ajrhss-1713	94	3	of	of	ADP
ajrhss-1713	94	4	the	the	DET
ajrhss-1713	94	5	procoagulative	procoagulative	ADJ
ajrhss-1713	94	6	link	link	NOUN
ajrhss-1713	94	7	was	be	AUX
ajrhss-1713	94	8	evidenced	evidence	VERB
ajrhss-1713	94	9	by	by	ADP
ajrhss-1713	94	10	a	a	DET
ajrhss-1713	94	11	moderate	moderate	ADJ
ajrhss-1713	94	12	increase	increase	NOUN
ajrhss-1713	94	13	in	in	ADP
ajrhss-1713	94	14	plasma	plasma	NOUN
ajrhss-1713	94	15	fibrinogen	fibrinogen	NOUN
ajrhss-1713	94	16	content	content	NOUN
ajrhss-1713	94	17	,	,	PUNCT
ajrhss-1713	94	18	a	a	DET
ajrhss-1713	94	19	shortening	shortening	NOUN
ajrhss-1713	94	20	of	of	ADP
ajrhss-1713	94	21	the	the	DET
ajrhss-1713	94	22	plasma	plasma	NOUN
ajrhss-1713	94	23	recalcification	recalcification	NOUN
ajrhss-1713	94	24	time	time	NOUN
ajrhss-1713	94	25	,	,	PUNCT
ajrhss-1713	94	26	an	an	DET
ajrhss-1713	94	27	increase	increase	NOUN
ajrhss-1713	94	28	in	in	ADP
ajrhss-1713	94	29	plasma	plasma	NOUN
ajrhss-1713	94	30	tolerance	tolerance	NOUN
ajrhss-1713	94	31	to	to	ADP
ajrhss-1713	94	32	heparin	heparin	NOUN
ajrhss-1713	94	33	,	,	PUNCT
ajrhss-1713	94	34	a	a	DET
ajrhss-1713	94	35	slight	slight	ADJ
ajrhss-1713	94	36	decrease	decrease	NOUN
ajrhss-1713	94	37	in	in	ADP
ajrhss-1713	94	38	blood	blood	NOUN
ajrhss-1713	94	39	fibrinolytic	fibrinolytic	ADJ
ajrhss-1713	94	40	activity	activity	NOUN
ajrhss-1713	94	41	(	(	PUNCT
ajrhss-1713	94	42	p	p	X
ajrhss-1713	94	43	>	>	X
ajrhss-1713	94	44	0.05	0.05	NUM
ajrhss-1713	94	45	)	)	PUNCT
ajrhss-1713	94	46	and	and	CCONJ
ajrhss-1713	94	47	a	a	DET
ajrhss-1713	94	48	negative	negative	ADJ
ajrhss-1713	94	49	ethanol	ethanol	NOUN
ajrhss-1713	94	50	and	and	CCONJ
ajrhss-1713	94	51	protamine	protamine	NOUN
ajrhss-1713	94	52	sulfate	sulfate	NOUN
ajrhss-1713	94	53	test	test	NOUN
ajrhss-1713	94	54	.	.	PUNCT
ajrhss-1713	95	1	we	we	PRON
ajrhss-1713	95	2	regarded	regard	VERB
ajrhss-1713	95	3	the	the	DET
ajrhss-1713	95	4	compensatory	compensatory	ADJ
ajrhss-1713	95	5	type	type	NOUN
ajrhss-1713	95	6	of	of	ADP
ajrhss-1713	95	7	hemostasis	hemostasis	NOUN
ajrhss-1713	95	8	impairment	impairment	NOUN
ajrhss-1713	95	9	as	as	ADP
ajrhss-1713	95	10	a	a	DET
ajrhss-1713	95	11	state	state	NOUN
ajrhss-1713	95	12	of	of	ADP
ajrhss-1713	95	13	moderate	moderate	ADJ
ajrhss-1713	95	14	hypercoagulability	hypercoagulability	NOUN
ajrhss-1713	95	15	and	and	CCONJ
ajrhss-1713	95	16	considered	consider	VERB
ajrhss-1713	95	17	it	it	PRON
ajrhss-1713	95	18	an	an	DET
ajrhss-1713	95	19	adequate	adequate	ADJ
ajrhss-1713	95	20	response	response	NOUN
ajrhss-1713	95	21	of	of	ADP
ajrhss-1713	95	22	the	the	DET
ajrhss-1713	95	23	body	body	NOUN
ajrhss-1713	95	24	to	to	ADP
ajrhss-1713	95	25	inflammation	inflammation	NOUN
ajrhss-1713	95	26	.	.	PUNCT
ajrhss-1713	96	1	a	a	DET
ajrhss-1713	96	2	subcompensatory	subcompensatory	ADJ
ajrhss-1713	96	3	type	type	NOUN
ajrhss-1713	96	4	of	of	ADP
ajrhss-1713	96	5	hemostatic	hemostatic	ADJ
ajrhss-1713	96	6	disorder	disorder	NOUN
ajrhss-1713	96	7	was	be	AUX
ajrhss-1713	96	8	observed	observe	VERB
ajrhss-1713	96	9	in	in	ADP
ajrhss-1713	96	10	26.6	26.6	NUM
ajrhss-1713	96	11	%	%	NOUN
ajrhss-1713	96	12	of	of	ADP
ajrhss-1713	96	13	patients	patient	NOUN
ajrhss-1713	96	14	aged	age	VERB
ajrhss-1713	96	15	3	3	NUM
ajrhss-1713	96	16	-	-	SYM
ajrhss-1713	96	17	7	7	NUM
ajrhss-1713	96	18	years	year	NOUN
ajrhss-1713	96	19	,	,	PUNCT
ajrhss-1713	96	20	in	in	ADP
ajrhss-1713	96	21	38.6	38.6	NUM
ajrhss-1713	96	22	%	%	NOUN
ajrhss-1713	96	23	of	of	ADP
ajrhss-1713	96	24	patients	patient	NOUN
ajrhss-1713	96	25	aged	age	VERB
ajrhss-1713	96	26	8	8	NUM
ajrhss-1713	96	27	-	-	SYM
ajrhss-1713	96	28	15	15	NUM
ajrhss-1713	96	29	years	year	NOUN
ajrhss-1713	96	30	,	,	PUNCT
ajrhss-1713	96	31	in	in	ADP
ajrhss-1713	96	32	children	child	NOUN
ajrhss-1713	96	33	with	with	ADP
ajrhss-1713	96	34	bronchial	bronchial	ADJ
ajrhss-1713	96	35	deformity	deformity	NOUN
ajrhss-1713	96	36	,	,	PUNCT
ajrhss-1713	96	37	a	a	DET
ajrhss-1713	96	38	subcompensatory	subcompensatory	ADJ
ajrhss-1713	96	39	type	type	NOUN
ajrhss-1713	96	40	of	of	ADP
ajrhss-1713	96	41	disorder	disorder	NOUN
ajrhss-1713	96	42	was	be	AUX
ajrhss-1713	96	43	observed	observe	VERB
ajrhss-1713	96	44	in	in	ADP
ajrhss-1713	96	45	65.7	65.7	NUM
ajrhss-1713	96	46	%	%	NOUN
ajrhss-1713	96	47	,	,	PUNCT
ajrhss-1713	96	48	with	with	ADP
ajrhss-1713	96	49	bronchiectasis	bronchiectasis	NOUN
ajrhss-1713	96	50	in	in	ADP
ajrhss-1713	96	51	33	33	NUM
ajrhss-1713	96	52	,	,	PUNCT
ajrhss-1713	96	53	4	4	NUM
ajrhss-1713	96	54	%	%	NOUN
ajrhss-1713	96	55	of	of	ADP
ajrhss-1713	96	56	patients	patient	NOUN
ajrhss-1713	96	57	,	,	PUNCT
ajrhss-1713	96	58	which	which	PRON
ajrhss-1713	96	59	was	be	AUX
ajrhss-1713	96	60	associated	associate	VERB
ajrhss-1713	96	61	with	with	ADP
ajrhss-1713	96	62	the	the	DET
ajrhss-1713	96	63	duration	duration	NOUN
ajrhss-1713	96	64	of	of	ADP
ajrhss-1713	96	65	the	the	DET
ajrhss-1713	96	66	disease	disease	NOUN
ajrhss-1713	96	67	and	and	CCONJ
ajrhss-1713	96	68	the	the	DET
ajrhss-1713	96	69	incidence	incidence	NOUN
ajrhss-1713	96	70	of	of	ADP
ajrhss-1713	96	71	bronchiectasis	bronchiectasis	NOUN
ajrhss-1713	96	72	.	.	PUNCT
ajrhss-1713	97	1	american	american	PROPN
ajrhss-1713	97	2	journal	journal	PROPN
ajrhss-1713	97	3	of	of	ADP
ajrhss-1713	97	4	research	research	NOUN
ajrhss-1713	97	5	in	in	ADP
ajrhss-1713	97	6	humanities	humanity	NOUN
ajrhss-1713	97	7	and	and	CCONJ
ajrhss-1713	97	8	social	social	ADJ
ajrhss-1713	97	9	sciences	science	NOUN
ajrhss-1713	97	10	volume	volume	NOUN
ajrhss-1713	97	11	20	20	NUM
ajrhss-1713	97	12	january	january	PROPN
ajrhss-1713	97	13	,	,	PUNCT
ajrhss-1713	97	14	2024	2024	NUM
ajrhss-1713	97	15	p	p	NOUN
ajrhss-1713	97	16	a	a	PRON
ajrhss-1713	97	17	g	g	NOUN
ajrhss-1713	97	18	e	e	NOUN
ajrhss-1713	98	1	|	|	ADV
ajrhss-1713	98	2	6	6	NUM
ajrhss-1713	98	3	www.americanjournal.org	www.americanjournal.org	NOUN
ajrhss-1713	98	4	when	when	SCONJ
ajrhss-1713	98	5	studying	study	VERB
ajrhss-1713	98	6	the	the	DET
ajrhss-1713	98	7	severity	severity	NOUN
ajrhss-1713	98	8	of	of	ADP
ajrhss-1713	98	9	the	the	DET
ajrhss-1713	98	10	condition	condition	NOUN
ajrhss-1713	98	11	of	of	ADP
ajrhss-1713	98	12	patients	patient	NOUN
ajrhss-1713	98	13	,	,	PUNCT
ajrhss-1713	98	14	the	the	DET
ajrhss-1713	98	15	subcompensatory	subcompensatory	ADJ
ajrhss-1713	98	16	type	type	NOUN
ajrhss-1713	98	17	of	of	ADP
ajrhss-1713	98	18	disorder	disorder	NOUN
ajrhss-1713	98	19	was	be	AUX
ajrhss-1713	98	20	found	find	VERB
ajrhss-1713	98	21	in	in	ADP
ajrhss-1713	98	22	71.4	71.4	NUM
ajrhss-1713	98	23	%	%	NOUN
ajrhss-1713	98	24	of	of	ADP
ajrhss-1713	98	25	patients	patient	NOUN
ajrhss-1713	98	26	with	with	ADP
ajrhss-1713	98	27	moderate	moderate	ADJ
ajrhss-1713	98	28	severity	severity	NOUN
ajrhss-1713	98	29	.	.	PUNCT
ajrhss-1713	99	1	in	in	ADP
ajrhss-1713	99	2	patients	patient	NOUN
ajrhss-1713	99	3	with	with	ADP
ajrhss-1713	99	4	a	a	DET
ajrhss-1713	99	5	subcompensatory	subcompensatory	ADJ
ajrhss-1713	99	6	type	type	NOUN
ajrhss-1713	99	7	of	of	ADP
ajrhss-1713	99	8	hemostasis	hemostasis	NOUN
ajrhss-1713	99	9	disorder	disorder	NOUN
ajrhss-1713	99	10	,	,	PUNCT
ajrhss-1713	99	11	there	there	PRON
ajrhss-1713	99	12	was	be	VERB
ajrhss-1713	99	13	a	a	DET
ajrhss-1713	99	14	higher	high	ADJ
ajrhss-1713	99	15	activation	activation	NOUN
ajrhss-1713	99	16	of	of	ADP
ajrhss-1713	99	17	the	the	DET
ajrhss-1713	99	18	procoagulant	procoagulant	NOUN
ajrhss-1713	99	19	link	link	NOUN
ajrhss-1713	99	20	of	of	ADP
ajrhss-1713	99	21	the	the	DET
ajrhss-1713	99	22	hemostasis	hemostasis	NOUN
ajrhss-1713	99	23	system	system	NOUN
ajrhss-1713	99	24	.	.	PUNCT
ajrhss-1713	100	1	these	these	DET
ajrhss-1713	100	2	patients	patient	NOUN
ajrhss-1713	100	3	had	have	VERB
ajrhss-1713	100	4	an	an	DET
ajrhss-1713	100	5	even	even	ADV
ajrhss-1713	100	6	more	more	ADV
ajrhss-1713	100	7	significant	significant	ADJ
ajrhss-1713	100	8	increase	increase	NOUN
ajrhss-1713	100	9	in	in	ADP
ajrhss-1713	100	10	fibrinogen	fibrinogen	NOUN
ajrhss-1713	100	11	content	content	NOUN
ajrhss-1713	100	12	.	.	PUNCT
ajrhss-1713	101	1	in	in	ADP
ajrhss-1713	101	2	decompensatory	decompensatory	NOUN
ajrhss-1713	101	3	type	type	NOUN
ajrhss-1713	101	4	i	i	PRON
ajrhss-1713	101	5	hemostasis	hemostasis	NOUN
ajrhss-1713	101	6	disorders	disorder	NOUN
ajrhss-1713	101	7	,	,	PUNCT
ajrhss-1713	101	8	the	the	DET
ajrhss-1713	101	9	level	level	NOUN
ajrhss-1713	101	10	of	of	ADP
ajrhss-1713	101	11	prothrombin	prothrombin	ADJ
ajrhss-1713	101	12	activity	activity	NOUN
ajrhss-1713	101	13	began	begin	VERB
ajrhss-1713	101	14	to	to	PART
ajrhss-1713	101	15	decrease	decrease	VERB
ajrhss-1713	101	16	,	,	PUNCT
ajrhss-1713	101	17	the	the	DET
ajrhss-1713	101	18	level	level	NOUN
ajrhss-1713	101	19	of	of	ADP
ajrhss-1713	101	20	fibrinogen	fibrinogen	NOUN
ajrhss-1713	101	21	significantly	significantly	ADV
ajrhss-1713	101	22	increased	increase	VERB
ajrhss-1713	101	23	(	(	PUNCT
ajrhss-1713	101	24	p<0.001	p<0.001	PROPN
ajrhss-1713	101	25	)	)	PUNCT
ajrhss-1713	101	26	,	,	PUNCT
ajrhss-1713	101	27	and	and	CCONJ
ajrhss-1713	101	28	more	more	ADV
ajrhss-1713	101	29	noticeably	noticeably	ADV
ajrhss-1713	101	30	than	than	ADP
ajrhss-1713	101	31	in	in	ADP
ajrhss-1713	101	32	the	the	DET
ajrhss-1713	101	33	subcompensatory	subcompensatory	ADJ
ajrhss-1713	101	34	type	type	NOUN
ajrhss-1713	101	35	of	of	ADP
ajrhss-1713	101	36	disorder	disorder	NOUN
ajrhss-1713	101	37	,	,	PUNCT
ajrhss-1713	101	38	the	the	DET
ajrhss-1713	101	39	most	most	ADV
ajrhss-1713	101	40	significant	significant	ADJ
ajrhss-1713	101	41	acceleration	acceleration	NOUN
ajrhss-1713	101	42	of	of	ADP
ajrhss-1713	101	43	recalcification	recalcification	NOUN
ajrhss-1713	101	44	time	time	NOUN
ajrhss-1713	101	45	was	be	AUX
ajrhss-1713	101	46	observed	observe	VERB
ajrhss-1713	101	47	,	,	PUNCT
ajrhss-1713	101	48	the	the	DET
ajrhss-1713	101	49	content	content	NOUN
ajrhss-1713	101	50	of	of	ADP
ajrhss-1713	101	51	heparin	heparin	NOUN
ajrhss-1713	101	52	in	in	ADP
ajrhss-1713	101	53	the	the	DET
ajrhss-1713	101	54	blood	blood	NOUN
ajrhss-1713	101	55	was	be	AUX
ajrhss-1713	101	56	significantly	significantly	ADV
ajrhss-1713	101	57	reduced	reduce	VERB
ajrhss-1713	101	58	,	,	PUNCT
ajrhss-1713	101	59	inhibition	inhibition	NOUN
ajrhss-1713	101	60	was	be	AUX
ajrhss-1713	101	61	noted	note	VERB
ajrhss-1713	101	62	.	.	PUNCT
ajrhss-1713	102	1	fibrinolytic	fibrinolytic	ADJ
ajrhss-1713	102	2	activity	activity	NOUN
ajrhss-1713	102	3	of	of	ADP
ajrhss-1713	102	4	the	the	DET
ajrhss-1713	102	5	blood	blood	NOUN
ajrhss-1713	102	6	,	,	PUNCT
ajrhss-1713	102	7	in	in	ADP
ajrhss-1713	102	8	25	25	NUM
ajrhss-1713	102	9	%	%	NOUN
ajrhss-1713	102	10	of	of	ADP
ajrhss-1713	102	11	children	child	NOUN
ajrhss-1713	102	12	all	all	DET
ajrhss-1713	102	13	paracoagulation	paracoagulation	NOUN
ajrhss-1713	102	14	tests	test	VERB
ajrhss-1713	102	15	fibrinogen	fibrinogen	NOUN
ajrhss-1713	102	16	b	b	NOUN
ajrhss-1713	102	17	,	,	PUNCT
ajrhss-1713	102	18	ethanol	ethanol	NOUN
ajrhss-1713	102	19	,	,	PUNCT
ajrhss-1713	102	20	protamine	protamine	NOUN
ajrhss-1713	102	21	sulfate	sulfate	NOUN
ajrhss-1713	102	22	test	test	NOUN
ajrhss-1713	102	23	were	be	AUX
ajrhss-1713	102	24	positive	positive	ADJ
ajrhss-1713	102	25	.	.	PUNCT
ajrhss-1713	103	1	conclusions	conclusion	NOUN
ajrhss-1713	103	2	thus	thus	ADV
ajrhss-1713	103	3	,	,	PUNCT
ajrhss-1713	103	4	the	the	DET
ajrhss-1713	103	5	presented	present	VERB
ajrhss-1713	103	6	data	datum	NOUN
ajrhss-1713	103	7	indicate	indicate	VERB
ajrhss-1713	103	8	a	a	DET
ajrhss-1713	103	9	significant	significant	ADJ
ajrhss-1713	103	10	pathogenetic	pathogenetic	ADJ
ajrhss-1713	103	11	significance	significance	NOUN
ajrhss-1713	103	12	of	of	ADP
ajrhss-1713	103	13	changes	change	NOUN
ajrhss-1713	103	14	in	in	ADP
ajrhss-1713	103	15	hemostasis	hemostasis	NOUN
ajrhss-1713	103	16	in	in	ADP
ajrhss-1713	103	17	patients	patient	NOUN
ajrhss-1713	103	18	with	with	ADP
ajrhss-1713	103	19	chronic	chronic	ADJ
ajrhss-1713	103	20	pneumonia	pneumonia	NOUN
ajrhss-1713	103	21	,	,	PUNCT
ajrhss-1713	103	22	which	which	PRON
ajrhss-1713	103	23	requires	require	VERB
ajrhss-1713	103	24	the	the	DET
ajrhss-1713	103	25	search	search	NOUN
ajrhss-1713	103	26	for	for	ADP
ajrhss-1713	103	27	new	new	ADJ
ajrhss-1713	103	28	methods	method	NOUN
ajrhss-1713	103	29	of	of	ADP
ajrhss-1713	103	30	pathogenetic	pathogenetic	ADJ
ajrhss-1713	103	31	therapy	therapy	NOUN
ajrhss-1713	103	32	based	base	VERB
ajrhss-1713	103	33	on	on	ADP
ajrhss-1713	103	34	the	the	DET
ajrhss-1713	103	35	anticoagulant	anticoagulant	ADJ
ajrhss-1713	103	36	effect	effect	NOUN
ajrhss-1713	103	37	.	.	PUNCT
ajrhss-1713	104	1	references	reference	NOUN
ajrhss-1713	104	2	1	1	NUM
ajrhss-1713	104	3	.	.	PUNCT
ajrhss-1713	104	4	kostin	kostin	PROPN
ajrhss-1713	104	5	a.s	a.s	PROPN
ajrhss-1713	104	6	.	.	PROPN
ajrhss-1713	104	7	,	,	PUNCT
ajrhss-1713	104	8	tereshchenko	tereshchenko	PROPN
ajrhss-1713	104	9	l.v	l.v	PROPN
ajrhss-1713	104	10	.	.	PUNCT
ajrhss-1713	105	1	the	the	DET
ajrhss-1713	105	2	state	state	NOUN
ajrhss-1713	105	3	of	of	ADP
ajrhss-1713	105	4	the	the	DET
ajrhss-1713	105	5	blood	blood	NOUN
ajrhss-1713	105	6	coagulation	coagulation	NOUN
ajrhss-1713	105	7	and	and	CCONJ
ajrhss-1713	105	8	anticoagulation	anticoagulation	NOUN
ajrhss-1713	105	9	system	system	NOUN
ajrhss-1713	105	10	in	in	ADP
ajrhss-1713	105	11	chronic	chronic	ADJ
ajrhss-1713	105	12	pneumonia	pneumonia	NOUN
ajrhss-1713	105	13	in	in	ADP
ajrhss-1713	105	14	children	child	NOUN
ajrhss-1713	105	15	.	.	PUNCT
ajrhss-1713	106	1	moscow	moscow	PROPN
ajrhss-1713	106	2	.	.	PUNCT
ajrhss-1713	107	1	2010	2010	NUM
ajrhss-1713	107	2	.	.	PUNCT
ajrhss-1713	108	1	-60	-60	X
ajrhss-1713	109	1	p.	p.	NOUN
ajrhss-1713	109	2	2	2	NUM
ajrhss-1713	109	3	.	.	X
ajrhss-1713	109	4	working	work	VERB
ajrhss-1713	109	5	classification	classification	NOUN
ajrhss-1713	109	6	of	of	ADP
ajrhss-1713	109	7	the	the	DET
ajrhss-1713	109	8	main	main	ADJ
ajrhss-1713	109	9	forms	form	NOUN
ajrhss-1713	109	10	of	of	ADP
ajrhss-1713	109	11	bronchopulmonary	bronchopulmonary	ADJ
ajrhss-1713	109	12	diseases	disease	NOUN
ajrhss-1713	109	13	in	in	ADP
ajrhss-1713	109	14	children	child	NOUN
ajrhss-1713	109	15	/	/	SYM
ajrhss-1713	109	16	geppe	geppe	PROPN
ajrhss-1713	109	17	n.a	n.a	PROPN
ajrhss-1713	109	18	.	.	PROPN
ajrhss-1713	109	19	,	,	PUNCT
ajrhss-1713	109	20	rozinova	rozinova	X
ajrhss-1713	110	1	n.n	n.n	PROPN
ajrhss-1713	110	2	.	.	PROPN
ajrhss-1713	110	3	,	,	PUNCT
ajrhss-1713	110	4	volkova	volkova	PROPN
ajrhss-1713	110	5	i.k	i.k	PROPN
ajrhss-1713	110	6	.	.	PROPN
ajrhss-1713	111	1	[	[	X
ajrhss-1713	111	2	and	and	CCONJ
ajrhss-1713	111	3	etc	etc	X
ajrhss-1713	111	4	.	.	X
ajrhss-1713	111	5	]	]	PUNCT
ajrhss-1713	111	6	.	.	PUNCT
ajrhss-1713	112	1	moscow	moscow	PROPN
ajrhss-1713	112	2	:	:	PUNCT
ajrhss-1713	112	3	russian	russian	ADJ
ajrhss-1713	112	4	respiratory	respiratory	ADJ
ajrhss-1713	112	5	society	society	NOUN
ajrhss-1713	112	6	,	,	PUNCT
ajrhss-1713	112	7	2009	2009	NUM
ajrhss-1713	112	8	.	.	PUNCT
ajrhss-1713	113	1	18	18	NUM
ajrhss-1713	113	2	p.	p.	NOUN
ajrhss-1713	113	3	3	3	NUM
ajrhss-1713	113	4	.	.	PUNCT
ajrhss-1713	113	5	strukov	strukov	PROPN
ajrhss-1713	113	6	s.m	s.m	PROPN
ajrhss-1713	113	7	.	.	PROPN
ajrhss-1713	113	8	,	,	PUNCT
ajrhss-1713	113	9	umarova	umarova	PROPN
ajrhss-1713	113	10	b.a	b.a	PROPN
ajrhss-1713	113	11	.	.	PROPN
ajrhss-1713	113	12	violation	violation	NOUN
ajrhss-1713	113	13	of	of	ADP
ajrhss-1713	113	14	the	the	DET
ajrhss-1713	113	15	interaction	interaction	NOUN
ajrhss-1713	113	16	of	of	ADP
ajrhss-1713	113	17	thrombin	thrombin	NOUN
ajrhss-1713	113	18	and	and	CCONJ
ajrhss-1713	113	19	fibrinogen	fibrinogen	NOUN
ajrhss-1713	113	20	by	by	ADP
ajrhss-1713	113	21	heparin	heparin	NOUN
ajrhss-1713	113	22	and	and	CCONJ
ajrhss-1713	113	23	receptors	receptor	NOUN
ajrhss-1713	113	24	of	of	ADP
ajrhss-1713	113	25	the	the	DET
ajrhss-1713	113	26	anticoagulant	anticoagulant	ADJ
ajrhss-1713	113	27	system	system	NOUN
ajrhss-1713	113	28	//	//	SYM
ajrhss-1713	113	29	vopr	vopr	PROPN
ajrhss-1713	113	30	.	.	PUNCT
ajrhss-1713	114	1	honey	honey	NOUN
ajrhss-1713	114	2	.	.	PUNCT
ajrhss-1713	115	1	chemistry	chemistry	NOUN
ajrhss-1713	115	2	.	.	PUNCT
ajrhss-1713	116	1	1996	1996	NUM
ajrhss-1713	116	2	.	.	PUNCT
ajrhss-1713	117	1	issue	issue	NOUN
ajrhss-1713	117	2	.	.	PUNCT
ajrhss-1713	118	1	3	3	X
ajrhss-1713	118	2	.	.	PUNCT
ajrhss-1713	119	1	p.	p.	NOUN
ajrhss-1713	119	2	132	132	NUM
ajrhss-1713	119	3	-	-	SYM
ajrhss-1713	119	4	135	135	NUM
ajrhss-1713	119	5	.	.	PUNCT
ajrhss-1713	119	6	4	4	NUM
ajrhss-1713	119	7	.	.	X
ajrhss-1713	120	1	ibatova	ibatova	PROPN
ajrhss-1713	120	2	sh	sh	PROPN
ajrhss-1713	120	3	.	.	PROPN
ajrhss-1713	120	4	m.	m.	PROPN
ajrhss-1713	120	5	,	,	PUNCT
ajrhss-1713	120	6	mamatkulova	mamatkulova	PROPN
ajrhss-1713	120	7	f.	f.	PROPN
ajrhss-1713	120	8	kh	kh	PROPN
ajrhss-1713	120	9	.	.	PROPN
ajrhss-1713	120	10	,	,	PUNCT
ajrhss-1713	120	11	ruzikulov	ruzikulov	PROPN
ajrhss-1713	120	12	n.y	n.y	PROPN
ajrhss-1713	120	13	.	.	PUNCT
ajrhss-1713	121	1	the	the	DET
ajrhss-1713	121	2	clinical	clinical	ADJ
ajrhss-1713	121	3	picture	picture	NOUN
ajrhss-1713	121	4	of	of	ADP
ajrhss-1713	121	5	acute	acute	ADJ
ajrhss-1713	121	6	obstructive	obstructive	ADJ
ajrhss-1713	121	7	bronchitis	bronchitis	ADV
ajrhss-1713	121	8	in	in	ADP
ajrhss-1713	121	9	children	child	NOUN
ajrhss-1713	121	10	and	and	CCONJ
ajrhss-1713	121	11	the	the	DET
ajrhss-1713	121	12	rationale	rationale	NOUN
ajrhss-1713	121	13	for	for	ADP
ajrhss-1713	121	14	immunomodulatory	immunomodulatory	ADJ
ajrhss-1713	121	15	therapy	therapy	NOUN
ajrhss-1713	121	16	.	.	PUNCT
ajrhss-1713	122	1	international	international	ADJ
ajrhss-1713	122	2	journal	journal	PROPN
ajrhss-1713	122	3	of	of	ADP
ajrhss-1713	122	4	current	current	ADJ
ajrhss-1713	122	5	research	research	NOUN
ajrhss-1713	122	6	and	and	CCONJ
ajrhss-1713	122	7	review	review	NOUN
ajrhss-1713	122	8	.	.	PUNCT
ajrhss-1713	123	1	vol	vol	NOUN
ajrhss-1713	123	2	12	12	NUM
ajrhss-1713	123	3	issue	issue	NOUN
ajrhss-1713	123	4	17	17	NUM
ajrhss-1713	123	5	.	.	PUNCT
ajrhss-1713	124	1	september	september	PROPN
ajrhss-1713	124	2	2020	2020	NUM
ajrhss-1713	124	3	.	.	PUNCT
ajrhss-1713	125	1	p.152	p.152	PROPN
ajrhss-1713	125	2	-	-	PUNCT
ajrhss-1713	125	3	155	155	NUM
ajrhss-1713	125	4	.	.	NOUN
ajrhss-1713	126	1	5	5	NUM
ajrhss-1713	126	2	.	.	X
ajrhss-1713	126	3	ibatova	ibatova	PROPN
ajrhss-1713	126	4	sh	sh	PROPN
ajrhss-1713	126	5	.	.	PROPN
ajrhss-1713	126	6	m.	m.	PROPN
ajrhss-1713	126	7	,	,	PUNCT
ajrhss-1713	127	1	f.	f.	PROPN
ajrhss-1713	127	2	kh	kh	PROPN
ajrhss-1713	127	3	.	.	PROPN
ajrhss-1713	127	4	mamatkulova	mamatkulova	PROPN
ajrhss-1713	127	5	,	,	PUNCT
ajrhss-1713	127	6	n.	n.	PROPN
ajrhss-1713	127	7	b.	b.	PROPN
ajrhss-1713	128	1	abdukadirova	abdukadirova	PROPN
ajrhss-1713	128	2	,	,	PUNCT
ajrhss-1713	128	3	yu	yu	PROPN
ajrhss-1713	128	4	.	.	PUNCT
ajrhss-1713	128	5	a.	a.	NOUN
ajrhss-1713	128	6	rakhmonov	rakhmonov	PROPN
ajrhss-1713	128	7	,	,	PUNCT
ajrhss-1713	128	8	m.	m.	NOUN
ajrhss-1713	128	9	m.	m.	PROPN
ajrhss-1713	128	10	kodirova	kodirova	PROPN
ajrhss-1713	128	11	.	.	PUNCT
ajrhss-1713	129	1	risk	risk	NOUN
ajrhss-1713	129	2	factors	factor	NOUN
ajrhss-1713	129	3	for	for	ADP
ajrhss-1713	129	4	development	development	NOUN
ajrhss-1713	129	5	of	of	ADP
ajrhss-1713	129	6	broncho	broncho	ADJ
ajrhss-1713	129	7	-	-	PUNCT
ajrhss-1713	129	8	ostructive	ostructive	ADJ
ajrhss-1713	129	9	syndrome	syndrome	NOUN
ajrhss-1713	129	10	in	in	ADP
ajrhss-1713	129	11	children	child	NOUN
ajrhss-1713	129	12	.	.	PUNCT
ajrhss-1713	130	1	international	international	ADJ
ajrhss-1713	130	2	journal	journal	NOUN
ajrhss-1713	130	3	of	of	ADP
ajrhss-1713	130	4	current	current	ADJ
ajrhss-1713	130	5	research	research	NOUN
ajrhss-1713	130	6	and	and	CCONJ
ajrhss-1713	130	7	review	review	NOUN
ajrhss-1713	130	8	.	.	PUNCT
ajrhss-1713	131	1	vol	vol	NOUN
ajrhss-1713	131	2	12	12	NUM
ajrhss-1713	131	3	.	.	PUNCT
ajrhss-1713	132	1	issue	issue	NOUN
ajrhss-1713	132	2	23	23	NUM
ajrhss-1713	132	3	december	december	PROPN
ajrhss-1713	132	4	2020.-p	2020.-p	NUM
ajrhss-1713	132	5	.	.	PUNCT
ajrhss-1713	133	1	3	3	NUM
ajrhss-1713	133	2	-	-	SYM
ajrhss-1713	133	3	6	6	NUM
ajrhss-1713	133	4	.	.	NOUN
ajrhss-1713	133	5	6	6	NUM
ajrhss-1713	133	6	.	.	X
ajrhss-1713	133	7	ibatova	ibatova	PROPN
ajrhss-1713	133	8	sh.m	sh.m	PROPN
ajrhss-1713	133	9	.	.	PROPN
ajrhss-1713	133	10	,	,	PUNCT
ajrhss-1713	133	11	baratova	baratova	PROPN
ajrhss-1713	134	1	r.sh	r.sh	VERB
ajrhss-1713	134	2	.	.	PROPN
ajrhss-1713	134	3	,	,	PUNCT
ajrhss-1713	134	4	mamatkulova	mamatkulova	PROPN
ajrhss-1713	134	5	f.kh	f.kh	PROPN
ajrhss-1713	134	6	.	.	PROPN
ajrhss-1713	134	7	,	,	PUNCT
ajrhss-1713	134	8	ergashev	ergashev	PROPN
ajrhss-1713	134	9	a.kh	a.kh	PROPN
ajrhss-1713	134	10	.	.	PROPN
ajrhss-1713	134	11	state	state	NOUN
ajrhss-1713	134	12	of	of	ADP
ajrhss-1713	134	13	immunity	immunity	NOUN
ajrhss-1713	134	14	in	in	ADP
ajrhss-1713	134	15	chronic	chronic	ADJ
ajrhss-1713	134	16	obstructive	obstructive	ADJ
ajrhss-1713	134	17	pulmonary	pulmonary	ADJ
ajrhss-1713	134	18	disease	disease	NOUN
ajrhss-1713	134	19	in	in	ADP
ajrhss-1713	134	20	children	child	NOUN
ajrhss-1713	134	21	.	.	PUNCT
ajrhss-1713	135	1	asian	asian	ADJ
ajrhss-1713	135	2	journal	journal	PROPN
ajrhss-1713	135	3	of	of	ADP
ajrhss-1713	135	4	multidimensional	multidimensional	ADJ
ajrhss-1713	135	5	research	research	NOUN
ajrhss-1713	135	6	(	(	PUNCT
ajrhss-1713	135	7	ajmr	ajmr	NOUN
ajrhss-1713	135	8	)	)	PUNCT
ajrhss-1713	135	9	.	.	PUNCT
ajrhss-1713	136	1	vol	vol	NOUN
ajrhss-1713	136	2	10	10	NUM
ajrhss-1713	136	3	,	,	PUNCT
ajrhss-1713	136	4	issue	issue	NOUN
ajrhss-1713	136	5	3	3	NUM
ajrhss-1713	136	6	,	,	PUNCT
ajrhss-1713	136	7	march	march	NOUN
ajrhss-1713	136	8	,	,	PUNCT
ajrhss-1713	136	9	2021	2021	NUM
ajrhss-1713	136	10	.	.	PUNCT
ajrhss-1713	137	1	p.	p.	NOUN
ajrhss-1713	137	2	132	132	NUM
ajrhss-1713	137	3	-	-	SYM
ajrhss-1713	137	4	136	136	NUM
ajrhss-1713	137	5	.	.	PUNCT
ajrhss-1713	138	1	7	7	X
ajrhss-1713	138	2	.	.	X
ajrhss-1713	138	3	ibatova	ibatova	PROPN
ajrhss-1713	138	4	sh.m	sh.m	PROPN
ajrhss-1713	138	5	.	.	PROPN
ajrhss-1713	138	6	,	,	PUNCT
ajrhss-1713	138	7	baratova	baratova	PROPN
ajrhss-1713	139	1	r.sh	r.sh	VERB
ajrhss-1713	139	2	.	.	PROPN
ajrhss-1713	139	3	,	,	PUNCT
ajrhss-1713	139	4	mamatkulova	mamatkulova	PROPN
ajrhss-1713	139	5	f.kh	f.kh	PROPN
ajrhss-1713	139	6	.	.	PROPN
ajrhss-1713	139	7	,	,	PUNCT
ajrhss-1713	139	8	ergashev	ergashev	PROPN
ajrhss-1713	139	9	a.kh	a.kh	PROPN
ajrhss-1713	139	10	.	.	PROPN
ajrhss-1713	139	11	state	state	NOUN
ajrhss-1713	139	12	of	of	ADP
ajrhss-1713	139	13	immunity	immunity	NOUN
ajrhss-1713	139	14	in	in	ADP
ajrhss-1713	139	15	chronic	chronic	ADJ
ajrhss-1713	139	16	obstructive	obstructive	ADJ
ajrhss-1713	139	17	pulmonary	pulmonary	ADJ
ajrhss-1713	139	18	disease	disease	NOUN
ajrhss-1713	139	19	in	in	ADP
ajrhss-1713	139	20	children	child	NOUN
ajrhss-1713	139	21	.	.	PUNCT
ajrhss-1713	140	1	asian	asian	ADJ
ajrhss-1713	140	2	journal	journal	PROPN
ajrhss-1713	140	3	of	of	ADP
ajrhss-1713	140	4	multidimensional	multidimensional	ADJ
ajrhss-1713	140	5	research	research	NOUN
ajrhss-1713	140	6	(	(	PUNCT
ajrhss-1713	140	7	ajmr	ajmr	NOUN
ajrhss-1713	140	8	)	)	PUNCT
ajrhss-1713	140	9	.	.	PUNCT
ajrhss-1713	141	1	vol.10	vol.10	NOUN
ajrhss-1713	141	2	,	,	PUNCT
ajrhss-1713	141	3	issue	issue	NOUN
ajrhss-1713	141	4	3	3	NUM
ajrhss-1713	141	5	,	,	PUNCT
ajrhss-1713	141	6	march	march	NOUN
ajrhss-1713	141	7	,	,	PUNCT
ajrhss-1713	141	8	2021	2021	NUM
ajrhss-1713	141	9	.	.	PUNCT
ajrhss-1713	142	1	p.	p.	NOUN
ajrhss-1713	142	2	132	132	NUM
ajrhss-1713	142	3	-	-	SYM
ajrhss-1713	142	4	136	136	NUM
ajrhss-1713	142	5	.	.	PUNCT
ajrhss-1713	142	6	8	8	NUM
ajrhss-1713	142	7	.	.	PUNCT
ajrhss-1713	142	8	sh.m	sh.m	PROPN
ajrhss-1713	142	9	.	.	PUNCT
ajrhss-1713	143	1	ibatova	ibatova	PROPN
ajrhss-1713	143	2	,	,	PUNCT
ajrhss-1713	143	3	f.kh	f.kh	PROPN
ajrhss-1713	143	4	.	.	PROPN
ajrhss-1713	143	5	mamatkulova	mamatkulova	PROPN
ajrhss-1713	143	6	,	,	PUNCT
ajrhss-1713	143	7	n.y	n.y	PROPN
ajrhss-1713	143	8	.	.	PROPN
ajrhss-1713	143	9	ruzikulov	ruzikulov	PROPN
ajrhss-1713	143	10	,	,	PUNCT
ajrhss-1713	143	11	yu.a	yu.a	PROPN
ajrhss-1713	143	12	.	.	PUNCT
ajrhss-1713	144	1	rakhmonov	rakhmonov	PROPN
ajrhss-1713	144	2	.	.	PROPN
ajrhss-1713	145	1	bronchoo	bronchoo	PROPN
ajrhss-1713	145	2	structive	structive	ADJ
ajrhss-1713	145	3	syndrome	syndrome	NOUN
ajrhss-1713	145	4	in	in	ADP
ajrhss-1713	145	5	children	child	NOUN
ajrhss-1713	145	6	:	:	PUNCT
ajrhss-1713	145	7	prevalence	prevalence	NOUN
ajrhss-1713	145	8	and	and	CCONJ
ajrhss-1713	145	9	difficulties	difficulty	NOUN
ajrhss-1713	145	10	of	of	ADP
ajrhss-1713	145	11	differential	differential	ADJ
ajrhss-1713	145	12	diagnostics	diagnostic	NOUN
ajrhss-1713	145	13	.	.	PUNCT
ajrhss-1713	146	1	academicia	academicia	NOUN
ajrhss-1713	146	2	:	:	PUNCT
ajrhss-1713	146	3	an	an	DET
ajrhss-1713	146	4	international	international	ADJ
ajrhss-1713	146	5	multidisciplinary	multidisciplinary	ADJ
ajrhss-1713	146	6	research	research	NOUN
ajrhss-1713	146	7	journal	journal	NOUN
ajrhss-1713	146	8	2021	2021	NUM
ajrhss-1713	146	9	,	,	PUNCT
ajrhss-1713	146	10	p.	p.	NOUN
ajrhss-1713	146	11	87	87	NUM
ajrhss-1713	146	12	-	-	SYM
ajrhss-1713	146	13	92	92	NUM
ajrhss-1713	146	14	.	.	PUNCT
ajrhss-1713	147	1	9	9	X
ajrhss-1713	147	2	.	.	X
ajrhss-1713	147	3	ibatova	ibatova	PROPN
ajrhss-1713	147	4	sh	sh	PROPN
ajrhss-1713	147	5	.	.	PROPN
ajrhss-1713	147	6	m.	m.	PROPN
ajrhss-1713	147	7	,	,	PUNCT
ajrhss-1713	147	8	abdurasulov	abdurasulov	PROPN
ajrhss-1713	147	9	f.p	f.p	PROPN
ajrhss-1713	147	10	.	.	PROPN
ajrhss-1713	147	11	,	,	PUNCT
ajrhss-1713	147	12	mamutova	mamutova	PROPN
ajrhss-1713	147	13	e.s	e.s	PROPN
ajrhss-1713	147	14	.	.	PROPN
ajrhss-1713	148	1	some	some	DET
ajrhss-1713	148	2	aspects	aspect	NOUN
ajrhss-1713	148	3	of	of	ADP
ajrhss-1713	148	4	diagnostics	diagnostic	NOUN
ajrhss-1713	148	5	of	of	ADP
ajrhss-1713	148	6	out	out	ADV
ajrhss-1713	148	7	-	-	PUNCT
ajrhss-1713	148	8	of	of	ADP
ajrhss-1713	148	9	-	-	PUNCT
ajrhss-1713	148	10	social	social	ADJ
ajrhss-1713	148	11	pneumonia	pneumonia	NOUN
ajrhss-1713	148	12	in	in	ADP
ajrhss-1713	148	13	children	child	NOUN
ajrhss-1713	148	14	indications	indication	NOUN
ajrhss-1713	148	15	for	for	ADP
ajrhss-1713	148	16	hospitalization	hospitalization	NOUN
ajrhss-1713	148	17	.	.	PUNCT
ajrhss-1713	149	1	epra	epra	PROPN
ajrhss-1713	149	2	international	international	PROPN
ajrhss-1713	149	3	journal	journal	PROPN
ajrhss-1713	149	4	of	of	ADP
ajrhss-1713	149	5	research	research	NOUN
ajrhss-1713	149	6	and	and	CCONJ
ajrhss-1713	149	7	development	development	NOUN
ajrhss-1713	149	8	(	(	PUNCT
ajrhss-1713	149	9	ijrd	ijrd	PROPN
ajrhss-1713	149	10	)	)	PUNCT
ajrhss-1713	149	11	volume	volume	NOUN
ajrhss-1713	149	12	:	:	PUNCT
ajrhss-1713	149	13	6	6	NUM
ajrhss-1713	149	14	|	|	NOUN
ajrhss-1713	149	15	issue	issue	NOUN
ajrhss-1713	149	16	:	:	PUNCT
ajrhss-1713	149	17	4	4	NUM
ajrhss-1713	149	18	|	|	ADV
ajrhss-1713	149	19	april	april	PROPN
ajrhss-1713	149	20	2021	2021	NUM
ajrhss-1713	149	21	.	.	PUNCT
ajrhss-1713	150	1	p.	p.	NOUN
ajrhss-1713	150	2	242	242	NUM
ajrhss-1713	150	3	-	-	SYM
ajrhss-1713	150	4	244	244	NUM
ajrhss-1713	150	5	.	.	PUNCT
ajrhss-1713	151	1	american	american	PROPN
ajrhss-1713	151	2	journal	journal	PROPN
ajrhss-1713	151	3	of	of	ADP
ajrhss-1713	151	4	research	research	NOUN
ajrhss-1713	151	5	in	in	ADP
ajrhss-1713	151	6	humanities	humanity	NOUN
ajrhss-1713	151	7	and	and	CCONJ
ajrhss-1713	151	8	social	social	ADJ
ajrhss-1713	151	9	sciences	science	NOUN
ajrhss-1713	151	10	volume	volume	NOUN
ajrhss-1713	151	11	20	20	NUM
ajrhss-1713	151	12	january	january	PROPN
ajrhss-1713	151	13	,	,	PUNCT
ajrhss-1713	151	14	2024	2024	NUM
ajrhss-1713	151	15	p	p	NOUN
ajrhss-1713	151	16	a	a	DET
ajrhss-1713	151	17	g	g	NOUN
ajrhss-1713	151	18	e	e	NOUN
ajrhss-1713	151	19	|	|	ADV
ajrhss-1713	151	20	7	7	NUM
ajrhss-1713	151	21	www.americanjournal.org	www.americanjournal.org	NOUN
ajrhss-1713	151	22	10	10	NUM
ajrhss-1713	151	23	.	.	PUNCT
ajrhss-1713	152	1	ibatova	ibatova	PROPN
ajrhss-1713	152	2	sh.m	sh.m	PROPN
ajrhss-1713	152	3	.	.	PROPN
ajrhss-1713	152	4	,	,	PUNCT
ajrhss-1713	152	5	mamatkulova	mamatkulova	PROPN
ajrhss-1713	152	6	f.kh	f.kh	PROPN
ajrhss-1713	152	7	.	.	PROPN
ajrhss-1713	152	8	,	,	PUNCT
ajrhss-1713	152	9	mukhamadiev	mukhamadiev	ADP
ajrhss-1713	152	10	n.k.state	n.k.state	NOUN
ajrhss-1713	152	11	of	of	ADP
ajrhss-1713	152	12	immunity	immunity	NOUN
ajrhss-1713	152	13	in	in	ADP
ajrhss-1713	152	14	chronic	chronic	ADJ
ajrhss-1713	152	15	obstructive	obstructive	ADJ
ajrhss-1713	152	16	pulmonary	pulmonary	ADJ
ajrhss-1713	152	17	disease	disease	NOUN
ajrhss-1713	152	18	in	in	ADP
ajrhss-1713	152	19	children	child	NOUN
ajrhss-1713	152	20	.	.	PUNCT
ajrhss-1713	153	1	central	central	ADJ
ajrhss-1713	153	2	asian	asian	ADJ
ajrhss-1713	153	3	journal	journal	NOUN
ajrhss-1713	153	4	of	of	ADP
ajrhss-1713	153	5	medical	medical	ADJ
ajrhss-1713	153	6	and	and	CCONJ
ajrhss-1713	153	7	natural	natural	ADJ
ajrhss-1713	153	8	sciences	science	NOUN
ajrhss-1713	153	9	volume	volume	NOUN
ajrhss-1713	153	10	:	:	PUNCT
ajrhss-1713	153	11	02	02	NUM
ajrhss-1713	153	12	issue	issue	NOUN
ajrhss-1713	153	13	:	:	PUNCT
ajrhss-1713	153	14	05	05	NUM
ajrhss-1713	154	1	|	|	ADV
ajrhss-1713	154	2	sep	sep	PROPN
ajrhss-1713	154	3	-	-	PUNCT
ajrhss-1713	154	4	oct	oct	PROPN
ajrhss-1713	154	5	2021	2021	NUM
ajrhss-1713	154	6	issn	issn	PROPN
ajrhss-1713	154	7	:	:	PUNCT
ajrhss-1713	154	8	2660	2660	NUM
ajrhss-1713	154	9	-	-	SYM
ajrhss-1713	154	10	4159	4159	NUM
ajrhss-1713	154	11	.	.	PUNCT
ajrhss-1713	155	1	p.	p.	NOUN
ajrhss-1713	155	2	103	103	NUM
ajrhss-1713	155	3	-	-	SYM
ajrhss-1713	155	4	107	107	NUM
ajrhss-1713	155	5	.	.	PUNCT
ajrhss-1713	155	6	11	11	NUM
ajrhss-1713	155	7	.	.	PUNCT
ajrhss-1713	156	1	ibatova	ibatova	PROPN
ajrhss-1713	156	2	sh.m	sh.m	PROPN
ajrhss-1713	156	3	.	.	PROPN
ajrhss-1713	156	4	,	,	PUNCT
ajrhss-1713	156	5	muhamadiev	muhamadiev	PROPN
ajrhss-1713	156	6	n.q	n.q	PROPN
ajrhss-1713	156	7	.	.	PROPN
ajrhss-1713	156	8	efficiency	efficiency	NOUN
ajrhss-1713	156	9	of	of	ADP
ajrhss-1713	156	10	immunomodulating	immunomodulate	VERB
ajrhss-1713	156	11	therapy	therapy	NOUN
ajrhss-1713	156	12	in	in	ADP
ajrhss-1713	156	13	acute	acute	ADJ
ajrhss-1713	156	14	obstructive	obstructive	ADJ
ajrhss-1713	156	15	bronchitis	bronchitis	ADV
ajrhss-1713	156	16	in	in	ADP
ajrhss-1713	156	17	children	child	NOUN
ajrhss-1713	156	18	.	.	PUNCT
ajrhss-1713	157	1	central	central	ADJ
ajrhss-1713	157	2	asian	asian	ADJ
ajrhss-1713	157	3	journal	journal	NOUN
ajrhss-1713	157	4	of	of	ADP
ajrhss-1713	157	5	medical	medical	ADJ
ajrhss-1713	157	6	and	and	CCONJ
ajrhss-1713	157	7	natural	natural	ADJ
ajrhss-1713	157	8	sciences	science	NOUN
ajrhss-1713	157	9	.	.	PUNCT
ajrhss-1713	158	1	volume	volume	NOUN
ajrhss-1713	158	2	:	:	PUNCT
ajrhss-1713	158	3	02	02	NUM
ajrhss-1713	158	4	issue	issue	NOUN
ajrhss-1713	158	5	:	:	PUNCT
ajrhss-1713	158	6	02	02	NUM
ajrhss-1713	158	7	|	|	ADJ
ajrhss-1713	158	8	march	march	NOUN
ajrhss-1713	158	9	-	-	PUNCT
ajrhss-1713	158	10	april	april	PROPN
ajrhss-1713	158	11	2021	2021	NUM
ajrhss-1713	158	12	issn	issn	PROPN
ajrhss-1713	158	13	:	:	PUNCT
ajrhss-1713	158	14	2660	2660	NUM
ajrhss-1713	158	15	-	-	SYM
ajrhss-1713	158	16	4159	4159	NUM
ajrhss-1713	158	17	.	.	PUNCT
ajrhss-1713	159	1	p.	p.	NOUN
ajrhss-1713	159	2	210	210	NUM
ajrhss-1713	159	3	-	-	SYM
ajrhss-1713	159	4	213	213	NUM
ajrhss-1713	159	5	.	.	PUNCT